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Thesis Summary 
 
There is increasing emphasis on microbiota-based strategies for treating disorders of 
the brain-gut axis. Probiotics are microorganisms which, when given in adequate 
amounts, can confer health benefits upon the host (Fontana et al., 2013). In this 
thesis I focus on the local effects of probiotics and germ free status on intestinal ion 
transport. I first examined the influence of two different probiotic strains 
Bifidobacterium infantis  35624 and L. salivarius UCC118 on active colonic ion 
transport in the mouse (Chapter 2). Importantly, I use the Ussing Chamber to 
examine and compare tissues, exposed chronically to these probiotics following in-
vivo feeding for two weeks, and acutely following direct addition during ex-vivo 
experimentation. This permitted examination of the translational value of acute ex-
vivo Ussing Chamber studies to in-vivo studies, thus determining the validity of the 
Ussing Chamber as a screening tool for potential probiotics. Furthermore, in addition 
to Ussing Chamber experiments, both in-vivo functional and molecular experiments 
were carried out following the two week feeding period, which provided information 
on the functional impact of the individual probiotic strains.  
 Next I examined the impact of the host microbiota itself on both baseline and 
stimulated colonic secretomotor function as well as probiotic induced changes in ion 
transport (Chapter 3). The Ussing Chamber was again used to examine segments of 
distal colon from both germ free and conventional mice, thus facilitating assessment 
of  the impact of the host microbiota on secretomotor function in the mouse. 
Understanding the host-microbiota's role in the mouse is critical to truly appreciating 
the impact of host-microbe relationships on intestinal ion transport in this species. 
Moreover, taking into consideration the detailed characterisation of probiotic 
xi 
induced changes in ion transport carried out in the previous chapter, the same 
probiotics were also tested in this study to determine whether the presence or 
absence of the host microbiota influenced responses to these microbes.  
 Finally, it has been well documented that many probiotics elicit their effects 
via secreted bioactives, however, identifying these bioactives has become a major 
limitation of many probiotic studies (Sánchez et al., 2010). Therefore, I studied the 
ex-vivo effects of an exogenous neuroactive compound, GABA, on murine colonic 
secretomotor and compared these with microbially produced GABA contained in 
supernatants from the probiotic Lactobacillus brevis DPC6108. This approach not 
only allowed for novel insight into GABAergic regulation of murine colonic 
secretomotor function, but more importantly, in the context of this thesis, allowed for 
the determination of probiotics as putative producers of bioactives with known 
ability to modulate intestinal secretomotor function. Furthermore, from a 
methodological point of view, this chapter allows for the validation of a new 
approach for screening potential probiotics and their bioactives.  
Taken together I conclude that commensal microbes have an important and strain 
specific functional influence on colonic ion transport and secretomotor function and 
these effects can be mediated via extracellular bioactives. Moreover, I believe that 
functional ex-vivo studies such as those carried out in this thesis have a critical role 
to play in our future understanding of host-microbe interactions in the gut. 
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Chapter 1: 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
2 
1.1 Summary of Intestinal Ion Transport:  Absorption and 
Secretion  
 
 The mammalian intestine contains a diverse array of electrolyte transporters 
upon which fluid transport depends. Ion channels and transporters allow for the 
establishment of electrical gradients which contribute to the movement of water 
across the intestinal wall (Kunzelmann and Mall, 2002). The intestinal epithelium is 
primarily absorptive, and the uptake of fluid is dependent on the absorption of 
solutes, in particular Na
+ 
and Cl
-
 (Figure 1.1). Na
+
 absorption is mediated mainly 
through electroneutral ion exchangers. Three Na
+
/H
+
 exchangers (NHE) are 
expressed to various degrees along the intestine (Gawenis et al., 2002). NHE1 is 
located basolaterally and is considered a housekeeping transporter, regulating 
intracellular pH and cell volume. In keeping with such a role, NHE1 knockout mice 
display altered intracellular pH in pancreatic acinar cells; however they do not 
display any major changes in NaCl transport (Brown et al., 2003). In contrast to the 
basolateral expression pattern of NHE1, NHE2 and NHE3 are in general expressed 
on the apical side of epithelial cells, and are found in both the small and large 
intestine (Gawenis et al., 2010) (Figure 1.1). Absence of NHE3 in mutant mice 
results in severe and chronic diarrhea, thereby suggesting that this exchanger plays a 
significant absorptive role in mouse intestine (Schultheis et al., 1998).  
Electrogenic Na
+
 absorption on the other hand occurs primarily in the colon by 
amiloride-sensitive epithelial Na
+
 channels (ENaC) located on the apical membrane 
of intestinal epithelia. ENaC is the major active ion channel for Na
+
 reabsorption, 
and has been shown to compensate for electrolyte loss associated with diarrhoea in 
NHE3 knockout mice (Schultheis et al., 1998). 
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With respect to Cl
-
 ion transport, electroneutral Cl
-
 absorption is primarily facilitated 
by two well characterised anion exchangers, down regulated in adenoma (DRA) and 
putative anion transporter-1 (PAT-1), both demonstrated to be Cl
-
/HCO3
-
 exchangers 
(Jacob et al., 2002; Simpson et al., 2007). DRA and PAT-1 are expressed apically, 
and are present in both the small intestine and colon (Wang et al., 2002). However, 
DRA appears to have higher expression in the colonic epithelium compared to the 
small intestine, while PAT-1 displays an opposite pattern of expression (Wang et al., 
2002). This would suggest that PAT-1 is more important for Cl
-
/HCO3
-
 exchange in 
the upper GI tract, while DRA is favoured in the colon (Wang et al., 2002). The 
clinical significance of DRA is highlighted by its absence, which is associated with a 
rare form of congenital Cl
-
 secretory diarrhoea (Höglund et al., 1996). Moreover, Cl
-
 
absorption, at least via PAT-1, is dependent on NHE3 Na
+ 
absorption (Singh et al., 
2010). 
Absorption of ions also occurs by nutrient-coupled transporters, for example the 
sodium glucose transporter 1 (SGLT1), primarily responsible for electrogenic Na
+
 
absorption  in the small intestine, and the short chain fatty acid (SCFA) transporter, 
SCFA/HCO3
-
 (Bachmann and Seidler, 2011).
 
SCFAs are the chief energy source for 
colonocytes and their production is dependent on host bacterial fermentation of 
carbohydrates or dietary fibre.  SCFAs stimulate HCO3
- 
secretion via SCFA/HCO3
-
 
anti-porters (Vidyasagar et al., 2005). However, they also inhibit Cl
-
- and cyclic 
adenosine monophosphate (cAMP)-dependent HCO3
- 
secretion (Vidyasagar et al., 
4 
2004). Colonic Na
+ 
absorption and Cl
-
 secretion are also influenced by 
 
Figure 1.1 Na
+
/H
+
 cation exchangers (NHE) 2/3 in addition to down-regulated in 
adenoma  (DRA) and putative anion transporter-1(PAT-1) anion exchangers import 
sodium (Na
+
)
 
and chloride (Cl
-
) across the apical membrane into intestinal epithelial 
cells while exporting a proton  (H
+
) and bicarbonate (HCO3
-
) . Basolateral NK-
ATPase and NHE-1 provides a gradient for the basolateral exit of ions and 
subsequent transport of water across the intestinal wall (left side, absorption). 
Chloride is pumped into the cell via the Na2ClK symporter the gradient for which is 
provided by the active basolateral NK-ATPase anti-porter which also recycles 
sodium out of the cell. Basolateral potassium channels recycle potassium (K
+
) out of 
the cell causing a negative intracellular charge and thus a drive toward apical exit 
through cAMP/cGMP activated cystic fibrosis transmembrane conductance regulator 
(CFTR) or calcium activated chloride channes (CaCC) (right side, secretion). (From 
(Lomasney and Hyland, 2013)). 
 
SCFAs which promote the expression of both NHE3 (Kiela et al., 2007) and ENaC 
(Zeissig et al., 2007) by intestinal epithelial cells, in addition to inhibiting cAMP- 
and cyclic guanosine monophosphate (cGMP)-mediated secretion (Vidyasagar et al., 
2005). Collectively these studies suggest a primarily pro-absorptive role for SCFAs 
in the regulation of colonic fluid and electrolyte transport.  
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 Though the intestine is considered primarily an absorptive organ, fluid 
secretion is pivotal to its proper physiological function, for example by facilitating 
passage of fecal content. Unlike fluid absorption however, secretion is primarily 
active, driven mainly by changes in intracellular Cl
-
 ion gradients and is regulated by 
apical ion channels and the activity of several basolateral transporters (Barrett and 
Keely, 2000). In brief, Cl
-
 is taken up by the basolateral sodium potassium chloride 
(NKCC1) symporter, considered a secondary active transporter, as the drive for Cl
-
 
uptake is provided by the primary active transporter, NaKATPase located on the 
basolateral side of intestinal epithelia. The low concentration of intracellular Na
+ 
creates a net electronegative environment within the cell producing a driving force 
for Cl
-
 extrusion through the apical membrane (Figure 1.1) (Barrett and Keely, 
2000). 
In addition to Cl
-
 secretion, secretion of HCO3
-
 occurs primarily by Cl
-
 and cAMP-
dependent pathways, SCFA/ HCO3
-
 electroneutral transporters as well as through 
DRA and PAT-1 (Binder et al., 2005). SCFAs also influence HCO3
- 
transport by 
inhibiting activation of both cAMP- and Cl
-
-dependent HCO3
- 
secretion (Vidyasagar 
et al., 2005), further supporting a pro-absorptive role for SCFAs. 
1.2 Pharmacological secretagogues for the study of ion 
transport 
 
 The classic approach to investigating intestinal ion transport processes 
involves the use of specific pharmacological ligands with the ability to target and 
modulate ion channels, exchangers or effecter molecules of interest.  
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1.2.1 Forskolin and cAMP induced ion transport 
 
 As previously mentioned, the second messenger cAMP is the primary driver 
of electrogenic ion and fluid secretion in the intestinal epithelium, mainly through 
increasing the activity of chloride secretion through apical CFTR channels (Barrett 
and Keely, 2000). Indeed, as will be discussed later, severe diarrhoea following 
enteric infection with several pathogens including Vibrio cholera and 
Enteropathogenic Escherichia coli is vastly dependant on toxin induced increases in 
the levels of intracellular cAMP (Field, 2003) Therefore compounds that mimic such 
an effect are very useful in studying the ability of novel therapeutics to modulate 
active ion secretion in intestinal epithelia. Moreover, in the context of host-microbe 
interactions, such compounds would be useful for studying the therapeutic potential 
of probiotics for the treatment of pathogen-induced diarrhoea (Lomasney and 
Hyland, 2013) where there is an enormous unmet medical need especially in the 
developing and third world (Cheng et al., 2005).  
 Forskolin is one such compound and has been widely used, along with its 
derivatives for studying the role of cAMP in a variety of mammalian tissues and cell 
types including the intestine and intestinal epithelial cells (Alasbahi and Melzig, 
2012). The compound itself is a labdane diterpenoid isolated from the roots of the 
Indian Plectranthus barbatus plant, also known as Coleus forskolii (Alasbahi and 
Melzig, 2012). It acts at an intracellular level to increase the activity of adenylyl 
cyclase (AC), the key enzyme responsible for catalyzing the conversion of adenosine 
triphosphate (ATP) to cAMP and pyrophosphate, thus increasing intracellular levels 
of cAMP (Sassone-corsi, 2012). There are at least 9 known isoforms of AC 
distributed throughout the body, of which forskolin is known to activate all but one 
7 
thus making it a relatively non-selective but useful tool for studying the role cAMP 
(Alasbahi and Melzig, 2012). cAMP has many downstream effecter molecules, 
however protein kinase A (PKA) is probably the most understood and relevant to 
intestinal ion transport. cAMP binds to the regulatory subunits of PKA causing its 
catalytic subunits to dissociate and mediate further effects down-stream (Sassone-
corsi, 2012) 
 With regard to ion transport PKA phosphorylates apical CFTR and 
basolateral NKCC1 resulting in sustained trans-cellular efflux of chloride and water 
into the lumen (Figure 1.2). Moreover, to facilitate a sustained secretion, cAMP can 
also stimulate further recruitment of both CFTR and NKCC1 to the apical and 
basolateral membranes respectively resulting in increased channel density (Barrett 
and Keely, 2000). Basolateral potassium secretion via the voltage gated KV7.1 
channels is also activated which provides an essential driving force for apical 
chloride efflux (Matos et al., 2007). Finally, in addition to stimulating secretory 
activity in epithelial cells, cAMP also inhibits absorption, specifically via PKA 
induced phosphorylation of NHE2/3 regulatory proteins (Yun et al., 1997). 
1.2.2 Bethanechol as a cholinergic agonist and Ca2+ mediated ion transport. 
 
 Bethanechol chloride also known as Carbamyl-β-methylcholine chloride is a 
synthetic ester which is structurally and pharmacologically related to acetylcholine 
but is resistant to degradation by acetylcholine esterase. It is a selective M3 
muscarinic acetylcholine (mACh) receptor agonist although it may also act on M1 
receptors (Hirota and McKay, 2006b). This compound, along with its less selective 
mACh receptor agonist carbachol, have been widely used to investigate cholinergic 
induced intestinal epithelial ion transport in a number of species including mouse 
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(Hirota and McKay, 2006). Both M1 and M3 mACh receptors are Gq protein coupled 
receptors which stimulate phospholipase C (PLC) leading to degradation of 
phosphatidylinositol 4-5 bisphosphate (PIP2) into diacylglycerol (DAG) and inositol 
1,4,5 triphosphate (IP3) which stimulate the release of intracellular Ca
2+
 stores from 
the endoplasmic reticulum (Figure 1.2) (van Koppen and Kaiser, 2003). It is this 
release of Ca
2+
 which mediates bethanechol-induced ion transport in intestinal 
epithelium in the form of Cl
-
 secretion. Similar to cAMP-induced Cl
-
 secretion, Ca
2+ 
activates basolateral K
+
 channels which provide a driving force for apical Cl
-
 efflux 
via Ca
2+
 activated Cl
-
 channels (CaCC). In the mouse colon in particular, Ca
2+
 
induced basolateral K
+
 efflux can occur via both a Ca
2+
 activated small conductance 
K
+
 channel (KCa3.1), but also via the chromanol 293b sensitive voltage gated K
+
 
channels (KV7.1) (Hirota et al., 2006). Ca
2+
 activated K
+
 channels also exist in the 
apical membrane of mouse colonic epithelial cells (KCa1.1), however these do not 
appear to be required for cholinergic induced Cl
-
 secretion but may allow for 
electroneutral secretion of KCl into the lumen (Hirota et al., 2006).  
 Finally, bethanechol induced chloride secretion is relatively transient in 
comparison to cAMP induced ion transport. This is likely due to the increase in both 
PKC which is activated by DAG  and the IP3 derivative  inositol 3,4,5,6-
tetrakisphosphate (IP4) which downregulate Ca
2+ 
activated
 
basolateral K
+
 channels 
and apical CaCC activity respectively (Hirota and McKay 2006). 
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Figure 1.2 - Pharmacological Tools to Modify Ion Transport - Clockwise - 
Amiloride directly blocks ENaC on the apical side of the epithelium. Forskolin 
activates adenyl cyclase (AC), increasing intracellular levels of cAMP which binds 
to PKA which in turn phosphorylates apical CFTR and basolateral NKCC1 inducing 
a sustained apical efflux of Cl. Furosemide directly blocks NKCC1, thus indirectly 
inhibiting apical Cl
-
 secretion. Chromanol 293b acts directly on Kv7.1 to block 
basolateral K
+
 exit. Bethanechol acts as an agonist at metabotropic muscarinic 
acetylcholine receptors (mAChR), in particular M3 but possibly M1. Activation of 
epithelial mAChR stimulates phospholipase C (PLC) leading to degradation of 
phosphatidylinositol 4-5 bisphosphate (PIP2) into diacylglycerol (DAG) and inositol 
1,4,5 triphosphate (IP3) which stimulate the release of intracellular Ca
2+
 stores from 
the endoplasmic reticulum. The increased intracellular Ca
2+
 activates a transient 
apical Cl
-
 efflux via Ca
2+
 activated Cl
- 
channels (CaCC) which is further driven by 
basloteral exit of K
+ 
via Ca
2+
 activated potassium channels (KCa3.1). The transient 
nature of response to bethanechol is likely due to the inactivation of CaCCs by 
inositol 3,4,5,6-tetrakisphosphate (IP4), a derivative of IP3, as well as the  PKC 
(activated by DAG) induced inactivation of KCa3.1. 
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1.2.3 Capsaicin 
 
 Capsaicin is an ingredient most often found in the genus of peppers known as 
Capsicum and responsible for the powerful sensation of heat associated with eating 
these vegetables. It is used in a vast range of culinary dishes, however, apart from its 
role in cuisine, capsaicin has been used for many years in numerous different 
countries as a therapeutic agent against a plethora of ailments (O’Neill et al., 2012). 
It has been used in particular for the treatment of pain, but pharmacological studies 
have also demonstrated physiological effects on cardiovascular, respiratory and 
gastrointestinal tissues (Holzer, 1991; Haanpää and Treede, 2012). The compound 
itself, trans-8-methyl-N-vanillyl-6-no-nenamide is a naturally occurring alkaloid 
derived from vanillyl amide, and similar to its precursor, is a potent antagonist of the 
transient receptor potential cation channel subfamily V member 1(TRPV1) (O’Neill 
et al., 2012). TRPV-1 is found all over the body and performs a variety of functions 
depending on location. In the periphery, including the GI tract, it is located mostly 
on primary sensory neurons and is believed to be responsible for the initial detection 
of noxious chemical and in particular heat stimuli, thus giving a "burning" sensation 
upon activation with capsaicin (Caterina et al., 1997). Indeed, TRPV-1 has been 
found in human colon and increased levels in patients with IBD is thought to be 
important in mediating visceral hypersensitivity (de Fontgalland et al., 2014). 
Studies in Ussing Chamber (See section 1.3; Figure 2) have also demonstrated an 
effect for capsaicin on intestinal ion transport (Vanner and Macnaughton, 2004a). 
Exposure to capsaicin activates sensory afferent neurons which in turn activate 
submucosal secretomotor neurons to release pro-secretory neuropeptides, such as 
substance P which can then cause an increase in luminal chloride efflux (See section 
1.4).  
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1.2.4 Tetrodotoxin  
 
Tetrodotoxin (TTX) is a powerful neurotoxin and is well known as the toxic 
substance found in the ovary and liver of the puffer fish; the fish itself is considered 
a supreme delicacy in Japan and indeed a licence is required to serve (Narahashi, 
2001). However, this fish is not the only marine animal to contain this toxin and 
moreover, the toxin itself is not synthesised by these animals but rather specific 
species of bacteria to whom the animals play host (Cheng et al., 1995) Therefore, 
production of this toxin is an inherent property of these marine animals' host 
microbiota and indeed environmental factors, including the influence of symbiotic 
host-microbial relationships can affect the production of TTX (Daly et al., 1997). 
TTX acts by blocking voltage gated sodium channels VGSC) on nerves, and indeed 
skeletal muscle, thus preventing the influx of Na
2+
 which inhibits the propagation of 
action potentials thus eliminating any associated neural or muscle function (Nieto et 
al., 2012). Therefore, TTX is a particularly useful ex-vivo pharmacological tool for 
investigating the role of the neural component of tissue in regulating both 
homeostatic function  as well as tissue responses to external stimuli (Miranda-
Morales et al., 2010). Consequently it has been used extensively in organ bath 
studies of intestinal tissues to study the neural components involved in motility and 
ion transport (Vanner and Macnaughton, 2004a). 
1.2.5 Veratridine 
 
Veratridine (3-veratroyl‐veracevine) (O’Neill (Ed.), 2013) is a natural plant alkaloid 
and neurotoxin most often derived from the genus of plants known as Veratrum 
(Catterall, 1975a, 1975b). It acts by reversibly binding to neural Na
2+ 
channels and 
inducing a continual, TTX sensitive, activation of action potentials in the nerve cell, 
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increasing its excitability (Catterall, 1975a).  The use of Veratridine as a 
pharmacological tool to examine enteric regulation of mucosal intestinal ion 
transport has provided invaluable functional insight into these process (Sheldon et 
al., 1990a). Due to its ability to act as a pan-neural stimulant, submucosal intestinal 
tissues exposed to veratridine have been shown to release a plethora of enteric 
neurotransmitters which combine to produce a powerful and sustained pro-secretory 
response resulting in the luminal efflux of NaCl (Sheldon et al., 1990a; Hyland and 
Cox, 2005). It should be noted however, that in the presence of extrinsic neural 
innervation, such as that found in whole intestinal tissues, stimulation with 
veratridine results in a net absorption of ions (Sheldon et al., 1990a). 
1.3 Measurement of Intestinal Ion Transport: The Ussing 
chamber 
  
The Ussing Chamber (Figure 1.3) was developed  by the Danish physiologist and 
biochemist, Hans Henriksen Ussing (1911-2000), considered the “founder of 
epithelial  transport” (Larsen, 2002; Palmer and Andersen, 2008). Using frog skin, 
Ussing discovered that the rate of active transport of ions across an epithelium could 
be measured as an electrical current provided that both sides of the epithelium were 
bathed in an identical electrolyte solution and that transepithelial  electrical potential 
was eliminated (Ussing and Zehran, 1951).  
 The apparatus, to which Ussing gives his name, consisted of two chambers 
with epithelial tissue mounted in between. Each half chamber was filled with Krebs 
solution and both halves of the chamber were gassed, with carbogen (95% O2, 5% 
CO2) to oxygenate the tissue and to provide constant circulation. In order to 
eliminate transepithelial electrical potential, electrodes were used to apply an 
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external current across the tissue until the potential was brought to zero. The current 
required to achieve this was termed “short circuit current” or Isc,  and Ussing 
demonstrated that changes in this current matched the unidirectional flux of ions 
across the epithelium (Ussing and Zehran, 1951) (Figure 1.3). Since then, Ussing 
chambers have been used to measure ion transport across a multitude of epithelium 
including lung and intestine (Clarke, 2009a), with the first intestinal epithelial 
studies occurring shortly after Ussing’s original experiments (Chaflin et al., 1958; 
Cooperstein and Hogben, 1959). To this day the Ussing chamber remains one of the 
most important tools to investigate electrolyte transport across epithelium (Larsen, 
2002).  
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Figure 1.3. The Ussing Chamber is composed of two identical half chambers, 
representing the apical and basolateral reservoirs.  Intestinal (colonic) tissue is 
mounted between both halves which are filled equally with chilled Krebs Henseleit 
(KH) buffer to eliminate osmotic and hydrostatic gradients. Carbogen (95%O2, 
5%CO2) supplies the necessary oxygen and maintains pH as well as providing gas-
lift to allow steady circulation of buffer and perfusion of the tissue. The chamber is 
kept at a constant temperature of 37°C. Tissue is voltage clamped to 0V by sending a 
set current directly across the tissue via voltage electrodes. The amount of current 
required to maintain the tissue at 0V (known as short circuit current) is measured by 
the current electrodes and recorded electronically. Test materials, compounds, drugs 
may be added to either side of the chamber (red arrows), and subsequent changes in 
short-circuit current recorded.  
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Short-circuit current represents net changes in electrogenic ion transport owing to the 
activity of several ion transporters, such as CFTR and ENaC (Figure 1.1). 
Nonetheless, epithelial electrolyte is also subject to significant influence by 
additional factors including the enteric nervous system (ENS) and local mucosal 
immune system (Cooke, 2000) 
1.4 Influence of the Enteric Nervous System on in Ion 
Transport 
 
 The ENS is a complex neural network capable of regulating gastrointestinal 
function independent of the central nervous system (Furness 2000). Structurally it is 
composed of a network of ganglia, which form two major inter-connected and highly 
organised plexi within the wall of the intestinal tract. These plexi are known as the 
myenteric or Auerbach's plexus and the submucosal or Meisner's plexus (Furness, 
2008).The myenteric plexus is located between the outer longitudinal and inner 
circular muscle layers of the external muscle coat of the intestine and is composed of 
numerous neurons which cluster and relay signals within neuronal ganglia (Furness, 
2008). The submucosal plexus as its name suggests, is located within the tunica 
submucosa and similar to the myenteric complex, is composed of nerve strands 
which group and relay signals within enteric ganglia (Furness, 2008).  Although the 
physical location of these plexi imply an obvious separation in function, with the 
myenteric plexus controlling intestinal muscle activity and the submucosal plexus 
regulating mucosal function, the plexi are not separate and communication between 
the two plexi is important for overall coordination of intestinal function (Furness, 
2008). Moreover, the ganglia within both neural plexi is composed of a mix of 
afferent neurons, interneurons, and (secreto)motor neurons (Furness, 2008). 
16 
Moreover, these plexi are also innervated by extrinsic sensory afferents, originating 
from the vagal and spinal afferents of the nodose and dorsal root ganglia 
respectively, both of which form an important line of communication with the brain, 
thus providing coordination between GI reflexes and central behavioural responses 
(such as food intake) as well as allowing for pain perception (Berthoud, 2004).  
 
Figure 1.4 The enteric nervous system has two plexuses, the myenteric plexus 
between the longitudinal and circular muscle layers and the submucosal plexus 
(SMP) that has outer and inner components. Nerve fiber bundles connect the ganglia 
and also form plexuses that innervate the longitudinal muscle, circular muscle, 
muscularis mucosae, intrinsic arteries and the mucosa (Adapted from Furness, 2008). 
 
1.4.1 Enteric nervous system and secretomotor function in the mouse 
 
 While most of our understanding of the properties of enteric neurons and 
enteric neural reflexes come from studies in guinea pig and larger mammals such as 
the pig, the emergence in recent years of transgenic mouse models for the study of 
enteric disorders such as IBD presents a significant advantage for studying the 
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enteric nervous system in this species (MacDonald, 1997; Lomax and Furness, 2000; 
Brown and Timmermans 2004). The studies described in this thesis also employ the 
mouse throughout for studying the effects of microbes and their bioactives on 
neurally evoked intestinal ion transport in the Ussing Chamber. The following 
sections will describe what is currently known about murine enteric structure and 
function as well as the chemical coding and potential roles of specific neurons. 
1.4.2 Morphological and electrophysiological properties of mouse enteric 
neurons. 
 
 The structure and electrophysiological properties of specific enteric neurons 
are important in determining their role within the ENS (Clerc and Furness, 2004; 
Nurgali et al., 2004). The neurons within the mammalian enteric nervous system can 
be divided into two distinct morphological and electrophysiological classifications 
respectively (Wong et al., 2008). Morphologically, the ENS is made up of Dogiel 
Type I and Dogiel Type II neurons (Furness, 2008). Dogiel Type I neurons are uni-
axonal and contain cell bodies with lamellar dendrites, while Dogiel Type II, in 
general, have large round or oval cell bodies and a smooth surface with multiple 
process extending to various sites in and along the intestinal tract (Furness, 2003). 
Electrophysiological studies have divided enteric neurons into S-type and AH type 
(Brown and Timmermans, 2004). S-type neurons are characterised by their 
monophasic potentials, the presence of fast excitatory post synaptic potentials and  
the absence of slow afterhyperpolarising potential (AHP) while AH-type produce 
biphasic responses, containing a hump on the repolarising phase of the action 
potential and generally contain slow AHP's and do not produce fast excitatory post-
synaptic potentials (EPSPs) (Nurgali et al., 2004).   
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 In the mouse the majority (~80-90%) of neurons in both neural plexi appear 
to be S-type neurons displaying Dogiel Type I morphology while the remaining 
(20%) are Dogiel Type II AH neurons (Nurgali et al., 2004; Wong et al., 2008). 
Dogiel Type I neurons in the myenteric plexus neurons innervate the circular muscle 
directly and appear to regulate longitudinal muscle reflexes through nerve 
projections in the tertiary plexus (layer of the myenteric plexus closest to the 
longitudinal muscle) (Sang et al., 1997;1998). In the submucosal plexus these 
neurons project toward the mucosal layer of the intestine and act as secretomotor 
neurons regulating mucosal function including intestinal ion and fluid transport and 
mucous secretion (Furness et al, 2004). Dogiel Type II neurons are present in both 
neural plexi of the mouse and due to the similar pattern of innervation, morphology 
and neural chemistry in comparison to guinea pig,  are believed to be intrinsic 
primary afferent neurons (IPANs), acting as the first step in enteric neural reflexes 
(Furness et al., 2004). Moreover, myenteric Dogiel Type II neurons in the mouse 
colon project to other myenteric ganglia and also project into the submucosal plexus 
as far as the mucosa suggesting a key role in regulating coordination of enteric 
reflexes (Furness et al., 2004). 
1.4.3 Chemical coding of murine enteric neurons 
 
1.4.3.(a) Myenteric Plexus 
 
 Although well defined in other small mammals (Furness, 2008) the ENS of 
the mouse has thus far been studied to lesser degree (Sang and Young, 1996, 1998; 
Sang et al., 1997; Furness et al., 2004; Nurgali et al., 2004; Wong et al., 2008). 
Immuno-histochemical staining of small intestine identified two major classes of 
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circular muscle motor neurons, those containing nitric oxide synthase, vasoactive 
intestinal peptide along with neuropeptide Y (NOS/VIP/NPY), and those containing 
calretinin along with substance P (CalR/SP) (Sang and Young, 1996). In addition 
myenteric ganglia in the small intestine were found to be innervated by seven classes 
of neuron, those containing NOS, VIP, NOS/VIP, NPY, CalR/calbindin (CalB), SP 
or 5-hydroxytriptamine (5-HT) (Sang and Young, 1996).(Table 1.1) Myenteric 
innervation of large intestinal circular muscle on the other hand proved to be 
considerably more diverse (at least within the range of neurotransmitters examined) 
with 5 major classes of neurons described and categorised as follows: NOS, 
NOS/VIP, GABA, SP, or CalR RSP containing neurons (Sang and Young, 1996). 
Ganglia within the myenteric plexus of the large intestine were found to be 
innervated by neurons containing NOS, VIP, CalB/CalR, CalR, SP, GABA or 5-HT 
(Sang and Young, 1996). 
 Circular motor neurons projecting anally are in general considered inhibitory 
neurons (as previously found in other species) and are largely immuno-reactive (IR) 
for NOS/VIP. In contrast to other species including rat and guinea pig, NPY-IR 
neurons are only located in a small subpopulation of small intestinal neurons (Sang 
et al., 1997). SP-IR neurons on the other hand projected orally and are therefore 
considered to be excitatory neurons, as previously observed in other species (Sang et 
al., 1997). 
 
    
2
0
 
 
Table 1.1 Chemical coding of murine myenteric neurons in small (SI) and large (LI) intestine measured as neurotransmitter immunoreactivity 
(NT-IR) (Data taken from (Sang and Young, 1998) 
 
   
SP CalR CalB NOS VIP 5-HT GABA 
 
   
SI LI SI LI SI LI SI LI SI LI SI LI SI LI 
% Ach-IR 
neurons 
containing 
other NT-
IR 
Cell Body ~50% ~50% 75% 75% 60% 60% ~5% <5% 15% <15% ? ? ? ~5% 
Terminals in 
Circular 
muscle  
90% 90% <100% <100%     0% 0% 0% 0%     ? 25% 
Terminals in 
Myenteric 
Plexus 
~66% ~75% 66% >33% 15% <25% ~5% ~2% ~5% >5% <5% 5% ? <20% 
Terminals in 
Tertiary 
Plexus 
90% 
  
100% 
  
  
  
0% 
  
0% 
  
  
  
  
  
% of other 
NT-IR 
neurons 
containing  
ACh-IR 
Cell Body 80% 80% ~99% ~100% 80% 80% ~10% ~10% 25% 25% 100% 100% ? ~33% 
Terminals in 
Circular 
muscle  
100% 100% 100% <100%     0% 0% 0% 0%     ? >75% 
Terminals in 
Myenteric 
Plexus 
75% >80% <100% >66% 50% 50% >5% ~5% >5% 15% 60% >50% 60% ~30% 
Terminals in 
Tertiary 
Plexus 
100% 
  
100% 
  
    0%   0%         
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 GABA-IR neurons were only found in significant density in the large 
intestine and were found to project both orally and anally to the circular muscle 
suggesting both inhibitory and excitatory control over intestinal motility (Sang et al., 
1997). Indeed, a small number of the anally projecting neurons were also NOS-IR. 
CalR-IR neurons in the mouse innervate both longitudinal and circular muscle and 
project anally. Moreover, some CalR-IR  neurons were also found to project locally 
to the circular muscle (Sang and Young, 1996; Sang et al., 1997).  
 This group also examined the orientation of inter-neurons in the mouse 
myenteric plexus and found that both in the small and large intestine, the NOS-, 
VIP-, CalB and 5-HT-IR neurons projected predominantly or exclusively anally. In 
the large intestine, most of the GABA-IR neurons also projected anally. Thus the 
majority of identified interneurons projected anally. In both regions, the SP-IR 
neurons projected orally and locally. In addition, the calretinin-IR neurons in both 
regions projected locally and the NPY-IR neurons in the small intestine also 
projected locally (Sang et al., 1997). This is a pattern previously demonstrated in 
guinea pig and may suggest that a larger diversity of neural transmission is projected 
anally to facilitate the major GI functional actions such as peristalsis. Moreover, the 
projection patterns for 5-HT throughout the mouse intestine were similar to those of 
both guinea pig and porcine ENS, while the polarity of VIP/NOS maintained a 
pattern which appears to be conserved across guinea pig, rat and human suggesting 
conservation of these neural patterns is important for mammalian ENS function in 
general (Sang et al., 1997).  
 Acetylcholine (ACh), considered an excitatory neurotransmitter in the ENS 
(Furness, 2008), was consistently co-localised with SP-IR neurons (all nerve 
terminals innervating muscle) in the small intestine, while as expected NOS/VIP-IR 
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neurons contained little or no ACh (none in the nerve terminals innervating muscle) 
supporting the view of these  motor neurons as excitatory and inhibitory respectively 
within the small intestine of the mouse (Sang and Young, 1998). The large intestine 
on the other hand, due to the presence of GABAergic and CalR-IR non-cholinergic 
motor neurons, appears to be more complex (Sang and Young, 1998)(Table 1). 
Although most GABAergic neurons within the myenteric plexus appeared to be non-
cholinergic, the majority of GABAergic nerve terminals in the circular muscle were 
indeed cholinergic, indicating an excitatory influence over migration complexes in 
that area (Sang and Young, 1998) (Table 1.1). The remaining population of 
GABAergic nerve terminals innervating the circular muscle may be non-cholinergic 
inhibitory neurons as a subpopulation of neurons was previously detected which also 
contained NOS (Sang and Young, 1996). Therefore the specific role of GABAergic 
neurons in the ENS remains unclear and due to their apparently more diverse nature 
relative to SP/VIP/NOS neurons, they likely play a more varied role in intestinal 
homeostatic regulation (Sang and Young, 1998). 
 While it was previously demonstrated that the majority of interneurons 
projected anally to other myenteric ganglia, this study clearly demonstrated a more 
wide-ranging population in comparison to motor neurons (Sang and Young, 1998). 
Although, no cholinergic VIP/NOS motor neuron terminals were detected in either 
small or large intestine, small subpopulations of cholinergic VIP/NOS nerve 
terminals were detected in the myenteric ganglia of both intestinal sections, indeed 
15% of large intestinal VIP neurons were shown to be cholinergic (Sang and Young, 
1998). Calbindin neurons also appeared to be relatively evenly divided between 
cholinergic and non-cholinergic. Although all 5-HT neuron cell bodies appeared to 
be cholinergic, this did not translate to nerve terminals as only around 50% and 60% 
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of 5-HT-IR nerve terminals in large and small intestine respectively, appeared to be 
cholinergic (Sang and Young, 1998). This observation was attributed to three 
possible reasons: nerve terminals arising from cell bodies not located in the 
myenteric plexus (e.g. submucosal plexus), potential problems with detection, and 
differences in the sub-cellular location of 5-HT and the cholinergic marker used 
(VChAT) (Sang and Young, 1998). 
1.4.3.(b) Submucosal Plexus 
 
 Although not described in detail Sang and Young noted immuno-reactivity 
for NPY, VIP, SP and CalR nerves in the submucosal plexus of mouse small and 
large intestine (Sang and Young, 1996). Furthermore, immuno-reactivity for NOS 
and 5-HT was restricted to large and small intestine respectively. Interestingly, 
following separation from the myectomy, there was a loss of NOS-IR neurons from 
the submucosal plexus of the large intestine indicating that these may innervate the 
submucosal plexus from the myenteric plexus, a further indication of coordination 
between enteric plexi in this species (Sang and Young, 1996). In addition, the 
volume of cholinergic innervation of the submucosal plexus was demonstrated to be 
40% and 20% in the small and large intestine respectively, and due to the presence of 
IR nerve fibres close to the mucosa, these were suggested to be secretomotor neurons 
(Sang et al., 1997). 
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Table 1.2. Distribution of neurotransmitter immuno-reactivity in the submucosal plexus of mouse intestine (Data adapted from Sang and Young, 
1996) 
 
 
 
Location
SP CalR CalB NOS VIP NPY GABA 5-HT
       -
       -
       -
      - -
       -
       -
       -
      - -
NeurotransmitterLocation in Neuron
Fibers in perivascular plexus
Fibres in Mucosa
Cell Body
Fibres
Fibers in perivascular plexus
Fibres in Mucosa
Small 
Intestine
Cell Body
Fibres
Large 
Intestine
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 The presence of Dogiel Type II AH neurons in the mouse submucosal plexus 
is uncertain, although the evidence thusfar appears to point against their 
existence.(Furness et al., 2004; Qu et al., 2008; Wong et al., 2008; Mongardi 
Fantaguzzi et al., 2009; Foong and Bornstein, 2013). With regard to the chemical 
coding of submucosal neurons, the most comprehensive study thusfar has been 
carried out in mouse ileum (Mongardi Fantaguzzi et al., 2009). In this study five 
groups of nerve cells in submucosal ganglia were described: cell bodies of 
VIP/NPY/CalR neurons (30%), VIP/NPY/CalR/TH neurons (20%), 
ChAT/CGRP/SOM neurons (30%; including a small sub-group of 
ChAT/CGRP/SOM/NPY neurons), neurons with ChAT and no other marker (about 
10%) and neurons with neither ChAT nor VIP (~ 8%). VIP/NPY/CalR/TH neurons 
have been shown to innervate the mucosa while VIP/NPY/CalR innervated 
submucosal blood vessels suggesting their roles as secretomotor and vasodilator 
neurons respectively (Vanner and Macnaughton, 2004b; Furness, 2008). This would 
suggest that VIP is a primary neurotransmitter of secretomotor neurons, as has been 
demonstrated in other species, including human, rat and guinea-pig (Furness, 2008, 
2012). CGRP/SOM/ChAT chemically coded neurons, which also innervate the 
mucosa are also likely to be the primary cholinergic secretomotor neurons as they 
share similar chemical coding to cholinergic secretomotor neurons in guinea pig 
(Furness et al., 2003). The functions of the remaining subgroups of neurons is not 
clear and will require further study.  
 Hence, three neuron types that account for most neurons in the submucosal 
ganglia of the mouse small intestine are: VIP-immunoreactive non- cholinergic 
secretomotor neurons (~30% of neurons), VIP- immunoreactive non-cholinergic 
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vasomotor neurons (~20% of neurons), and cholinergic secretomotor neurons, many 
of which also contain CGRP and somatostatin (~45% of neurons). 
1.4.4 The role of prominent submucosal secretomotor neurotransmitters in the 
regulation of mouse intestinal ion transport. 
 
1.4.4.(a) Summary 
 
 It is interesting to note that the same neurotransmitter systems (ACh/SOM 
and VIP/NPY) are expressed in secretomotor neurons across several mammalian 
species indicating their importance as primary neurotransmitters of mammalian 
secretomotor function  (Furness, 2008). With regard to intestinal fluid and electrolyte 
transport both ACh and VIP stimulate ion and fluid secretion while SOM and NPY 
inhibit fluid and electrolyte secretion (Furness, 2008; Tough et al., 2011). In 
addition, it has been previously shown, at least for VIP/NPY, that these 
neuropeptides also co-localise within the same neurosecretory vesicles, suggesting 
they are released together (Cox et al., 1994). This likely represents the requirement 
for the enteric nervous system to tightly regulate fluid secretion and prevent excess 
fluid loss. Therefore, given the likely importance of these neurotransmitters in 
controlling intestinal ion transport, it is important to understand how they may 
impact on epithelial ion transport in the mouse. The following sections will briefly 
describe what is known about these major neurotransmitters in mouse. 
1.4.4.(b) Acetylcholine(ACh) 
 
The neurotransmitter, acetylcholine, is synthesised by the enzyme, actetyltransferase 
from the precursors acetyl-CoA and choline. Cholinergic receptors are divided into 
two major categories, the G-protein coupled mACh receptors, of which there are five 
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subtypes (M1-M5), and the ionotropic nicotinic, ACh receptors of which there are 5 
subunits which can be made up of five subunits that may be in homomeric or 
heteromeric combinations (Hirota and McKay, 2006a)  
Atropine, a mACh receptor antagonist, has been used extensively in Ussing Chamber 
to confirm cholinergic regulation of ion transport in several species, including 
mouse, which display a decrease in baseline Isc (Diener et al., 1989; Chandan et al., 
1991b; Sayer et al.,2002). nACh receptor also causes very small decreases in 
baseline Isc and is consistent between species including mouse (Sun et al., 2000; 
Sayer et al., 2002). However, the majority of studies examining cholinergic 
regulation of ion transport have focused on cholinergic stimulation of ion transport 
(Hirota and McKay, 2006a). In particular, carbachol and bethanechol have been used 
as cholinergic agonist, which can stimulate Cl
-
 and fluid secretion resulting in a 
transient increase in Isc  (Hirota and McKay, 2006a). The accepted dogma in most 
species states that cholinergically driven ion transport is due to activation of M1 
mACh receptor on submucosal secretomotor neurons followed by activation of M3 
mACh receptors on intestinal epithelial cells (Hirota and McKay, 2006a). However, 
in mouse intestine, cholinergic regulation of ion transport is not well understood 
(Hirota and McKay, 2006b). In mouse small intestine cholinergic response were 
insensitive to neural blockade with TTx in the small intestine (Sheldon et al., 1989) 
while in the mouse large intestine, carbachol induced changes in Isc were sensitive 
and insensitive to neural blockade in the mid and distal colon respectively (Carew 
and Thorn, 2000; Sayer et al., 2002). Bethanechol however, displays sensitivity to 
TTX in the distal colon of mice (Sagmanligil and Levin, 1993). However, a recent 
study has revealed that unlike most other species such as rat and guinea pig (Hirota 
and McKay, 2006a), bethanechol induced changes in Isc are independent of epithelial 
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M3 mACh receptors and may rely on M1 mACh receptors in M3 deficient mice 
(Haberberger et al., 2006; Hirota and McKay, 2006a). 
1.4.4.(c) Vasoactive intestinal Peptide 
 
VIP is a neuropeptide with wide distribution in the enteric nervous system of the 
mouse (Sang and Young, 1996, 1998; Sang et al., 1997; Mongardi Fantaguzzi et al., 
2009), where it plays important regulatory role in many physiological processes 
(Furness, 2008). VIP may mediate its effects at two receptor subtypes (VPAC1 and 
VPAC2), which are members of class B receptors belonging to the super-family of 
GPCR (Couvineau and Laburthe, 2012). Activation of these receptors increases AC 
levels and causes increases in Isc in intestinal mucosa due to cAMP driven ion Cl
-
 ion 
secretion (Schwartz et al., 1974). Furthermore, this response is sensitive to inhibition 
by NPY (Holliday et al., 2000; Hyland et al., 2003), supporting the idea that NPY 
plays an important regulatory role over VIP stimulated ion transport.  Moreover, 
both neuropeptides  co-localise within submucosal secretomotor neurons (Mongardi 
Fantaguzzi et al., 2009). In the mouse, Isc responses to this neuropeptide in 
descending colon, VIP responses were insensitive to neural blockade, suggesting that 
VIP stimulation of electrolyte transport occurs at the level of the epithelium (Hyland 
and Cox, 2005). 
1.4.4.(d) Neuropeptide Y  
 
Recent studies in mouse colon have established a clear anti-secretory role for NPY 
(Y) receptors with regard to regulation of epithelial fluid and ion transport (Hyland 
et al., 2003; Cox, 2007). In the murine submucosa there are two receptors are 
involved in NPY regulation of intestinal transport, Y1 receptors located primarily on 
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intestinal epithelial cells and Y2 located pre-junctionally on enteric secretomotor 
neurons (Hyland et al., 2003). Both Y receptors are involved in intestinal anti-
secretory tone, although NPY only mediates Y2  receptor anti-secretory tone while 
peptide YY, another Y receptor ligand, is responsible for Y1  mediated tone (Tough 
et al., 2011). However, with regard to regulation of stimulated epithelial ion 
transport, epithelial Y1 receptors appear to play a more substantial role in limiting 
VIP induced increases in Isc (Hyland et al., 2003). The anti-secretory effect is likely 
due to the fact that all Y receptors belong to a family of Gi/o coupled receptors and 
thus inhibit intracellular AC production, which would in turn reduce cAMP induced 
chloride secretion by VIP (Michel et al., 1998). Although Y2 receptors are 
considered to be mostly located on inhibitory secretomotor neurons, a residual Y2 
receptor mediated inhibition of ion transport is present following neural blockade 
with TTx suggesting the existence of non-neural Y2 receptors in the murine colonic 
mucosa (Hyland et al., 2003). 
1.4.4.(e) Somatostatin 
 
Currently 5 somatostatin receptors (SSTRs)  have been described SSTR 1-5 and 
similar to NPY receptors, SSTRs are also functionally coupled to the inhibition of 
AC via pertussis toxin sensitive G-proteins (Patel et al., 1994; Pepe et al., 2012). 
This appears to be the case in mouse colon as somatostatin was shown to inhibit 
cAMP dependant increases in Isc in the Ussing Chamber following stimulation with 
either prostaglandin E2 or dibutyryl-cAMP. However, the same effect was not seen 
in duodenum suggesting that SOM may be more important in the regulation of 
stimulated ion secretion in the large intestine (Samson et al., 2000). Furthermore, in 
addition to inhibiting cAMP induced ion transport, SOM also inhibited carbachol 
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induced increases in Isc in both mouse duodenum and the large intestine, further 
supporting the importance of this peptide in the regulation of cholinergic ion 
transport in the mouse (Samson et al., 2000). However, pre-treatment with TTX 
demonstrated that the effects of SOM were neurally independent with the exception 
of SOM inhibition of cholinergic induced ion transport in mouse colon (Samson et 
al., 2000). 
 Although the presence of SSTR 1-3 and 5 have has been detected in the 
murine intestinal mucosa (Wang et al., 2011), there are a lack of studies localising 
SSTRs in the mouse intestine. A recent study has demonstrated that SOM can 
increase electroneutral NHE8 ion exchanger expression, in the mouse small 
intestinal mucosa (Wang et al., 2011). Moreover, following addition to Caco2 cells, 
changes in NHE8 expression could be observed after one hour (Wang et al., 2011).  
1.4.4.(f) Gamma-aminobutyric acid 
  
 GABA, long recognised as one of the major inhibitory neurotransmitters in 
the central nervous system, is now being acknowledged as a key regulator of ENS 
and neuroendocrine function (Krantis, 2000). GABAergic neurons in the mouse 
appear to be classified predominantly as inter-neurons (Sang et al., 1997), an 
observation which has been noted across several mammalian species examined 
(Krantis, 2000). In the ENS glutamate through decarboxylation of glutamate by the 
enzyme glutamic acid decarboxylase (GAD), is converted to GABA which can then 
generate physiological signals through interaction with GABA receptors (Krantis, 
2000). GABA receptors are divided into two main types, ionotropic (GABAA and 
GABAC) and metabatropic (GABAB). GABAA and GABAC receptors are members 
of the superfamily of ligand gated ion channels (Chebib and Johnston, 1999). 
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GABAA receptors are hetero-oligomeric composed of a combination of α1-6, β1-4 
and γ1-4  subunits, while GABAC  receptors are homo-oligomeric consisting of ρ1 or 
ρ2 subunits (Chebib and Johnston, 1999). GABAB on the other hand are hetero-
oligomeric seven transmembrane G-protein coupled receptors, composed of  
GABAB1 and GABAB2 subunits, which can activate Ca
2+
 and K
+
 channels (Chebib 
and Johnston, 1999).  
 
 Recent studies have confirmed the presence of both GABAA and GABAB 
receptors in mouse mucosa and submucosal plexus respectively (Casanova et al., 
2009b; Li et al., 2012a). When tagged with green fluorescent protein, the GABAB1  
receptor subunit was found to be highly expressed in submucosal neurons of both 
ileum and colon, however, no evidence of epithelial or enteroendocrine GABAB1 
expression was found in the mouse (Casanova et al., 2009b). Although other 
subunits have not been identified thus far, given that GABAB receptors form via 
heterodimerization, this would suggest GABAB receptors in the mouse mucosa and 
submucosa are primarily neuronal in nature (Takahashi et al., 2000a; Casanova et al., 
2009b). This is in line with previous studies in myenteric plexus of mouse and other 
species indicating that they are pre-junctional in nature and are involved in inhibitory 
regulation of intestinal motor complexes (Chebib and Johnston, 1999; Sanger et al., 
2002). However, with regard to intestinal ion transport, a role thusfar in any species, 
has yet to be fully elucidated (Hyland and Cryan, 2010). 
 
 Conversely, GABAA  receptors, in the small intestine at least, have been 
demonstrated to influence mucosal ion transport in guinea pig, rat and mouse, 
however the mechanisms appear to differ between each species (Hardcastle et al., 
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1991; MacNaughton et al., 1996; Li et al., 2012a). In the rat, GABAA antagonism 
with bicuculline caused a Cl
-
 and neurally dependant decrease in basal ion transport 
as measured by Isc, while GABA itself had no effect (Hardcastle et al., 1991). 
However, this effect was lost upon removal of the myenteric plexus indicating that 
myenteric rather than submucosal neurons are responsible for the GABAA mediated 
effects and may be important for coordination of enteric reflexes in this species 
(Hardcastle et al., 1991).  
 
 In guinea pig small intestine, both GABA and a GABAA receptor agonist 
caused a Cl
-
 dependant and neurally-dependant biphasic increase in Isc, suggesting a 
role for GABAA receptor signalling in the regulation of mucosal fluid and electrolyte 
transport compared to rat (Hardcastle et al., 1991; MacNaughton et al., 1996). 
Indeed, the biphasic response was believed to be due to activation of cholinergic 
induced chloride transport during the first phase while an indirect stimulation of 
mucosal mast cell histamine release was proposed to account for a large proportion 
of the second phase. (MacNaughton et al., 1996). In the mouse, at least in the ileum, 
GABAA are expressed in the mucosa and apically on the intestinal epithelium where 
it was demonstrated they can directly mediate Cl
- 
efflux and fluid secretion due to 
their ionotropic nature (Li et al., 2012a). Moreover, this effect was demonstrated to 
be neurally independent, as pre-treatment with TTx did not prevent GABA 
stimulated intestinal fluid secretion (Li et al., 2012a)  
1.5 The Impact of the host microbiota on ENS 
 
The gut microbiota is a complex and dynamic ecosystem which contains ten 
times the the number of cells in the human body and consists of up to five hundred 
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different bacterial species. This "superorganism"  which consists primarily of seven 
different phyla, most notably Bacteroidetes and Firmicutes, forms its own 
functioning genome, known as the gut microbiome, containing up to 3.3 million 
genes and is almost 150 times larger than its human counterpart (Fraher et al., 2012). 
These organisms live in symbiosis with the host and indeed are believed to play a 
critical role in host development and health (Lutgendorff et al., 2008; Sommer and 
Bäckhed, 2013). More recently it is becoming more and more evident that an 
abnormal gut flora contributes to alterations in the mucosa and local immune system 
leading to gastrointestinal disease (DuPont and DuPont, 2011). For example, 
disturbances in host-microbiota populations of Bacteroidetes and Firmicutes species 
due to anti-biotic treatment, can open the way for opportunistic enteric pathogens 
such as Clostridium difficile  to cause infection and diarrhoea (Khoruts, 2014; 
Shankar et al., 2014). Salmonella and Campylobacter infection  have also been 
associated with prior anti-biotic treatment(Effler et al., 2001; Varma et al., 2006). 
Moreover, an important aspect of susceptibility to these infections is old-age, which 
has also been associated with marked perturbations in normal enteric flora (Rampelli 
et al., 2013) further emphasising the link between microbiota and host. Interestingly 
Clostridium difficile associated diarrhea is highly amenable to a radical form of 
therapy known as fecal microbiota transplantation, which is believed to restore 
"healthy" populations of the host-microbiota (Petrof and Khoruts, 2014).  Chronic 
inflammatory disorders of the gut such as IBD and IBS are also highly associated 
with disturbances in the host microbiota (Shanahan and Quigley, 2014). Indeed, IBS, 
a disorder which displays remarkable symptom heterogeneity, particularly 
disturbances in motility and ion transport, can be divided in to three subtypes 
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(Diarrheal, Constipation predominant and alternating IBS)- all associated with a 
characteristic host-microbe population (Parkes et al., 2012).  
Given that functional GI disorders such as IBS are heavily influenced by the 
host-microbiota, it is reasonable to assume that alterations in host microflora alter 
ENS activity and function and studies on motility in germ-free (GF) animals have 
given strong support to this proposal (Caenpeel, 1989; Husebye, 1992, 1994, 2001). 
GF or gnotobiotic animals, usually rodents, are animals which have been bred in 
specific isolated and bacteria free conditions and thus contain no host-microbiota 
(Smith et al., 2007). Some of the earliest studies carried out in GF rats demonstrated 
a slower intestinal transit associated with a reduction in intestinal migrating motor 
complexes (MMC) responsible for propelling food along the gut, after meals and 
following fasting. (Dupont et al., 1965; Abrams and Bishop, 1967; Gustafsson and 
Norman, 1969; Van Eldere et al., 1988; Caenepeel et al., 1989). As MMC are 
influenced by the ENS innervating the intestinal muscle, these studies were some of 
the first to indicate a critical role for the host microbiota in the development and 
normal function of the enteric nervous system. 
Moreover, when GF rats were exposed to conventional intestinal microflora 
the occurrence and spatial distribution of MMC were increased to the level observed 
in conventional rats after a period of 7-10 days (Husebye et al., 1992;1994). 
Furthermore, changes in neuropeptide Y expression were also observed indicating an 
effect on neurochemical coding (Husebye et al., 1994). Interestingly however, 
certain migratory patterns such as slow wave frequency were not reversed upon 
conventionalisation and this was suggested to be due to developmental maturity, 
indicating that timing of colonisation is important for complete and proper 
development of the motility function (Husebye et al., 1994). Another study carried 
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out by the same group examined the influence of specific bacterial species on 
motility in germ free rats (Husebye et al., 2001). It was found that primary 
metabolisers and anaerobic microbes, including Bifidobacterium and Lactobacillus 
have the most effect, whereas aerobic E. coli X7 has little or no effect (Husebye et 
al., 2001). Moreover, different microbes had differential effects on motility, while 
Clostridium tabicum n sp. VP 04 was most effective, a combination of L. 
acidophilus A10 and B. bifidum B11 was more effective than L. acidophilus A10 
alone, which had little effect, demonstrating the strain dependant effects  on enteric 
neural function (Husebye et al., 2001). 
More recently the influence of the host microbiome in mice has been 
investigated (McVey Neufeld et al., 2013; Collins et al., 2014). McVey-Neufeld and 
colleagues examined the impact of the host microbiome on the electrophysiological 
parameters of jejunal myenteric neurons (McVey Neufeld et al., 2013). Although, no 
difference was observed for Dogiel Type I (S neurons),  Dogiel Type II (IPANs) 
demonstrated significantly less excitability in comparison to specific pathogen free 
(SPF) and conventionalised mice (McVey Neufeld et al., 2013). This was interesting 
as previous studies in probiotics had demonstrated the strain specific ability of L. 
rhamnosus JB-1 to increase the excitability of IPANs in rats by acting on specific 
calcium dependent K
+
 channel (Wang et al., 2010b, 2010c). In the latter study, the 
influence of the host microbiome on ENS development was examined at an early 
postnatal time period (P3) in mouse small intestine and major differences in 
myenteric plexus structure and chemical coding were observed (McVey Neufeld et 
al., 2013). The GF jejunum and ileum, but not duodenum, displayed abnormal 
morphology with unevenly spaced ganglia and thinner, less abundant connecting 
nerve fibers, and a significantly decreased neuron density in comparison to SPF mice 
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(McVey Neufeld et al., 2013). The number of cells per myenteric ganglia was 
decreased in both jejunum and ileum of germ free mice, the number of NOS-IR cells 
was increased in both segments and this corresponded with a decrease in circular 
muscle contraction frequency and amplitude in both segments (McVey Neufeld et 
al., 2013). Moreover, circular muscle contraction frequency and amplitude could be 
increased in GF jejunum, but not SPF, following nitrergic blockade, giving a further 
indication that over prominence of this signalling network may be responsible for 
decreased motility in GF animals (McVey Neufeld et al., 2013). 
However, while our understanding of host microbial influences on myenteric 
ENS development is increasing, very little is known with regard to the influence of 
the host microbiota on intestinal secretomotor function. No studies thus far have 
directly examined the influence of the host microbiota on submucosal plexus 
structure and function, however, one study in pig has demonstrated the ability of a 
probiotic Pediococcus acidilactici to increase the number of CGRP-IR neurons in 
the submucosal plexus of the ileum (di Giancamillo et al., 2010). With regard to ion 
transport, however, in a study carried out in GF rat large intestine. This study 
focused on Na
+
 transport and found significant increases in mucosal to serosal flux 
Jms of Na
+
  in the caecum and proximal colon corresponding with an increase in Isc 
and decrease in tissue conductance were noted (Rösel and von Engelhardt, 1996). No 
differences in Jms of Na
+ 
were observed in the distal colon, however, an increase in 
Isc was observed only in the distal part of the distal colon. In the caecum and 
proximal colon, the changes in Na
+
 transport were likely due to increased activity of 
apical electroneutral Na
+
/H
+
 activity (Figure 1.1) as amiloride treatment failed to 
alter the increased in Isc while blocking of NaKATPase (a driving force for Na
+
/H
+
 
activity) abolished net Na
+
 fluxes (Rösel and von Engelhardt, 1996). In the distal 
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part of the distal colon, the increased Isc was associated with a change from 
electroneutral Na
+
 transport to primarily electrogenic transport as amiloride had 
significant effects on the increased Isc. This study demonstrates the significant 
segmental differences in Na
+
 transport, believed to be due to differences in 
aldosterone levels, in the large intestine and thus demonstrates how these differences 
can impact on host microbe interactions (Rösel and von Engelhardt, 1996). 
Moreover, it provides some of the first evidence that the enteric microflora can 
impact on intestinal secretomotor function and thus warrants further study into 
possible mechanisms. 
1.6 Probiotic Secreted Bioactives 
 
 In the gut, bacteria, including the commensal host microbiome are separated 
from the intestinal epithelial wall by anti-bacterial peptides in the small intestine and 
by two layers of mucous in the large intestine (Johansson et al., 2011a, 2011b). 
Indeed the thick layer of nutrient rich mucous is essential for colonisation of 
commensal microbes in the large intestine (Liu et al., 2013). Therefore, given the 
lack of direct contact between commensal or probiotic microbes and the host 
intestinal wall, much attention has recently been focused on extracellular secreted 
bioactives which may mediate many of the beneficial host-microbe interactions with 
probiotics (Sánchez et al., 2010). Studies using cell free probiotic supernatants or 
conditioned media have discovered that peptides and other bioactive molecules 
secreted by the bacteria are responsible for many of the positive effects of probiotics 
in both pathogen induced and inflammatory bowel disorders (Sánchez et al., 2010)  
 L. rhamnosus GG ATCC 53103 is an extremely well characterised probiotic 
(Lebeer et al., 2012) which has demonstrated effects on intestinal barrier function 
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and health. As previously mentioned extracellular proteins produced by this 
probiotic have been shown to upregulate barrier function and TJ protein function in 
epithelial cells under normal conditions (Escamilla et al., 2012; Patel et al., 2012; 
Sultana et al., 2013). Moreover, some of these effects could be attributed to a 
secreted (Escamilla et al., 2012) and heat stabile protein (Patel et al., 2012). However 
the precise identity of these proteins remains elusive. Other studies have 
demonstrated protective effects of identified soluble factors from L. rhamnosus GG 
ATCC 53103 on barrier function and survival during inflammatory challenge (Tao et 
al., 2006; Seth et al., 2008; Yan et al., 2011). Identified proteins p40 and p75 can 
stimulate cell survival mechanism in the intestinal epithelial cells via epidermal 
growth factor receptor, activating Akt and via a PIK3 dependant and p38 ERK1/2 
independent mechanism protecting against intestinal injury in inflammatory bowel 
conditions (Li et al., 2012a).  
 The  production of self-produced antibiotics or bacteriocins is a relatively 
common trait among probiotics, in particular Lactobacilli (Dobson et al., 2012). 
Several lactobacillus species are known to produce bacteriocins including L. 
rhamnosus GG ATCC 53103 (Lu et al., 2009), which produce NPSRQERR and 
PDENK and Lactobacillus salivarius UCC 118 which produces the bacteriocin Abp 
118 (Corr et al., 2007). Interestingly, although it is not believed that bacteriocin 
interact directly with the intestinal mucosa, a recent study has demonstrated that 
these factors may interfere with the ability of the probiotic to protect against H2O2 
induced barrier dysfunction and change in TJ protein expression (Miyauchi et al., 
2012b).  
 With regard to intestinal ion transport, thus far no bioactives have been 
identified, which impact directly on intestinal ion transport although several 
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probiotics appear to function through secreted bioactives (Lomasney and Hyland, 
2013). CM from B. breve BBC50, could inhibit both carbachol and forskolin induced 
changes in Isc  via downregulation of PKC, while CM from both L. acidophilus  
ATCC 4357 and L. rhamnosus ATCC 53103 where able to increase Cl
-
/OH
-
 
exchange in Caco-2 IEC (Borthakur et al., 2008) (Table 1.4) could upregulate DRA 
expression acutely via a PI3K dependant mechanism (Borthakur et al., 2006) and 
chronically via upregulation of promotor genes (Raheja et al., 2010) L. acidophilus  
ATCC 4357 secreted factors, which are heat labile, can also increase Na
+
/H
+
 
exchange via direct upregulation of NHE3 expression and function  suggesting that 
the probiotic bioactives act on NaCl absorption (Singh et al., 2012). Furthermore, 
although a direct effect on intestinal ion transport was not demonstrated, CM from 
Bifidobacterium infantis Y1 was able to restore baseline and secretagogue induced 
changes in Isc in mice with colitis, demonstrating the ability of secreted factors of 
this probiotic to protect against inflammation induced changes in ion transport 
(Ewaschuk et al., 2008). Again however, although the effects of these bioactives was 
associated with signalling via PI3K, possibly indicating effects on cell survival (Seth 
et al., 2008) and epithelial ion transporter expression (Borthakur et al., 2008), their 
identity and thus mechanism of action remains elusive. 
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1.7 Cytokines as prominent targets for probiotics 
modulation  
 
1.7.1 Indirect effects of  commensal microbes on intestinal ion transport 
 
 Microbes with the ability to modulate both pro- and anti-inflammatory 
inflammatory cytokines may be useful in the context of ulcerative colitis associated 
with hyper-secretion, such as those which target IFN-γ, TNF-α (Resta-Lennert and 
Barrett 2006) or  Il-10 (Ewaschuk et al., 2008). However, a decrease in secretory 
responses has in general been observed in inflamed tissues (Sandle et al., 1990). 
Such observations are supported by studies demonstrating a reduction in the 
expression of CFTR in human colonic cell lines in vitro following exposure to IFN- 
and TNF-, previously demonstrated amongst other cytokines to be increased in 
patients with inflammatory bowel disease (Hering et al., 2012 ). However, the data 
with respect to changes in CFTR expression are not consistent in this regard (Lohi et 
al., 2002;Sanchez  et al, 2002; Bertelsen et al., 2004). Nonetheless, CFTR is not the 
only ion channel sensitive to inflammatory mediators, and both NKCC1 and 
NaKATPase also appear to be targets for the inflammatory cytokine, IFN-γ in human 
intestine, where it results in a down regulation in their activity (Bertelsen et al., 
2004). As both these basolateral transporters are critical in influencing electrogenic 
Cl
-
 secretion, the influence of IFN-γ on their activity likely accounts for CFTR-
independent effects (Bertelsen et al., 2004). Similarly, a study in T84 epithelial cells, 
in which IFN- γ reduces NaKATPase and NKCC1 expression support this 
observation (Sugi et al., 2001). It is perhaps not surprising therefore that probiotics 
such as Lactobacillus acidophilus, known to have protective effects in inflammatory 
bowel disease (Greenhill, 2011), have also been shown to prevent IFN-γ induced -
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changes in ion transport (Resta-Lennert and Barrett, 2006). The apical channel, DRA 
has also been shown to be downregulated in ulcerative colitis patients and animal 
models of the disease (Yang et al., 1998), while expression of ENaC displays an 
insensitivity to  aldosterone in human ulcerative colitis colonic biopsies (Amasheh et 
al., 2004). Here again, this may be due to the presence of the pro-inflammatory 
cytokines,  TNF-α and Il-1β, both of which have been shown to downregulate ENaC 
in rat distal colon (Barmeyer et al., 2004). IFN-γ has also been shown to 
downregulate both NHE2 and NHE3 expression in rat intestine and human intestinal 
epithelial cells (Rocha et al., 2001). As such, microbes with the ability to upregulate 
specific ion channels or transporters, known to be decreased during inflammation, 
may be of benefit in restoring fluid and electrolyte homeostasis in inflammatory 
bowel diseases. For example, Lactobacillus  acidophilus has been demonstrated to 
increase the expression of DRA in vitro as well as in mice (Raheja et al., 2010).  
However, and as has already been alluded to, the anti-inflammatory effects of 
microbes and probiotics are likely to indirectly influence intestinal and colonic ion 
transport.  
 With regard to specific diseases, animal models of colitis are associated with 
alterations in colonic fluid and electrolyte transport, Isc and ion transporter 
expression and these alterations appear to be amenable to modulation by probiotics 
(Madsen et al., 2001; Ewaschuk et al., 2008) or indeed elements of the host 
microbiota (Ghosh et al., 2011).  The probiotic mix, VSL-3(containing 9×10
10 
colony forming units (CFU) of bifidobacteria (Bifidobacterium longum, 
Bifidobacterium infantis, and Bifidobacterium breve), 8×10
10
 lactobacilli 
(Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus delbrueckii subsp. 
Lactobacillus bulgaricus, and Lactobacillus plantarium), and 20×10
10
 of 
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Streptococcus salivarius subsp. Thermophilus) partially recovered baseline Isc and 
forskolin-induced Cl
-
 secretion in the IL-10 knockout mouse model of colitis 
(Madsen et al., 2001). Despite the ability of VSL-3 to reduce  TNF-α and IFN-γ, 
recovery of baseline Isc, and the diminished response to forskolin, were only 
observed in IL-10 knockout mice, suggesting that the effects of VSL-3 on Isc may 
occur via an immune-independent  mechanism (Madsen et al., 2001).  In vitro 
exposure  of T84 colonic epithelial cell monolayers to VSL-3 increased Isc, and this 
effect appeared to be  specific to VSL-3, as two unrelated bacterial strains 
(Lactobacillus reuteri and Streptococcus bovis)  were unable to produce the same 
result in the T84 monolayers (Madsen et al., 2001). Though the precise mechanisms 
through which VSL-3 exerts its effects have yet to be fully characterised, there is 
evidence that one of the bacterial components of VSL-3, Bifidobacterium infantis, 
could potentially be responsible for the change in Isc induced by VSL-3, as 
Bifidobacterium infantis produced a recovery of baseline Isc in IL-10 knockout mice 
(Ewaschuk et al., 2008). Indeed, bacterial-induced modulation of IL-10 has also been 
associated with changes in Isc, as Bifidobacterium breve-induced reductions in Isc, in 
a mouse model of hypersensitivity, were sensitive to neutralisation of IL-10, 
suggesting this cytokine either directly or indirectly reduces Isc (Zhang et al., 2009). 
However not all bacteria exert similar effects in the same context, and Lactobacillus 
salivarius UCC118, in two models of experimental colitis, one of which was the IL-
10 knockout mouse, had no effect on Isc, but prevented an inflammation-induced 
increase in permeability (Feighry et al., 2008). 
An elegant study by (Ghosh et al., 2011) demonstrated that inflammation 
induced changes in expression of the colonic ion transporter, DRA are sensitive to 
modulation by the microbiota. Citrobacter rodentium-induced colitis in susceptible 
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C3H/HeOuJ mice, resulted in a marked reduction in DRA gene expression relative to 
non-susceptible C57BL/6 mice (Ghosh et al., 2011). However, susceptible 
C3H/HeOuJ mice with the micribiota of a non-susceptible C57BL/6 donor displayed 
a significantly smaller change in expression of DRA following infection with 
Citrobacter rodentium (Ghosh et al., 2011). Given that mice infected with 
Citrobacter rodentium display severe dehydration, one could speculate that changes 
in key colonic ion transporters like DRA may account such an observation.  These 
data not only suggest that the host microbiota may influence susceptibility to 
infection, but that it may also account for symptom severity through modulation of 
colonic ion transporters.  
1.7.2 Cytokine regulation of short circuit current 
  
 Given the prominent role of cytokine modulation in mediating the effects of 
many probiotics, understanding the direct role of cytokines in regulating intestinal 
ion transport can give insight into the possible pathways through which probiotics 
take effect. Therefore, some of the prominent cytokines which have gained attention 
with regard to their ability to regulate both baseline and stimulated changes in Isc will 
be discussed, thus giving insight into the possible role of cytokines in mediating 
probiotic induced responses observed in the Ussing Chamber (Table 1.3) 
 Interleukin-10 (IL-10) is one such cytokine which has received much 
attention due to its impact in inflammatory bowel disorders and which can also 
influence in electrolyte transport in the gut (Leach et al., 1999). Some of the first 
work demonstrating the impact of IL -10 on ion transport were carried out in the 
Ussing Chamber on rat small intestine (Madsen et al., 1996). Serosal but not 
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mucosal addition of exogenous IL -10 dose dependently decreased baseline Isc in a 
neurally independent manner believed to be due an increase in net NaCl absorption 
(Madsen et al., 1996). IL -10 also increased cAMP, but not calcium induced changes 
in Isc which correlated with a decrease in intracellular cAMP levels. However, 
although Isc was increased, net Cl
-
 fluxes decreased following stimulation with either 
forskolin or carbachol and a residual secretory flux, believed to be due to bicarbonate 
secretion, remained. Therefore IL -10 induces its anti-secretory effects by decreasing 
cAMP-mediated Cl- efflux while increasing electroneutral NaCl absorption. In the 
absence of this cytokine IL -10
-/-
 mice display a decrease in baseline Isc and 
responses to forskolin in the colon (Ewaschuk et al., 2008).  
 Like IL -10, initial studies carried out in T84 intestinal epithelial cell cultures 
identified an anti-secretory function for IL -4 (Colgan et al., 1994). When exposed 
for 48h, Il-4 attenuated both carbachol and forskolin mediated increases in Isc and 
this was believed to be independent to changes in barrier function suggesting a direct 
effect on trans-cellular ion transport (Colgan et al., 1994). Interestingly, a later study 
comparing the effects of IL-4 and IL-10 on T84 cells co-cultured with 
Staphylococcus aureus enterotoxin B (SEB) activated immune cells, demonstrated 
that IL-10 but not IL-4, when added to the co-culture, or to immune cells before co-
culture and SEB activation, restored losses in forskolin stimulated ion transport as 
well as barrier permeability (Lu et al., 1998). This strongly suggests, when taken 
together with studies from IL-10
-/- 
(Ewaschuk et al., 2008), that IL-10, during 
immunological compromise, plays a powerful immunologically mediated role in the 
restoration of ion transport, while IL-4 is ineffective and may play more direct role 
in homeostatic regulation of epithelial chloride ion transport (Colgan et al., 1994). 
Importantly, this study not only points to differential regulation of intestinal ion 
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transport by cytokines, but demonstrates that cytokine induced effects are situation 
dependent, relying greatly on environment, in particular the presence or absence, as 
well as the type of physiological stress (Madsen et al., 1996, 1999; Lu et al., 1998).  
 Indeed, IL-11 causes a decrease in basal Isc in both rat small and large 
intestine (Greenwood-Van Meerveld et al., 2000). However, segmental differences 
were observed. In the colon, IL-11 induced changes in baseline Isc were TTx 
sensitive and took 8 times longer than TTx insensitive responses in small intestine 
indicating a significant difference in cytokine regulation of ion transport between 
small and large intestine  (Greenwood-Van Meerveld et al., 2000). The exact 
mechanistic effects of IL-11 are unknown, although studies in mouse stomach 
demonstrate a change in mRNA expression of genes corresponding to several major 
mucosal ion transporters also present in intestine, including an increase in CFTR 
mRNA levels (Howlett et al., 2012). This suggests IL-11 may act to modulate Isc by 
regulating the activity and expression of key transporters involved in trans- epithelial 
intestinal fluid and electrolyte movement. 
 Indeed this appears to be the case for interferon gamma (IFN-γ), a pro-
inflammatory cytokine highly implicated in the pathogenesis of IBDs, such as 
ulcerative colitis, which are associated with severe diarrhea  (Binder, 2009). With 
regard to ion transport IFN-γ has been shown to down regulate both baseline and 
stimulated ion transport in several studies (Yoo et al., 2000; Rocha et al., 2001; 
Bertelsen et al., 2004). In these studies cAMP induced increases in Isc are decreased 
following exposure to IFN-γ and this has been associated with a decrease in 
expression of CFTR (Resta-Lenert and Barrett, 2006), NKCC1 and NaKTPase (Sugi 
et al., 2001; Bertelsen et al., 2004). However, this cytokine has also been shown to 
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down-regulate regulate Na
+
 coupled glucose transport (Yoo et al., 2000) as well as 
the expression of key transporters involved in fluid and electrolyte absorption, 
including NHE2/3 (Rocha et al., 2001). Moreover, the effects of IFN-γ on Isc  in 
mice, are also present in immuno-deficient mice suggesting that it's effects are not 
immunologically dependent (Yoo et al., 2000). Indeed it is believed that one of the 
main mechanisms for the effects of IFN-γ on ion transport is via rearrangement of F-
actin filaments in epithelial cells thus disruption. This suggests that IFN-γ acts by 
decreasing ion transport function rather than targeting specific secretory or 
absorption processes. Indeed, mouse models of IBD, including the IL-10
-/-
 mouse are 
associated with an increase in the levels of IFN-γ, and treatments to decrease this, 
including probiotics are associated with decreased levels of IFN-γ secretion 
(Ewaschuk et al., 2008). 
 
  
4
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Table 1.3 Influence of cytokines on Isc current  
Cytokine 
Pro or Anti-
inflammatory 
Overall Effect Isc responses Molecular  Changes Model Reference 
IFN-γ 
Pro Anti-secretory 
↓ baseline Isc          
↓cAMP 
stimulated ΔIsc   
↓CFTR expression             
↓NKCC1expression            
↓NaKATPase 
expression  
CD-1 Mouse 
small intestinal 
primary culture           
Human fetal 
small intestine 
xenograft      
Rat small 
intestine Caco-2 
IEC 
Yoo et al., 2000;   
Rocha et al., 2001; 
Bertelsen et al., 
2004 
IL-1β 
Pro Pro-secretory 
↑↑↑ baseline Isc Increase in 
prostaglandin (PGE2) 
stimulation of Cl- and 
K+ secretion         
↓ENaC expression and 
activity                         
↑NO release via 
neurkinin receptors??? 
Mouse colon  
Rabbit distal 
colon 
Homaidan et al., 
1995 Schumann et 
al., 2012 Eutamene 
et al., 1995 
TNF-α 
Pro Pro-secretory 
↑↑↑ baseline Isc Increase in 
prostaglandin (PGE2) 
stimulation of Cl- and 
K+ secretion    ↓ENaC 
expression and activity 
HT-29 IEC         
Human Sigmoid 
Colon                
Rat Distal 
Colon 
Kandill et al., 1994 
Amasheh et al., 
2004    Zeissig et 
al., 2008 
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IL -6 
Pro Pro-secretory 
↑ baseline Isc          
↑veratridine 
stimulated ΔIsc       
↑bethancehol 
stimulated ΔIsc 
Stimulation of 
cholinergic 
secretomotor neurons 
↑cholinergic 
secretomotor activity 
Rat O'Malley et al., 
2011 
IL -4 
NA Anti-secretory 
↑cAMP 
stimulated ΔIsc                          
↑carbachol 
stimulated ΔIsc 
??? T-84 IEC Colgan et al., 1994             
Lu et al., 1998 
IL -13 
NA Pro secretory 
↑ baseline Isc          
↑cAMP 
stimulated ΔIsc                       
↑carbachol 
stimulated ΔIsc 
↑ CFTR activity  and  
expression 
Mouse jejunum Wu et al., 2011 
IL -10 
Anti Anti-secretory 
↓baseline in 
conventional 
tissue      
↑cAMP 
stimulated ΔIsc   
Increase in NaCl 
absorption                
↑HCO3- secretion       
↑Na+ absorption           
↓Cl- secretion       
↓intracellular cAMP 
Rat small 
intestine 
Madsen et al., 1996 
Ewaschuk et al., 
2010 
IL -11 
Anti Anti-secretory 
↓ baseline Isc  Increase in CFTR  Rat Small and 
Large intestine 
Greenwood-Van 
Meerveld et al., 
2000                      
Howlett et al., 2012 
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In contrast to those discussed thus far, several cytokines have been known to cause 
an increase in Isc. Tumour necrosis factor alpha (TNF-α) regulates a variety of cell 
types involved in inflammatory responses and is also thought to be a critical cytokine 
involved in the pathogenesis of IBD (Binder, 2009). One of the first studies 
examining the effects of TNF-α on epithelial ion transport was carried out in porcine 
ileum mounted in Ussing Chamber (Kandil et al., 1994). Serosal application of TNF-
α caused a chloride dependant increase in Isc,  comparable in magnitude to 
prostaglandin E2 (PGE2) stimulated changes in Isc and which was sensitive to 
indomethacin, an inhibitor of prostaglandin production (Kandil et al., 1994).  
  This effect was not be observed in T84 cell mono-layers in the absence of 
fibroblasts, which produce high levels of PGE2, amongst other prostaglandins 
(Kandil et al., 1994). This strongly suggests that TNF-α acts indirectly via PGE2, to 
increase baseline epithelial Cl
-
efflux. Moreover, studies in HT-29 cells demonstrated 
no direct effect of TNF-α on basal Isc, supporting an indirect regulation of epithelial 
ion transport by TNF-α (Schmitz et al., 1999; Gitter et al., 2000). In addition to 
stimulating Cl- ion transport, TNF-α can also decrease intestinal sodium absorption 
by downregulating apical ENaC activity and subunit expression (Amasheh et al., 
2004; Zeissig et al., 2008). TNF-α mediated decreases in aldosterone stimulated 
sodium absorption in human sigmoid colon were accompanied by downregulation of 
γ and β ENaC subunits (Amasheh et al., 2004). Furthermore,  similar results were 
observed in rat distal colon, where ENaC regulation is thought to be similar to that of 
human sigmoid colon, and the effect could be reversed following inhibition of 
ERK1/2, but not p38, MAPK (Zeissig et al., 2008). This suggests that TNF-α inhibits 
electrogenic sodium absorption by downregulating apical ENaC expression via an 
ERK signalling mechanism.  
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 Finally, IL-6,  has been shown to mediate colonic hypersecretion in rats via a 
cholinergic, neurally dependent mechanism (O’Malley et al., 2011). This effect is 
also dependent on downstream activation of ERK, JAK-STAT, and NF-κB signaling 
cascades. Moreover, IL-6 potentiated bethanechol and veratridine, induced changes 
in Isc and depending on strain, capsaicin responses (O’Malley et al., 2011, 2012).  
1.8 Direct effect of microbes on intestinal epithelial ion 
transport and ion channel, transporter or exchanger 
expression 
 
1.8.1 Pathogen-induced effects on intestinal ion transport and ion channel, 
transporter or exchanger expression 
 
 Ussing chambers have proved to be a useful tool in understanding the way in 
which pathogens such as Vibrio cholera and Escherichia coli influence intestinal ion 
transport and fluid secretion (De et al., 1959). These pathogens secrete a variety of 
virulence factors such as E. coli heat stable/labile toxin, cholera toxin and Shigella 
toxin which have the capacity to disrupt intestinal ion transport, and aggressively 
activate ion secretion pathways resulting in excess fluid secretion.  
 Mechanistically, increased epithelial Cl
-
 transport is the most common target 
of bacterial toxins. Cl
- 
secretion typically occurs as a result of increased CFTR or 
calcium activated chloride channel (CaCC) activity. In the case of cholera toxin, 
CFTR activation is as a result of ADP-ribosylation of AC leading to increased 
intracellular cAMP, activation of PKA which, in turn, phosphorylates the CFTR 
regulatory domain resulting in increased Cl
- 
secretion (Kimberg et al., 1971; Sharp 
and Hynie, 1971). Similarly, E. coli heat stabile toxin increases cGMP via 
ribosylation of guanylate cyclase (Field M. 2003). CaCC on the other hand is 
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targeted by Vibrio parahaemolyticus, via a thermostabile direct hemolysin, though 
the precise mechanism are unclear (Takahashi et al., 2000a). Ion absorption is also 
disrupted by pathogens. For example, intestinal cells exposed to E. coli display 
increased expression of DRA through direct injection of a virulence factor into the 
cell the cytosol by a type 3 secretion system (T3SS) (Gill et al., 2007). These 
proteins disrupt intra-cellular microtubule networks thereby  causing significant 
internalisation, and thus decreased cell surface expression of DRA (Gill et al., 2007).  
 In addition to its effects on Cl
-
 secretion, cholera toxin can also inhibit 
Na
+
/H
+
 exchange by both NHE2 and NHE3 via post-translational and post-
transcriptional mechanisms respectively (Subramanya et al., 2007). In contrast, E. 
coli increases the activity of NHE2 (Hodges K. 2006), however in common with 
cholera toxin decreases NHE3 activity in-vitro in intestinal epithelial cells (Hodges 
et al., 2008). While the precise mechanisms involved are still under investigation, it 
is known that alterations in NHE3 exchange has greater implications with regard to 
diarrhoeal diseases (Gawenis et al., 2007) Finally, E. coli can also decrease intestinal 
SGLT-1 activity within 30 minutes by up to 85%, in human intestinal epithelial cells 
in-vitro though it is not currently understood how this occurs (Dean et al., 2006). 
1.8.2 Effects of probiotics and commensal organisms on intestinal ion transport 
and ion channel, transporter or exchanger expression  
 
 While the mechanisms underlying pathogen-induced effects on intestinal ion 
transport have been relatively well characterised, the effects of commensal 
organisms or probiotics on the absorptive and secretory processes of the mammalian 
intestine are less well studied (Table 1). Lactobacillus acidophilus (LA), for 
example, has been shown to induce the expression of apical DRA exchangers both in 
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vitro, in Caco-2 intestinal epithelial cells, and in vivo in murine colon (Borthakur et 
al., 2008). In Caco-2 cells Cl
-
/OH
-
 exchange was increased following a three hour 
treatment with LA, and this corresponded with increased expression of DRA. This 
effect was not specific to LA, and a similar response was also observed for 
Lactobacillus reuteri. Further characterisation of the LA-induced effect on Cl
-
/OH
-
 
exchange demonstrated that viable bacteria were required to alter Cl
-
/OH
-
 exchange. 
Moreover, the LA effect was mediated via a secreted factor and via a phosphatidyl-
inositol 3 kinase (PI3K)-dependent pathway (Borthakur et al., 2008). Following their 
initial findings, the same group subsequently analysed the long-term effects of LA 
on Cl
-
/OH
-
 exchange in Caco-2 cells and in mouse colon. Following an eight hour 
treatment with LA, Cl
-
/OH
-
 exchange was significantly increased as predicted from 
previous studies. This effect functionally correlated with increased, 4,4'-
diisothiocyano-2,2'-stilbene disulphonic acid (DIDS)-sensitive, Cl
-
 uptake, and 
occurred in a concentration- and time-dependent manner (Raheja et al., 2010). At a 
genetic level, the LA-induced effect appeared to occur through transcriptional 
regulation, resulting in increased DRA promotor activity, and a resultant increase in 
both DRA gene and protein expression in mouse colon (Raheja et al., 2010) (Figure 
1.4).  
A combination of LA and Streptococcus thermophilus (ST) have also been 
demonstrated to influence the expression of key ion transporters, namely CFTR and 
NKCC1 (Figure 1.4) by preventing their down-regulation by IFNγ (Resta-Lennert 
and Barrett, 2006). As inhibition of PI3K functionally mimicked the effects of 
ST/LA on IFN-γ-induced reductions in forskolin-stimulated Isc in HT-29 cells, the 
authors speculated that PI3K may mediate the effects of ST/LA (Resta-Lennert and 
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Barrett, 2006). However, the biochemical pathways involved in the combined effects 
of LA and ST on the expression of CFTR and  
NKCC1 were insensitive not only to inhibition of PI3K, but also to inhibitors 
of p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated 
kinases (ERK)1/2 (Resta-Lennert and Barrett, 2006). However, other bacteria such 
as Bifidobacterium breve Bb C50 (Bb C50) have more clearly defined biochemical 
pathways.  
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Decreased serine/threonine phosphorylation of important transcriptional 
regulators, namely inhibitors of NF-kappa-B alpha and p38 MAPK, have been 
identified as being responsible for the effect of Bb C50 on Cl
-
 secretion (Heuvelin et 
al., 2009).  However, Bb C50 does not appear to alter CFTR expression (Heuvelin et 
al., 2010).  
Nutrient transporters involved in the transport of electrolytes are also 
sensitive to modulation by microbes or probiotics, and this has been demonstrated to 
be the case for Enterococcus faecum with respect to Na
+
/glucose transport and Na
+
-
coupled L-glutamine transport (Lodemann et al., 2006), and to a lesser extent for 
Bacillus cereus var toyoi (Lodemann et al., 2008).  Fourteen days feeding with 
Enterococcus faecum increased glucose-stimulated Isc following mucosal addition 
Figure 1.4. From left to right, sodium butyrate increases sodium hydrogen cation exchanger 3 
(NHE3) promotor activity. Secreted factors from Lactobacillus acidophilus (LA) increase 
down-regulation in adenoma (DRA) promotor activity associated with an increase in mRNA 
and protein expression of DRA, and increases channel activity via a phosphatidyl-inositol 3 
kinase (PI3K)-dependent pathway. Lactobacillus acidophilus/Streptococcus thermophilus 
restore interferon-γ (IFN-γ) induced inhibition of chloride (Cl–) secretion possibly through 
restoration of cystic fibrosis transmembrane conductance regulator (CFTR) involving 
PI3K/p38MAPK and ERK1/2 signalling. Lactobacillus rhamnosus attenuates cAMP induced 
Cl– secretion, while S. boulardi reduces cAMP and calcium-induced Cl– secretion. 
Bifidobacterium breve C50 reduces carbachol (CCh) induced Cl– secretion, possibly involving 
protein kinase C (PKC). 
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and appeared to enhance L-glutamine-stimulated Isc, though not significantly 
(Lodemann et al., 2006). In contrast, tissues from animals fed Bacillus cereus var 
toyoi  displayed no significant difference in response to glucose or L-glutamine, 
however tissues from Bacillus cereus var toyoi -fed animals displayed a significantly 
enhanced Isc response to stimulation with PGE2 (Lodemann et al., 2008). Such 
studies highlight the ability of bacteria to selectively target specific nutrient 
transporters or PGE2-signalling pathways.  
 Supporting the in vivo effects of Enterococcus faecum on glucose-stimulated 
Isc, in vitro studies with culture supernatants obtained from another bacterium, 
Lactobacillus acidophilus, dramatically increased glucose absorption by Caco-2 
colonic epithelial cells following acute exposure (Rooj et al., 2010). This effect was 
sensitive to blockade of SGLT-1 with phloretin, while blocking GLUT glucose 
transporters had no effect, suggesting that SGLT-1 activity is selectively targeted by 
a secreted component of Lactobacillus acidophilus. However, other  studies with 
Enterococcus  faecum and two Lactobacilli (Lactobacilus reuteri and Lactobacilus 
salivarus), suggest that more gross structural changes in intestinal tissues, such as  
increased villus length, increased surface area or  alterations in  barrier function may 
account for increased glucose transport (Awad et al., 2009,2010; Scharek et al., 
2005)
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Table 1.4 Summary of microbial/probiotic effects on identified molecular targets and fluid 
and electrolyte transport 
Microbe Direct/ 
Indirect 
effect 
Possible 
molecular 
target 
Effect on 
Target 
Effect on ion 
transport 
References 
Lactobacillus 
acidophilus 
 
Direct 1. DRA 
2. CFTR 
3. NKCC1 
1. Increased 
apical 
expression 
and activity 
2/3 Protection 
from 
inflammatory 
mediated 
down-
regulation 
1. Increased 
Cl
-
/3.
- 
 apical 
exchange. 
2. Restoration 
of 
secretagogue 
induced Isc 
Raheja et al., 
2010. 
Borthakur et 
al., 2008. 
Resta-
Lennert and 
Barret, 2006 
Lactobacillus 
rhamnosus 
Direct DRA Possible 
increased 
expression 
and activity 
Possible 
increased 
apical  Cl
-
/OH
-
 
exchange 
Raheja G. et 
al., 2010 
Streptococcus 
thermophilus 
 
Direct 1. CFTR 
2. NKCC1 
1/2.Protection 
from 
inflammatory 
mediated 
down-
regulation 
1/2.Restoration 
of 
secretagogue 
induced Isc 
Resta-
Lennert and 
Barret, 2006 
Bifidobacterium 
infantis 
Indirect Il-10 Possible 
upregulation 
of pathway  
Restoration of 
baseline and 
secretagogue 
induced Isc 
Ewaschuk 
J.B. et al., 
2008 
Bifidobacterium 
breve  
Indirect Il-10 Possible 
activation or 
upregulation 
Reduced 
allergy 
induced 
increases in  Isc 
Zhang L.L. 
et al., 2009 
Bifidobacterium 
breve C50 
Direct PKC Decreased 
activity 
Reduced 
carbachol 
induced ISC 
Heuvelin E. 
et al., 2010 
Saccharomyces 
boulardii 
 
Direct 1. PKC 
2. Nitric 
oxide 
pathway 
1. Increased 
activity 
2. Pathway 
induction 
1/2.Reduced 
calcium and  
cAMP induced 
increases in Isc 
Czerucka D. 
et al., 1994 
Girard P. et 
al., 2003 
Enterococcus 
faecum  
Indirect Na
+
/Glucose 
transporters 
unknown Increase in 
glucose 
stimulated Isc 
Awad A. et 
al., 2009 
Bacillus cereus 
var toyoi  
Indirect Na
+
/Glucose 
transporters 
unknown Increase in 
glucose 
stimulated Isc 
Lodemann U 
et  al., 2010 
Echerechia coli 
F18 
 
Direct PKC/cAMP Decreased 
activity 
Decrease in 
basal and 
cAMP induced 
changes in Isc  
Ohland C.L. 
et al., 2012. 
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1.9 The Influence of Microbes and Putative Probiotics on 
Short Circuit Current (Isc) and Epithelial Cell Signalling 
 
1.9.1 The influence of probiotics on secretagogue induced Isc 
 
 Microbes and probiotics can also influence secretagogue-evoked responses. 
For example, both Bb C50 and its culture medium inhibited carbachol-induced Isc, 
and similarly, though to a lesser extent, forskolin-induced Isc in human intestinal 
epithelial cells (HT29-19A) (Heuvelin et al., 2010). In the same study Lactobacilus 
rhamnosus was also shown to reduce forskolin- but not carbachol-induced increases 
in Isc, suggesting a species-specific effect of Bb C50 on calcium induced ion 
transport (Heuvelin et al., 2010). Moreover, the effect of BB C50 on carbachol-
induced changes in Isc correlated with a decrease in protein kinase C (PKC) activity, 
which may in turn decrease CFTR channel activity and subsequently Isc  (Akabas, 
2000). In contrast forskolin-induced protein kinase A (PKA) activity was unaffected 
by Bb C50, suggesting a PKA-independent pathway may be responsible for the 
decrease in Isc in response to forskolin in the presence of Bb C50.  
Like Bb C50 and Lactobacillus rhamnosus, the yeast, Saccharomyces 
boulardii (Sb), also affects epithelial cAMP signalling. In human colonic epithelial 
cells (T84), Sb attenuates both receptor- and non-receptor mediated increases in 
intracellular cAMP, and subsequent serosal to mucosal flux of 
125
I, representative of 
Cl
-
 ion transport (Czerucka & Rampal, 1999).  The reduction in calcium-mediated 
responses in the presence of conditioned media from Sb, however, occurred 
independent of a decrease in Ins(1,4,5)P3,  and therefore the authors speculate that Sb 
may induce the expression of negative regulators of calcium-induced secretion 
(Czerucka & Rampal, 1999).  Consistent with such effects been partially receptor-
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mediated, previous studies, by the same group, demonstrated that the Sb-induced 
inhibition of stimulated cAMP displayed sensitivity to pertussis toxin, implicating 
the involvement of G protein coupled receptors in mediating the effect of Sb 
(Czerucka et al., 1994). In vivo studies with Sb support the hypothesis that the yeast 
may have anti-secretory properties.  Following administration of Sb for eight days to 
pigs, intestinal baseline Isc was lower, as were theophylline-induced increases in Isc, 
and these effects were accompanied by decreased Na
+
 absorption and Cl
-
 secretion 
respectively (Schroeder et al., 2004.). However, 16 days following administration 
such effects were no longer apparent, suggesting that further adaptation may occur 
following longer term administration of the yeast. 
1.9.2 Probiotics can prevent adverse pathogen induced changes in intestinal ion 
transport. 
 
Given that a number of beneficial microbes have been functionally 
characterised with respect to their effect on intestinal ion transport, their application 
to counter pathogen-induced changes in intestinal fluid and electrolyte secretion have 
also been examined. In particular, a Sb-derived 120kDa heat labile protein inhibits 
cholera toxin (CT)-induced Cl
-
 secretion in IEC-6 intestinal epithelial cells 
(Czerucka et al., 1994). Subsequent studies using Sb further supported the functional 
significance of this finding in vivo, and demonstrated an anti-diarrhoeal effect of Sb 
in a castor oil-induced rat model of diarrhoea (Girard et al., 2003).  Moreover, both a 
pig model of  Escherichia coli Abbotstown-induced diarrhoea and Caco-2 intestinal 
epithelial cells exposed to pathogenic Escherichia coli,  displayed sensitivity to the 
probiotics Escherichia coli nissle (Schroeder et al., 2006) and Lactobacillus 
plantarum 299V respectively (Michail et al., 2002). However, neither of these 
studies provided a mechanistic explanation for the observed effects on diarrhoea or 
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Isc, though the effects of Lactobacillus plantarum 299V are thought to occur via 
competitive inhibition of Escherichia coli rather than via direct effects on intestinal 
ion transport (Michail et al., 2002). Similar studies have also demonstrated the 
ability of Steptococcus thermophilus and  Lactobacillus acidophilus to prevent 
enteroinvasive Escherichia coli (EIEC)-induced increases in basal Cl
-
 secretion, 
however neither probiotic had a significant effect on baseline Isc  per se (Resta 
Lennert and Barrett 2003). Whether these probiotics act via competitive inhibition, 
directly through stabalising certain ion transporters, and/or indirectly through 
associated associated signalling pathways is unknown and likely depends on the 
specific strain (Figure 1.4) 
A timely study has however provided an interesting and comprehensive 
bacterial strain comparison using several strains of both pathogenic (EPEC), non-
pathogenic (Escherichia coli F18), mutant (Escherichia coli  Δescn (type III 
secretion virulence factor deleted), commensal (Escherichia coli C1 and C28/2) and 
probiotic bacteria (Escherichia coli Nissle 1917) to shed some light on the 
mechanisms through which pathogenic and non-pathogenic bacteria may 
differentially regulate intestinal ion transport (Ohland et al., 2012). 
Hyporesponsiveness to forskolin in vitro in intestinal epithelial cells (T84) was a 
characteristic feature for all strains, including enterohaemorragic Escherichia coli 
(EHEC; Ohland et al., 2012).  Functionally, this initial inhibition of forskolin-
induced Isc may be important for facilitating bacterial adhesion to the intestinal 
mucosa, however, conversely, some EPEC caused an initial increase in baseline Isc in 
vitro, and this may represent a protective physiological response to prevent EPEC 
adhesion (Ohland et al., 2012). Despite EPEC initially inducing an increase in Isc, 
both EPEC and EHEC ultimately resulted in a hyposecretory state, the mechanisms 
 60  
underlying which varied between pathogenic and non-pathogenic strains (Ohland et 
al., 2012). Both EPEC and commensal (F18) bacteria appeared to cause this 
hyposecretion downstream of cAMP production; whereas EPEC caused 
mislocalisation and thus reduced activity of apical CFTR (Ohland et al., 2012). It is 
suggested that intra-cellular signals known to regulate CFTR activity may also be 
involved in mediating the hypo-secretion induced by pathogenic and non-pathogenic 
bacterial strains used by (Ohland et al., 2012), such as PKC/PKA.  
1.10 Probiotics and the Intestinal Epithelial Barrier 
 
1.10.1 Summary 
 
The regulation of the gut barrier is critical to successful maintenance of a healthy 
relationship between the host and  its enteric inhabitants, the host microbiota . Under 
certain conditions such as infections or stress, the integrity of the epithelial barrier is 
compromised and para-cellular permeability to non desirable luminal content , such 
as pathogenic bacteria is increased, allowing access to sites where direct interaction 
with immune cells can occur (Gareau et al., 2006, 2008; Catalioto et al., 2011). 
Moreover enhanced  ENS cholinergic signalling is believed to play a major role in 
intestinal permeability implying a link between increased barrier permeability and 
ENS dysfunction (Cameron and Perdue, 2007; Gareau et al., 2007) Indeed, increased 
para-cellular permeability is believed to be major underlying factor in the 
pathogenesis of functional GI disorders such as IBS where a leaky gut causes over 
exposure of sensory neurons to luminal antigens (Piche et al., 2009; Piche, 2014). 
 The intestinal barrier itself is a complex defensive system which consists of a 
tight epithelial cell wall, a mucous layer, which varies in thickness along the 
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intestine, active immunoglobulins, in particular immunoglobulin A, and epithelial 
produced anti-microbials (McGuckin et al., 2009). In addition to protecting against 
invading pathogens, the intestinal barrier, in particular the epithelial cell layers is 
critical for maintaining efficient trans-cellular ion transport. Cell-cell adhesion 
proteins are critical in this regard, as they maintain the structural integrity of the 
epithelium, and thus the osmotic electrical gradients vital for ion transport 
regulation. The most well characterised of these are the tight junction (TJ) protein 
complexes which are composed of several transmembrane proteins and include, 
occludins, several members of the claudin family as well as scaffolding proteins 
which include the zonula occludens (ZO) family,ZO1-3 (Tsukita et al., 2001) The 
occludins and claudins are major components of the para-cellular junctional 
complex, forming a barrier which is selectively permeable to several small molecules 
and ions including Cl
-
 (Figure 1.5, Hartstock et al., 2008). This selective 
permeability is made possible by several members of the claudin family which have 
can directly regulate passive transport of ions and nutrients via an extracellular loop 
domain, with selectivity for cations (Hartstock et al., 2008). The scaffolding proteins 
(ZO-1-3), as suggested by their name, provide a structural link for the main 
transmembrane proteins of the junctional complex to the actin cytoskeleton of the 
intestinal enterocyte (Figure 1.5; Hartstock et al., 2008).  
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Figure 1.5. Transmembrane proteins occludin and claudin seal the paracellular space 
between adjacent epithelial cells and claudins in particular allow for selective 
transport of small molecules such nutrients and cations through the paracellular 
space. The ZO family proteins, act as adaptors that connect transmembrane proteins 
to the actin cytoskeleton of the enterocyte. (Image adapted from; (Turner, 2009) 
 
1.10.2 Interactions between the microbiota and Tight Junction Proteins 
 
 Various pathogens, including E. coli, have been shown to affect TJ proteins 
indirectly via phosphorylation of the myosin light chain, a key component of the 
contractile actomyosin ring which interacts with TJ complexes (Scott 2002). 
However, pathogens such as Shigella flexneri, Salmonella enterica serovar 
Typhimuriu can also directly interrupt TJ proteins by altering phosphorylation states 
and overall distribution of TJ proteins, such as occuldin and  ZO1(Kohler 2007, 
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Boyle,. 2006).In contrast, however, probiotics have been demonstrated to have a 
positive influence with regard to maintenance and protection of  the epithelial 
barrier, and do so by a number of mechanisms including increasing secretion of  
mucous, anti-microbials such as beta defensins and altering tight junction proteins 
(Ohland and Macnaughton, 2010a).  
 Most studies to date have implied a protective role for probiotics against 
pathogen or inflammatory induced changes in TJ protein expression, activity and 
organisation. For example, several species of Lactobacillus including L. salivarius 
UCC 118 are capable of protecting against hydrogen peroxide induced disruption in 
barrier function and TJ membrane localisation, and this ability is inversely related to 
bacteriocin production  (Miyauchi et al., 2012a). Furthermore a recent study has 
demonstrated  powerful potential probiotic treatment of barrier dysfunction. This 
study demonstrated the ability of a probiotic, B. fragilis NCTC 9343, previously 
effective in correcting model colitis (Mazmanian et al., 2008), to reverse barrier 
permeability in the maternal immune activation (MIA) model, a model of autism 
spectrum disorders (Hsiao et al., 2013). Moreover reversal was also associated with 
amelioration of MIA induced changes in TJ proteins, claudins 8 and 15.  Such 
studies highlights the broad impact of barrier modulating probiotics and emphasise 
the need for further investigation of therapeutic potential. However, although much 
is known about the potential for probiotics to protect against disease induced changes 
in TJ function and expression, the effects of probiotic on normal TJ function is 
relatively underappreciated and more recent studies have begun to show the ability 
of probiotics to directly interact with and modulate TJ proteins in the absence of  
physiological insults (Table 1.5). 
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 One of the first studies to examine direct interactions of probiotics with TJ 
proteins  examined the effects of Lactobacillus acidophilus ATCC4356 and 
Streptococcus thermophilus ATCC1925 on barrier function in Caco-2 intestinal 
epithelial cells  demonstrating differential effects when using the probiotics in 
combination rather than separately (Resta-Lenert and Barrett, 2003). When used 
separately, both probiotics induced an increase in TER after 12 hours and up to 24 
hours, however, when used in combination, a larger increase in TER was observed 
after only 6 hours and the effect also persisted after 24 hours indicating a lasting 
change in para-cellular permeability and barrier integrity (Resta-Lenert and Barrett, 
2003). The increase in TER following the probiotic combination was associated with 
an increase in phosphorylated ZO-1 and Occludin. Interestingly, although pre-
treatment with  L. acidophilus ATCC4356/S. thermophilus ATCC1925 combination 
prevented a pathogen induced down regulation of actinin phosphorylation, the 
probiotics had no effects on actinin in non-infected cells (Resta-Lenert and Barrett, 
2003). Furthermore, as pre-treatment was required for the protective effects of the 
probiotics this suggests that, the protection of actinin phosphorylation was likely due 
to direct microbe-microbe interaction (possibly competitive antagonism), while the 
effects on ZO-1 and Occludin-1 were due to direct host-microbe interactions 
between the probiotics and the intestinal cells. Therefore, the importance of studying 
baseline effects of probiotics is evident to distinguish direct effects of probiotic host-
microbe interactions and thus establish the mechanisms involved. Furthermore, as 
will be highlighted by the following studies, the importance of examining individual 
strains is crucial.  
 A recent study examined the influence of several Lactobacillus strains on 
barrier function and TJ proteins in T84 IECs, demonstrating strain specific 
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influences (Hummel et al., 2012). All probiotic strains used , L. acidophilus PZ 
1041, L. gasseri PZ 1160, L. fermentum PZ 1162, and L. rhamnosus PZ 1121 
increased TER. The increase in TER correlated with an increased expression of E-
cadherin following incubation with L. acidophilus PZ 1041, L. gasseri PZ 1160, L. 
fermentum PZ 1162, but not L. rhamnosus PZ 1121 while an increase in activated β-
catenin, was induced in particular by L. acidophilus PZ 1041 and L. rhamnosus PZ 
1121 (Hummel et al., 2012). Moreover, membrane expression of activated PKC-δ, 
which can bind to E-cadherin and disturb the AJ complex, was decreased by all four 
Lactobacillus strains suggesting this is a possible probiotic target. Interestingly, in 
contrast to the gram negative strain E coli Nissle 1917 which augmented ZO-2 
protein expression likely through a decreased activation and expression of PKC-ζ 
(Zyrek et al., 2007), little or no upregulation of ZO-2 was observed following 
Lactobacillus strains in this study, while L. acidophilus PZ 1041 even caused a 
decreased in ZO-2 protein expression (Hummel et al., 2012). Together, these results 
highlight the impact of specific extracellular envelopes on host-microbe interactions 
and though a clear difference in molecular targeting between gram-postive and 
gram-negative probiotics is apparent, strain differences are also seen between strains 
of the same species. 
 L. rhamnosus GG ATCC 53103 is an extremely well characterised probiotic 
and has been noted for its positive and protective immuno-modulator effects through 
secretion of effector proteins (Yan et al., 2011). A recent study in neonatal C57/BL6 
mice demonstrated that  L.  rhamnosus GG ATCC 53103 could accelerate small 
intestinal barrier maturation and this was associated with an increase in Claudin-3 
protein expression (Patel et al., 2012). Interestingly, while the bioactive involved 
was heat resistant up to 70°C, heat killing the bacteria at this temperature prevented 
 66  
cytotoxic effects associated with a high dose of probiotic while maintaining the 
positive effects on barrier maturation and TJ protein expression (Patel et al., 2012). 
This suggests that bioactive molecules produced by probiotics may be isolated and 
used in the absence of live bacterial cultures thus avoiding dangers associated with 
administering live bacterial cultures to hosts with compromised barrier and immune 
function (Liong, 2008). L. rhamnosus GG ATCC 53103 has also been shown to 
upregulate tight junction proteins in human colonic epithelial cells via an 
unidentified secreted molecule and increased TER and TJ protein expression in 
human epidermal skin cells in a strain specific manner independent of  Toll Like 
Receptor (TLR) 2 signalling (Escamilla et al., 2012; Sultana et al., 2013)  
 In contrast to L. rhamnosus GG ATCC 53103, Lactobacillus plantarum 
WCFS1 has been shown to increase apical but not cytoplasmic expression of 
Occludin and ZO-1 in both human duodenal biopsies and Caco-2 cell mono-layers, 
and the increase in Occludin could be recapitulated using a TLR-2 agonist 
suggesting this as a possible molecular target of this probiotic strain (Karczewski et 
al., 2010).  
 Lactobacillus plantarum MB452 is probiotic used in the probiotic mix 
VSL#3 which has previously shown efficacy for the treatment of pain, TJ proteins 
disruption and barrier dysfunction in inflamed intestine (Madsen, 2001; Schlee et al., 
2008; Dai et al., 2012). When isolated and exposed to T84 cell mono-layers, 
Lactobacillus plantarum MB452 induced an increase in TER and increased protein 
expression of ZO-1, ZO-2, Occludin and cingulin (Anderson et al., 2010). 
Furthermore, gene expression analysis demonstrated an up-regulation and 
downregulation respectively of genes associated with tight junction stability and 
disassembly (Anderson et al., 2010). Moreover, genes altered in this study differed 
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from those altered in previous studies using probiotic mix, VSL#3, such as 
decreasing inflammatory cytokines (Jijon et al., 2004; Schlee et al., 2008) indicating 
the specific effects of each probiotic.  
 Conditioned medium (CM) from Bifidobacterium infantis Y1, used in the 
probiotic mix VSL#3 (previously demonstrated to enhance epithelial barrier function 
(Madsen et al., 2001)) demonstrated a superior ability to increase TER in T-84 cells 
following 4 hours of incubation (Ewaschuk et al., 2008). This was associated with 
decreased paracellular permeability to mannitol and correlated with an increase in 
Occludin, ZO-1, Claudin 1,3 and 4 expression (Ewaschuk et al., 2008). Moreover, 
when tested in Il-10
-/- 
mouse model of colitis, CM from this probiotic restored barrier 
function (TER) and this was associated with a restoration of baseline and forskolin 
induced changes in Isc  (Ewaschuk et al., 2008). This suggests that restoration of 
barrier function through modulation of tight junction proteins also plays an important 
role in the ability of this probiotic to protect against loss in epithelial ion transport 
function, although effects on trans-cellular ion transporters cannot be discounted 
(Resta-Lenert and Barrett, 2006). 
 Two other strains have been demonstrated to have direct effects on TJ 
proteins. Caco-2 cell mono-layers exposed to cell-free supernatants of 
Bifidobacterium lactis 420, demonstrated an increase in TER as well as a 
modification of TJ proteins associated with a change in cyclo-oxygenase activity 
(Putaala et al., 2008). Finally, although carried out in human epidermal 
keratinocytes, Bifidobacterium longum ATCC 51870 was able to strain dependently 
increase TER after 24 hours incubation and this correlated with an increase in the 
expression of ZO-1, Occludin, Claudins 1 and 4 (Sultana et al., 2013). Moreover, 
this effect appeared to be TLR-2 mediated as, pre-treatment of the cells using a TLR-
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2 neutralising anti-body abolished the effect of the probiotic on TER (Sultana et al., 
2013). Peptidoglycan, a known TLR-2 agonist and known to be expressed on the cell 
surface of gram positive bacteria, a may have been partially responsible for effect of 
Bifidobacterium longum ATCC 51870, as this peptide also induced an increase in 
TER but did not appear to alter TJ protein expression (Sultana et al., 2013). 
 Finally, E. coli Nissle 1917, one of the earliest identified probiotic strains and 
also one of the most studied (Nissle, 1916; Jacobi and Malfertheiner, 2011), has been 
demonstrated to have positive effects in both pathogen induced and inflammatory 
bowel disorders (Jacobi and Malfertheiner, 2011). However, recently the effects of 
this species on baseline TJ protein fuction have been tested in human and mouse 
intestinal cell monolayers (Ukena et al., 2007; Zyrek et al., 2007; Veltman et al., 
2012; Hering et al., 2013). In comparison to gram positive Lactobacillus strains 
which target PKC-δ and upregulate AJ protein complexes in T-84 IEC's (Hummel et 
al., 2012), E. coli   Nissle   1917, a gram negative bacteria, exposed to the same cell 
line, appears to target PKC-ζ causing, increasing its membrane expression but 
decreasing phosphorylation and thus activity resulting in increased TER correlated 
with increased ZO-2 expression and TJ localisation (Zyrek et al., 2007). In contrast, 
although increases in ZO-1 mRNA and protein expression and decreased 
permeability were observed in murine IEC isolated from germ free mice, no changes 
were observed in ZO-2 or TER, (Ukena et al., 2007). Although this may indicate a 
role for the host-microbiota in regulating host responses to E. coli Nissle 1917, given 
that previous effects were observed in T-84 IEC's, devoid of functioning 
microbiome, the differential effect is likely due to methodology as cells were 
isolated from whole tissue following in-vivo treatment with the probiotic (Ukena et 
al., 2007). Interestingly, although no effects were observed on baseline Isc, E. coli 
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Nissle 1917 restored sodium absorption in germ free mice with DSS induced colitis 
demonstrating that the positive impact on barrier function can also impact ion 
transport (Ukena et al., 2007).  
 In slight contrast to these studies, a more recent study has managed to 
identify a secreted bioactive factor produced by E. coli Nissle 1917 which positively 
modulates barrier integrity and TJ protein expression (Hering et al., 2013). HT-
29/B6 IEC's were treated with supernatant from E. coli Nissle 1917,  which resulted 
in an increase in TER, and Claudin-14 with no changes in ZO-1, Occludin, Claudin 
1-5, 7,8,10 or baseline Isc (Hering et al., 2013). In divergence from previous the 
previous studies, this effect was mediated through increased phosphorylation and 
activity of PKC-ζ as well as  ERK1/2, and this effect was lost in E. coli   Nissle   
1917 mutants lacking TcpC protein (Hering et al., 2013). As previous studies used 
live bacterial cells, this may suggests that isolation of secreted bioactives from E. 
coli   Nissle   1917  can produce different effects in the absence of the cell, similar to 
Lactobacillus rhamnosus GG ATCC 53103 (Patel et al., 2012), demonstrating the 
importance of fully elucidating the bioactive content and activity of individual 
probiotic strains.   
 However, as this experiment was carried out in a different cell line, further 
studies are required to verify the differential effects of  E. coli   Nissle 1917 and its 
extracellular bioactives on intestinal function. Overall, these studies demonstrate the 
ability of probiotics to directly modulate TJ protein function and barrier function, 
including ion permeability and transport function, in healthy tissue, warranting 
further investigation of probiotic effects on baseline intestinal barrier function.  
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Table 1.5. Direct Effects of probiotics on TJ function in normal conditions 
Probiotic  Physical Effect Signalling Molecule Signalling 
Mechanism 
Model Reference 
Bifidobacterium infantis Y1 
(VSL#3) 
↑ TER                                                                               
↓ paracellular 
permeability                   
(to mannitol)                                            
↑ Occludin, ZO-1,                               
↑ Claudin 1,3 and 4                                                                       
↓ Claudin 2   
Unidentified (Present 
in cultured 
supernatant) 
↑ ERK1/2 
phosphorylation                               
↓p38 
phosphorylation 
T84 (Human 
IEC)
Ewaschuk 
et al., 2010 
Bifidobacterium lactis 420 
↑ TER Unidentified secreted 
metabolite 
Unknown Caco-2 
(Human IEC) 
Putaala et 
al., 2008 
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1 
Bifidobacterium longum ATCC 
51870 
↑ TER                                                                         
↑ZO-1,                        
Occludin,                      
Claudins 1 and 4             
May be partially
mediated by 
peptidoglycan 
TLR-2 mediated Normal 
human 
epidermal 
keratinocytes 
(NHEK) 
Sultana et 
al., 2013 
Escherichia   coli   Nissle   1917 
↑ TER,                                                                          
↑ZO-2 expression and TJ 
localisation                        
Unidentified ↑PKC-ζ expression                                   
↓PKC-ζ 
phosphorylation (↓ 
activity) 
T84 (Human
IEC) 
Zyrek et 
al., 2006 
↑ ZO-1 expression (non-
DSS treated)                                                                                   
No changes in TER                                                       
↓ permeability ( to Evans 
blue)                           ↓ 
Unidentified Unknown Isolated IEC 
from DSS 
treated Germ 
free Balb/c 
Ukena et 
al., 2007 
   
7
2
 
inhibition of sodium 
absorption    
mice 
↑ TER,                                                                              
↑ Claudin-14 expresson.                                         
↓ permeability to Na+ 
and Cl-                            
(No influence on ZO-1/2)     
TcPC (Present in
cultured
supernatant) 
↑PKC-ζ 
phosphorylation (↑ 
activity)          ↑ERK 
1/2 phosphorylation 
(↑activity)                                    
HT-29/B6 
(Human IEC) 
Hering et 
al., 2013 
Escherichia   coli   Nissle   1917 
↑ TER (TJ proteins??) Unidentified Differential 
regulation of miR-
203, miR-483-3p, 
miR-595. 
T84 (Human 
IEC) 
Veltman et 
al., 2012 
Lactobacillus acidophilus 
ATCC4356 /Streptococcus 
↑ TER, ↓ permeability;  Unidentified heat 
inactivated bacterial 
↑ occludins, ZO-1, 
ERK 1/2 
Caco-2 
(Human IEC) 
Resta-
Lennert 
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thermophilus ATCC1925 cell factor phosphorylation 
(↑activity) 
and Barret, 
2003 
Lactobacillus acidophilus PZ  
1041 
↑TER,                                                                              
↑E-cadherin expression 
Unidentified (Possibly 
Gram positive 
dependant) 
↓PKC-δ membrane 
expression                
↑β-catenin 
phosphorylation  
(↑activity) 
T84 (Human 
IEC) 
Hummel et 
al.,2012 
Lactobacillus casei ATCC   334 
↑ZO-1 Secreted molecule ≥ 
100kDa 
Unknown  Human colon 
carcinoma cell 
line HCT-116 
Escamila et 
al., 2012 
Lactobacillus fermentum PZ 1162 
↑TER,                                                                              
↑E-cadherin expression 
Unidentified (Possibly 
Gram positive 
dependant) 
↓PKC-δ membrane 
expression                 
T84 (Human 
IEC) 
Hummel et 
al.,2012 
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Lactobacillus gasseri PZ 1160 
↑TER,                                                                              
↑E-cadherin expression 
Unidentified (Possibly 
Gram positive 
dependant) 
↓PKC-δ membrane 
expression                 
T84 (Human 
IEC) 
Hummel et 
al.,2012 
Lactobacillus plantarum MB452 
(VSL#3) 
↑TER,                                                                        
↑ZO-1 and 2, Occludin 
and cingulin expression 
among others (See ref. 
for full list)                                              
↓ expression of genes 
associated with barrier 
degredation (See ref. for 
full list) 
Unidentified Unknown Caco-2 
(Human IEC) 
Anderson 
et al., 2010 
Lactobacillus plantarum WCFS1 
↑Apical Occludin and Unidentified but  not 
present in conditioned 
Possibly TLR-2 
Healthy 
Human 
Karczweski 
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ZO-1 medium, possibly cell 
envelope proteins e.g. 
lipoteichoic acids and 
lipoproteins (Buwitt-
Beckmann et al., 
2006) 
  
mediated duodenal 
biopsy 
et al., 2010 
↑Apical ZO-1 Caco-2 
(Human IEC) 
Lactobacillus rhamnosus GG 
ATCC 53103 
↑ TER                                                                  
↑ZO-1, Occludin, 
Claudin-1 expression            
Unidentified Unknown Normal 
human 
epidermal 
keratinocytes 
(NHEK) 
Sultana et 
al., 2013 
↑ZO-1 Secreted molecule ≥ Unknown  Human colon 
carcinoma cell 
Escamila et 
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100kDa line HCT-116 al., 2012 
↑Claudin-3,                                                                  
↓ permeability,                                      
↑maturation of intestinal 
barrier 
Heat stabile to 70°C Unknown C57BL/6J 
mouse ileum 
(distal 3rd of 
small 
intestine) 
Patel et al., 
2012 
Lactobacillus rhamnosus PZ 
1121 
↑ TER  Unidentified (Possibly 
Gram positive 
dependant) 
↓PKC-δ membrane 
expression                    
↑β-catenin 
phosphorylation  
(↑activity) 
T84 (Human 
IEC) 
Hummel et 
al.,2012 
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1.11  Microbial Endocrinology 
 
 The relationship between enteric microbiota and the enteric nervous system 
has resulted in the evolution of new field termed microbial endocrinology (Lyte, 
2004). Microbial endocrinology is a relatively new inter-disciplinary field bringing 
together microbiology and neuroscience with the aim of gaining greater insight into 
host-microbial interactions and their role in health and disease (Lyte, 2011). It has 
been well established that the neuroendocrine system can influence the growth and 
pathogenesis of certain pathogenic bacteria, including Clostridium perfringens (Lyte, 
2004). However, for a long time this was considered to be an indirect effect due to 
ENS depression of the host immune system (Evans et al., 1948). It wasn't until the 
early 1990's that several well characterised neurotransmitters, in particular, 
norepinephrine were shown to directly enhance the growth of numerous gram 
negative species of bacteria (Lyte and Ernst, 1992) .This implied the existence of 
neurotransmitter receptors on bacterial cells and together with the known ability of 
bacteria to produce the corresponding ligands, led to the proposal of a bi-directional 
axis of communication between the nervous system and host microbes (Lyte , 2010).  
Therefore, given the vast role of the ENS in intestinal function and regulation as well 
as the relatively in depth understanding achieved to date, an approach examining the 
influence of microbially produced neuropeptides may indeed go long way in the 
quest to fully understand host-microbe interactions and the bioactive peptides 
involved. 
  In conclusion it is becoming clear that understanding host-microbe 
relationships is now critical to further advancing our knowledge of the 
gastrointestinal tract and developing microbial based therapies. Moreover, given the 
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vast milieu and variety of known microbial strains, their secreted bioactives and 
indeed those yet to be identified, it is essential that appropriate  experimental 
methodologies and techniques are developed and validated to screen for strains with 
specific therapeutic potential. 
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Aims and Objectives 
 
Intestinal ion transport is an important and highly regulated process, disturbances of 
which have been implicated in numerous intestinal disorders, and in particular in 
diarrheal disease, and are a common underlying cause of symptoms associated with  
inflammatory bowel diseases and irritable bowel syndrome (IBS) (Seidler et al., 
2006)(Binder, 2009)  
Emerging evidence now suggests a relationship between the occurrence of 
major GI disorders and dysbiosis of the host microbiota. Recently, several studies 
have begun to uncover evidence of a microbial influence on intestinal ion transport, 
including direct effects on Na
+
and Cl
-
 transport processes (Raheja et al., 2010), 
active Cl
-
 secretion (Heuvelin et al., 2010) as well as indirectly through immune and 
barrier function modulation (Bron et al., 2012). Indeed, the promise of  therapies 
including probiotic therapy and fecal microbiota transplant, targeted at altering the 
host-microbiome, in treating gastrointestinal(GI) disorders associated with adverse 
disturbances in ion transport, such as IBS and colitis, emphasise the importance of 
understanding host-microbe interactions (Shanahan and Quigley, 2014).  
The overall objective of this thesis was to gain further insight into the 
mechanisms underlying commensal microbial influences on intestinal ion transport. 
In this regard, I examined the impact of commensal host-microbe interactions on 
colonic secretomotor function in mouse. I set out to achieve this by investigating: 
 The impact of two specific probiotic microbe strains Bifidobacterium 
infantis 35624 and Lactobacillus salivarius UCC118 on murine 
colonic secretomotor function, both in-vivo and ex-vivo. (Chapter 2 ).   
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 The impact of the host-microbial environment on colonic 
secretomotor function and  host-microbe-probiotic (Bifidobacterium 
infantis 35624 and Lactobacillus salivarius UCC118) interactions 
using germ free mice.  (Chapter 3) . 
 An alternative approach to identifying the bioactives involved in 
mediating the physiological influences of probiotics. The influence of 
supernatants from a probiotic (Lactobacillus brevis DPC6108) known 
to produce a high, but specific concentration of a known probiotic 
metabolite, in this case, the neuroendocrine molecule γ-amino butryic 
acid (GABA). Secretomotor responses measured in Ussing Chamber 
were compared to those produced by the same concentrations of pure 
exogenous GABA, thus allowing us to determine the role of GABA 
as a probiotic bioactive with the ability to influence intestinal ion 
transport.  (Chapter 4) 
 The Ussing Chamber, an important physiological instrument both 
historically and currently for the study of intestinal ion transport and 
barrier function,  as a tool to study the impact of commensal microbes 
and their bioactives on ion transport (Chapters 2-4).  
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Chapter 2: 
Converging effects of a 
Bifidobacterium and Lactobacillus 
probiotic strain on mouse intestinal 
physiology 
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2.1 Abstract 
 
Evidence has grown to support the efficacy of probiotics in the management of 
gastrointestinal disorders, many of which are associated with dysregulated fluid and 
electrolyte transport. A growing body of evidence now suggests that the host 
microbiota and probiotics can influence intestinal ion transport, and that these effects 
often occur in a strain-dependent manner. In this study, I sought to investigate the 
effects of two therapeutically relevant organisms, Bifidobacterium infantis 35624 
and Lactobacillus salivarius UCC118, on small intestinal transit, fecal output and 
water content, transepithelial resistance (TER) and colonic secretomotor function. 
Mice fed either strain for two weeks displayed significantly reduced small intestinal 
transit in vivo compared to vehicle, though neither bacteria influenced fecal pellet 
output or water content. Colon from mice fed both strains displayed increased 
colonic TER, without a concomitant change in the gene expression of the tight 
junction proteins, claudin 1 and occludin. However, L. salivarius UCC118 
selectively inhibited neurally-evoked ion secretion in tissues from animals fed this 
particular strain.  Consistent with this finding, the neurotoxin, tetrodotoxin (TTx), 
significantly inhibited the short-circuit current response induced by L. salivarius 
UCC118 following addition to colonic preparations in Ussing chambers. Responses 
to Bifidobacterium infantis 35624 also displayed sensitivity to TTx, though to a 
significantly lesser degree than L. salivarius UCC118. Both strains similarly 
inhibited cholinergic-induced ion transport after addition to Ussing chambers. 
Further studies, therefore, are now warranted with respect to investigating the effects 
of B. infantis 35624 and L. salivarius UCC118 in disease contexts associated with 
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increased small intestinal transit and neurally-mediated infectious diarrhea in 
particular.  
Keywords: Commensal, enteric nervous system, short-circuit current, tight junction 
protein,  Ussing Chamber 
2.2 Background 
 
Probiotics are defined as live microorganisms, that, when ingested in adequate 
amounts, provide health benefits to the host (Fontana et al., 2013). Lactobacilli and 
Bifidobacteria represent two extensively studied probiotic species with demonstrated 
strain-dependant efficacy in a number of gastrointestinal diseases (Ritchie and 
Romanuk, 2012). In particular, Bifidobacterium longum subsp. infantis 35624 (B. 
infantis 35624) specifically relieves many of the symptoms associated with the 
functional bowel disorder, irritable bowel syndrome (IBS) (O’Mahony et al., 2005; 
Whorwell et al., 2006). Moreover, preclinical studies demonstrate that B. infantis 
35624 selectively inhibits colorectal distension-induced abdominal pain in contrast 
to Lactobacillus salivarius UCC118 (L.salivarius UCC118) and  Bifidobacterium 
breve UCC2003 (McKernan et al., 2010). These findings recapitulate those observed 
clinically, in which B. infantis 35624 was more effective at improving IBS 
symptoms when compared to a lactobacillus strain or placebo (O’Mahony et al., 
2005). However, in the context of experimental colitis both B. infantis 35624 and L. 
salivarius UCC118 had similar effects (McCarthy et al., 2003). Therefore, these two 
commensal organisms appear to exert different effects on the host depending on the 
context in which they are studied. However, the effects of B. infantis 35624 or 
L.salivarius UCC118 on host gastrointestinal physiology remain largely unknown.  
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In this regard, I sought to investigate the effects of B. infantis 35624 and L. 
salivarius UCC118 on intestinal transit and colonic ion transport. Intestinal fluid and 
electrolyte transport is a tightly regulated process which maintains a balance between  
electrolyte secretion and absorption (Kunzelmann and Mall, 2002). Electrogenic 
chloride ion secretion is driven by the apically expressed cystic fibrosis 
transmembrane conductance regulator (CFTR) and calcium-activated chloride 
channels, while epithelial sodium channels are responsible for active sodium 
absorption (Barrett and Keely, 2000).  
 
 Several studies now suggest that probiotics can directly or indirectly 
influence intestinal epithelial ion transport, and subsequently short-circuit current 
(Isc) (Lomasney and Hyland, 2013). Specifically, Lactobacillus acidophilus can 
influence the activity of key regulators of intestinal ion transport including CFTR, 
the downregulated in adnoma (DRA) anion exchanger and the basolaterally-
expressed sodium-potassium-chloride cotransporter (NKCC1) (Borthakur et al., 
2008; Resta-Lenert and Barrett, 2009; Raheja et al., 2010). These effects, however, 
are not unique to Lactobacillus acidophilus, and other strains can also influence 
these targets, for example Lactobacillus rhamnosus (DRA)(Raheja et al., 2010) and 
Streptococcus thermophiles (CFTR and NKCC1)(Resta-Lenert and Barrett, 2009). 
Moreover, the host microbiota (Lomasney et al., 2014), as well as specific probiotic 
and commensal organisms (Czerucka et al., 1994; Ewaschuk et al., 2008; Resta-
Lenert and Barrett, 2009; Heuvelin et al., 2010; Ohland et al., 2012), have the 
capacity alter secretagogue-evoked ion transport. 
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  Studies examining the effects of B. infantis 35624 and L.salivarius UCC118 
on intestinal ion transport, in the context of intestinal inflammation at 
least(Sommerfield et al., 2003; Feighery et al., 2008), suggest that these two strains 
may differentially influence colonic secretomotor function. Therefore, in this study I 
sought to determine the effects of B. infantis 35624 and L. salivarus UCC118 in 
healthy animals on small intestinal transit, fecal output and water content. I also 
characterized the effects of both strains on colonic ion transport and secretomotor 
function after either two weeks feeding or following acute addition to Ussing 
chambers.  
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2.3 Materials and Methods 
 
All drugs were obtained from Sigma-Aldrich Ltd. (Ireland) unless otherwise stated. 
The following compounds were used, with the final concentration and diluent in 
parenthesis, amiloride (100µM dissolved in dH2O) (Matos et al., 2007), bethanechol 
(100µM; dissolved in dH2O)(Hirota and McKay, 2006b), forskolin (10µM dissolved 
in DMSO) (Hyland and Cox, 2005), furosemide (100µM dissolved in 
DMSO)(Cuthbert et al., 1999), tetrodotoxin (300nM dissolved in sodium citrate 
buffer)(Ikehara et al., 2010) and veratridine (30µM; dissolved in 70% ethanol) 
(Hyland and Cox, 2005). Krebs buffer was prepared as follows, 1.2mM NaH2PO4 , 
117mM NaCl, 4.8mM KCl, 1.2mM MgCl2, 25mM NaHCO3, 11mM CaCl2 and 
10mM glucose. Chloride-free Krebs buffer was prepared to an equivalent osmolarity 
by replacing Cl
- 
with appropriate amounts of nitrate (Johns, 1980). of 116mM 
NaNO3, 5.4mM KNO3, 1.2mM NaH2PO4, 2.5mM Ca(NO3)2, 1.2mM Mg(NO3)2, 
22mM NaHCO3 and 11.2mM glucose .. B. infantis 35624 and L. salivarius UCC 118 
were from Alimentary Health Ltd. (Cork, Ireland). 
2.3.1 Animals 
 
Male Swiss Webster mice (22-35g) were obtained from Harlan, UK. All animals 
were kept on a 12-12h dark-light cycle (lights on at 7am) with food and water ad 
libitum, and were fasted overnight prior to measurement of small intestinal transit.   
All mouse experiments were conducted following institutional ethics guidelines and 
were in full accordance with the European Community Directive (86/609/EEC). 
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2.3.2 Preparation of probiotics  
 
Freeze-dried preparations of B. infantis 35624 and L. salivarus UCC118 were 
obtained from Alimentary Health Ltd. Briefly, both B. infantis 35624 and L. 
salivarus UCC118 were produced in large-scale fermenters, the bacterial pellet 
harvested, washed and the resultant supernatant discarded. The biomass was 
subsequently freeze-dried with cryoprotectant (Alimentary Health Ltd) was used as 
vehicle for comparison throughout. CFU was determined by the spread plate 
technique.  
2.3.2.(a) Probiotic feeding 
 
Freeze-dried probiotics and vehicle were reconstituted daily in dH2O, and a volume 
of 300μl containing 1 x 109 CFU/ml was administered to the mice daily by oral 
gavage for two weeks.  Mice in the same treatment groups were housed in pairs.  
2.3.2.(b) Preparation of probiotics for Ussing chamber studies 
 
For Ussing chamber studies bacteria were resuspended in Krebs buffer and added to 
the mucosal reservoir of the Ussing chamber to yield 1 x 10
9
 CFU/ml. The pH of the 
final suspensions was assessed; Krebs buffer (pH 7.0), vehicle + Krebs buffer (pH 
7.01), B.infantis 35624 + Krebs buffer (pH 6.94) and L. salivarius UCC118 + Krebs 
buffer (pH 6.97). To heat kill the probiotics, suspensions were maintained at 100°C 
for 30 minutes and were subsequently allowed to cool for 15 minutes prior to 
addition to the Ussing chamber. Probiotics were determined to be viable after 
resuspension in Krebs buffer, and failed to grow following heat treatment (data not 
shown).  
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2.3.3 Measurement of small intestinal transit 
 
To examine small intestinal transit, mice fed B. infantis 35624, L. salivarus UCC118 
or vehicle for two weeks were administered activated charcoal (0.5g in 10ml + 0.5% 
methylcellulose) by oral gavage (0.1ml/10g). 20 mins later mice were euthanized by 
cervical dislocation, the small intestine immediately removed and the distance 
travelled by the charcoal measured. 
 
2.3.4 Measurement of stress-induced fecal output and fecal water content 
 
To measure fecal output, mice fed B. infantis 35624, L. salivarus UCC118 or vehicle 
for two weeks, were placed individually in open single house rat cages lined with 
white photographic paper under direct light (lux reading of 1000). Fecal pellet output 
was measured every 15 mins for a period of 90 mins. Feces were collected in glass 
vials and sealed upon collection.  To measure fecal water content, faecal samples 
were weighed before and after desiccation at 60°C for 16 hours. The difference in 
weight was calculated as wet weight.   
2.3.5 Ussing Chamber Studies  
 
Mice fed B. infantis 35624 or L. salivarus UCC118 for two weeks were euthanized 
by cervical dislocation, the distal colon removed and placed in chilled Krebs 
solution. Seromuscular stripping was carried out by blunt dissection under a 
stereomicroscope, and both the longitudinal and circular muscle layers removed. The 
resulting mucosal-submucosal segments were mounted in Ussing chambers (exposed 
tissue area of 0.12cm
2
), maintained in Krebs solution at 37°C and oxygenated with 
carbogen gas (95% O2, 5% CO2). Tissues were voltage clamped to zero using an 
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automatic voltage clamp (DVC-1000/EVC-4000, World Precision Instruments, 
Sarasota, USA). Once a stable baseline was achieved, basal short-circuit current (Isc) 
and TER were recorded. Tissue responses to the neural activator, veratridine, as well 
as to bethanechol and forskolin, to assess calcium- and cAMP-mediated ion secretion 
respectively, were then measured.  All measurements were continuously recorded on 
a computer using LabTrax data acquisition hardware and analysed using DataTrax 
software (World Precision Instruments).  
 
 Using a separate group of experimentally naïve mice, I assessed the acute 
effects of B. infantis 35624 or L. salivarus UCC118 on colonic ion transport. Mice 
were euthanized and colonic tissue prepared as above. Once a stable baseline was 
achieved, basal Isc and TER were recorded, and either B. infantis 35624, L. salivarus 
UCC118 or vehicle added to the mucosal reservoir. The resultant peak change in Isc 
was recorded, after which bethanechol (15 mins) and forskolin (15 mins) were 
routinely added to the serosal reservoir. To investigate the contribution of chloride 
ions to the change in Isc induced by B. infantis 35624 or L. salivarus UCC118, 
Krebs was replaced with chloride-free Krebs buffer. To examine the contribution of 
ENaC, NKCC1 and the enteric nervous system on probiotic-stimulated changes in 
Isc, tissues were pre-treated with amiloride (mucosal), furosemide (serosal) or TTx 
(serosal) respectively.   
2.3.6 Analysis of tight junction protein gene expression 
 
Total RNA was extracted using a commercially available kit (Qiagen,Valencia, CA, 
USA). mRNA was reverse transcribed using a high-capacity cDNA reverse 
transcription kit 
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(Applied Biosystems, Foster City, CA, USA) in a G-Storm thermocycler (G-Storm, 
Ringmer, East Sussex, UK). Gene expression was analysed by qualitative real-time 
polymerase chain reaction using TaqMan Gene expression assays and the AB7300 
system (Applied Biosystems). Occludin (Ocln) was detected using the probe # 
Mm00500912_m1and claudin (Cldn 1) using probe #Mm00516701_ml. The 
expression of each gene was normalised to β actin. All samples were analysed in 
duplicate. 
 
2.3.7 Statistics 
 
Data were analysed and graphed using Graphpad Prism 5 by either one- or two-way 
ANOVA followed by post-hoc analysis using Bonferroni's Multiple Comparison 
Test. Data are presented as mean ± SEM and a P < 0.05 was considered statistically 
significant. 
  
  91 
2.4 Results 
 
2.4.1 Effects of B. infantis 35624 or L. salivarus UCC118 on small intestinal 
transit, fecal output and fecal water content after two weeks feeding 
 
Figure 2.1: Small intestinal transit was significantly decreased in animals fed 
Bifidobacterium infantis 35624 and Lactobacillus salivarius UCC118 relative to 
vehicle in vivo. *P<0.05. n=7-8.  
 
B. infantis 35624 and L. salivarus UCC4331 differentially influenced bowel 
movement difficulty in IBS patients without a concomitant change in stool 
consistency (O’Mahony et al., 2005). Therefore, I assessed whether B. infantis 
35624 or L. salivarus UCC118 differentially influence small intestinal transit as well 
as fecal output and water content. Both B. infantis 35624 and L. salivarus UCC118 
significantly decreased small intestinal transit relative to vehicle after two weeks of 
feeding (Fig. 2.1; P < 0.05). However neither strain significantly altered stress-
induced fecal output or water content (Fig. 2.2 A & B). Therefore, both strains exert 
similar inhibitory effects on small intestinal transit, but do not appear to influence 
fecal output or water content.  
Table 2.1: Gene expression of the tight junction proteins Occludin 1 and Claudin 1 
in the mouse colon following two weeks of feeding with Bifidobacterium infantis 
35624 and Lactobacillus salivarius UCC118.  
Gene Gene expression following probiotics (delta Ct) 
  Vehicle (n=8) B.infantis (n=11) L.salivarius (n=9) 
Occludin  0.88±0.15 0.85±0.13 0.99±0.15 
Claudin 1 0.48±0.11 0.43±0.07 0.47±0.08 
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Figure 2.2: Neither Bifidobacterium infantis 35624 nor Lactobacillus salivarius 
UCC118 significantly influenced stress-induced fecal pellet output (A) or water 
content (B) in response to a mild stress. n=10-11. 
 
2.4.2 Effects of B. infantis 35624 and L. salivarus UCC118 on transepithelial 
resistance and tight junction protein gene expression after two weeks feeding 
 
A number of probiotics have the capacity to influence intestinal epithelial barrier 
function  (Ohland and Macnaughton, 2010b). In particular, L. salivarus UCC118 has 
demonstrated beneficial effects on colonic permeability during colitis (Feighery et 
al., 2008), and can protect against  hydrogen peroxide-induced reductions in TER in 
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vitro  (Miyauchi et al., 2012). Therefore, after feeding mice B. infantis 35624 and L. 
salivarus UCC118 for two weeks I assessed colonic TER in Ussing chambers, and 
analyzed tissues for the expression of  two tight junction protein genes known to be 
influenced by L. salivarus UCC118 (24).  Both B. infantis 35624 and L. salivarus 
UCC118 increased TER, the later significantly so (Fig. 2.3). However, neither 
probiotic altered the gene expression of either claudin 1 or occludin after two weeks 
feeding (Table 2.1).  The observed increase in TER may be indicative of potential 
barrier-enhancing properties of the strains.  
 
Figure 2.3: Colonic transepithelial resistance (TER) was assessed in mucosa-
submucosa preparations mounted in Ussing chambers. Tissues from animals fed 
Bifidobacterium infantis 35624 displayed a significantly increased TER relative to 
those from the vehicle-fed group. *P<0.05. n=8-9. 
 
 
2.4.3 Ex vivo assessment of baseline and secretagogue-evoked colonic ion 
transport in animals fed B. infantis 35624 and L. salivarus UCC118 
 
To further investigate the effects of B. infantis 35624 and L. salivarus UCC118 on 
colonic physiology I examined tissue responses to a number of secretory stimuli in 
animals fed both bacterial strains for two weeks. Specifically, I examined calcium-
stimulated ion transport using the cholinomimetic, bethanechol, cAMP-mediated ion 
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transport using forskolin and neurally-mediated ion transport using the sodium 
channel activator, veratridine. Both strains reduced baseline Isc relative to vehicle (P 
< 0.05, Fig. 2.4A), however neither strain significantly influenced the tissue 
response to either bethanechol (Fig. 2.4B) or forskolin (Fig. 2.4C). Veratridine-
induced ion transport was, however, significantly decreased in tissues collected from 
animals fed L. salivarus UCC118 only (Fig. 2.4D; P<0.05). Thus, both B. infantis 
35624 and L. salivarus UCC118 similarly influence basal colonic ion transport. 
However, only L. salivarus UCC118 inhibits neurally-mediated responses.  
 
 
Figure 2.4: Baseline (A) and stimulated (B-D) short-circuit current (Isc) responses 
were assessed in colonic tissues from animals fed Bifidobacterium infantis 35624 
and Lactobacillus salivarius UCC118. Both bacteria significantly decreased basal 
Isc (A), and neither had a significant effect on either bethanechol- or forskolin-
induced ion transport (B & C). Lactobacillus salivarius UCC118 significantly 
inhibited veratridine-induced ion transport relative to vehicle and Bifidobacterium 
infantis 35624(D). *Vehicle versus probiotic, *P<0.05; 
# 
Bifidobacterium infantis 
35624 versus Lactobacillus salivarius UCC118,
 #
 P<0.05. n=5-8.  
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2.4.4 Characterization of the acute effects of B. infantis 35624 or L. salivarus 
UCC118 on colonic ion transport in Ussing chambers 
 
 
Figure 2.5: The acute effects of Bifidobacterium infantis 35624 and Lactobacillus 
salivarius UCC118 on colonic short-circuit current (Isc) responses were measured 
following addition of either microbe to the mucosal compartment of the Ussing 
chamber.  Both viable and heat-killed Bifidobacterium infantis 35624 (A) and 
Lactobacillus salivarius UCC118 (B) significantly increased baseline Isc relative to 
vehicle. *P<0.05, **P<0.01, ***P<0.01. n=5-9. 
 
 
To characterize the potential mechanisms underlying the effects of B. infantis 35624 
and L. salivarus UCC118 on colonic ion transport , I took a number of experimental 
approaches; (i) ion exclusion studies, using chloride-free Krebs, to investigate the 
contribution of chloride ions to the  Isc response evoked by B. infantis 35624 and  L. 
salivarus UCC118 (ii) pharmacological studies using furosemide to inhibit 
basolateral NKCC1 and amiloride to inhibit epithelial sodium channels and (iii) the 
neurotoxin, TTx, to the examine the effects of B. infantis 35624 and L. salivarus 
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UCC118 on enteric neurons. In additional experiments, the bacterial strains were 
heat-killed to investigate whether viable bacteria were required to induce their 
effects on colonic ion transport. The acute effects of B. infantis 35624 and L. 
salivarus UCC118 on bethanechol- and forskolin-induced changes in Isc were also 
examined. Both viable and heat-killed B. infantis 35624 and L. salivarus UCC118 
significantly increased baseline Isc relative to vehicle following mucosal addition to 
the Ussing chamber (Fig. 2.5). 
Table 2.2: The effects of pharmacological manipulation and ion exclusion on the 
baseline response of mouse colon to Bifidobacterium infantis 35624 and 
Lactobacillus salivarius UCC118 in Ussing chambers.  
Manipulation B.infantis 35624 L.salivarius UCC118 
Krebs 18.91±4.21 µA.cm
-2
  (n=6) 22.53±7.45 µA.cm
-2
 (n=6) 
Chloride-free Krebs 17.30±3.24 µA.cm
-2
  (n=6) 52.70±12.00 µA.cm
-2
 *(n=6) 
Vehicle (dH2O) 20.74±5.18 µA.cm
-2 
(n=6) 25.52±3.32 µA.cm-2 (n=5) 
Amiloride  26.07±1.31 µA.cm
-2 
(n=10) 27.47±4.47 µA.cm
-2
 (n=5) 
Vehicle (DMSO) 25.24±3.71 µA.cm
-2 
(n=6) 28.81±0.71 µA.cm
-2 
(n=6) 
Furosemide 21.77±7.94 µA.cm
-2 
(n=7) 23.12±3.04 µA.cm
-2 
(n=6) 
* P <0.05, Krebs versus Chloride-free Krebs. 
 
 In experiments conducted with chloride-free Krebs, the response to L. 
salivarus UCC118 was significantly increased relative to vehicle (Table 2.2). 
Neither basolateral addition of furosemide nor apical addition of amiloride 
significantly altered the Isc response elicited by either bacterial strain (Table 2.2). 
Pre-treatment of tissues with TTx significantly inhibited the response to both B. 
infantis 35624 (P < 0.01; Fig. 2.6A) and to L. salivarus UCC118 (P < 0.001; Fig. 
2.6B), with the extent of inhibition greater for L. salivarus UCC118 (approx. 60% 
reduction in Isc response; Fig. 2.6A & B).  
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Figure 2.6: To investigate the sensitivity of the Bifidobacterium infantis 35624- and 
Lactobacillus salivarius UCC118-induced effects on short-circuit current (Isc) to 
neural blockade, tissues were pre-treated with tetrodotoxin (TTx) prior to luminal 
addition of the microbes. The magnitude of the Isc response to Lactobacillus 
salivarius UCC118 was significantly greater than that of Bifidobacterium infantis 
35624, and the response to both bacteria displayed sensitivity to TTx (A). 
Representative trace demonstrating the effect of TTx on the Lactobacillus salivarius 
UCC118-induced response in mouse colon (B). * Bifidobacterium infantis 35624 
versus Lactobacillus salivarius UCC118, **P<0.01,***P<0.001; 
# 
vehicle versus 
TTx,
 #
 P<0.05, 
##
 P<0.01. n=5-6.  
 
 
Both B. infantis 35624 (P < 0.05) and L. salivarus UCC118 (P < 0.01) significantly 
inhibited bethanechol-induced Isc (Fig. 2.7A), and neither strain influenced cAMP-
mediated ion transport (Fig. 2.7B). Thus, chloride ions do not appear to significantly 
contribute to the increase in Isc observed in response to acute exposure of tissues to 
B. infantis 35624 or L. salivarus UCC118, though their removal influences the 
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response to L. salivarus UCC118.  Both strains interact with the enteric nervous 
system, with L. salivarus UCC118 displaying greater sensitivity to the neurotoxin 
and both bacteria similarly inhibit cholinergic-induced ion transport. 
 
Figure 2.7: The acute effects of Bifidobacterium infantis 35624 and Lactobacillus 
salivarius UCC118 on bethanechol- and forskolin-induced ion transport were 
assessed following mucosal addition of the microbes to the Ussing chamber. Both 
Bifidobacterium infantis 35624 and Lactobacillus salivarius UCC118 significantly 
decreased bethanechol-induced ion transport (A), while neither bacteria had an effect 
on forskolin responses (B). *P<0.05. n=4-6. 
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2.5 Discussion 
 
I have demonstrated that both B. infantis 35624 and L. salivarius UCC118 similarly 
inhibit small intestinal transit, increase TER and decrease baseline short-circuit 
current in tissues obtained from mice fed each strain for two weeks. However, in 
animals fed L. salivarius UCC118, neurally-evoked colonic ion transport was 
selectively inhibited. The TTx sensitivity of the L. salivarius UCC118 response 
observed in Ussing chamber studies further supports a predominantly neural effect of 
this organism on secretomotor function. Also notable, following acute exposure of 
tissues to either B. infantis 35624 or L. salivarius UCC118, was the similar 
inhibition of cholinergic-induced ion transport by both microbes. Additional 
experiments revealed that removal of chloride ions significantly increased the 
magnitude of the baseline response to L. salivarius UCC118 only, and that both 
strains induced similar effects on baseline short-circuit current irrespective of heat-
killing in acute tissue experiments.  
 
 Recent evidence suggests that probiotics exert both strain- and region-
specific effects on gut physiology(Wu et al., 2013). For example, Lactobacillus 
rhamnosus and Lactobacillus reuteri differentially influence migrating myoelectric 
complex parameters in mouse jejunal and colonic preparations (Wu et al., 2013). 
Moreover, the probiotic mix, VSL#3, also exerts region-specific effects on 
gastrointestinal motility in isolated tissue preparations (Massi et al., 2006a). Our data 
suggest that the inhibitory effects of B. infantis 35624 and L. salivarius UCC118 on 
small intestinal transit are not strain-dependent, and do not influence fecal output or 
water content when examined under mildly stressful conditions. I did not investigate 
the mechanism by which B. infantis 35624 or L. salivarius UCC118 inhibit small 
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intestinal transit further. Nevertheless, evidence suggests that probiotics may 
influence motility at the level of the enteric nervous system (Kunze et al., 2009a; 
Wang et al., 2010a, 2010b) or through direct effects on smooth muscle cells (Bär et 
al., 2009). Clinically, increased small bowel transit has been associated with 
diarrhoea-predominant IBS, stress and anxiety (Husebye, 1999). Therefore, probiotic 
interventions, using bacterial strains with the capacity to slow small intestinal transit, 
may be efficacious in these contexts. However, consideration must be given to the 
possibility that changes in small intestinal transit observed in this study could also be 
due to a change in the rate of gastric emptying (GE). For example Lactobacillus 
reuteri DSM 17938 has been shown to accelerate GE in human infants (Indrio et al., 
2009, 2011) while a combination of Lactobacillus rhamnosus R0011 and 
Lactobacillus helveticus R0052 delayed GE in a mouse model of post-infectious gut 
dysfunction (Verdu et al., 2008). Moreover, the delay in GE correlated with an 
improvement in para-cellular permeability(Verdu et al., 2008).  
 
 It has been suggested that an altered microbiota may contribute to intestinal 
inflammation, and therefore disrupted epithelial barrier function (McKernan et al., 
2010). Several probiotics exert beneficial effects on epithelial barrier function by 
regulating, for example, mucin gene expression, production of β-defensins, 
bacteriocins and secretory IgA as well as modulation of tight junction proteins 
(Ohland and Macnaughton, 2010a). I observed an increase in colonic TER in tissues 
from animals fed B. infantis 35624 or L. salivarius UCC118 for two weeks, which 
suggests that both strains may have the capacity to increase epithelial barrier 
function. However, I did not find an associated change in the gene expression of two 
tight junction genes, claudin 1 and occludin. In vivo studies, in the context of 
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experimental colitis, support a beneficial effect of L. salivarius UCC118 on intestinal 
permeability and suggest that this effect is bacteriocin-dependent, as bacteriocin-
negatve L. salivarius UCC118 did not significantly improve colitis-associated 
deficits in permeability in vivo (Miyauchi et al., 2012b). Moreover, in vitro studies 
further confirmed the beneficial effect of L. salivarius UCC118 on hydrogen-
peroxide induced changes in both TER and permeability, and this beneficial effect 
was accompanied by a redistribution of tight junction proteins, including claudin 1 
and occludin (Miyauchi et al., 2012b). The later findings may account for the 
absence of any change in gene expression observed in our study. However, changes 
in TER may not necessarily accompany changes in permeability. For instance, the 
beneficial effect of L. salivarius UCC118 on colitis-associated deficits in 
permeability were not accompanied by a change in TER or short-circuit current 
(Feighery et al., 2008). Our study, however, is the first to indicate a role for B. 
infantis 35624 in the modulation of TER. Potential mechanisms underlying this 
effect may include changes in tight junction gene expression, localisation or protein 
kinase activity previously described for other strains of B. infantis (Ewaschuk et al., 
2008; Bergmann et al., 2013). 
 
 There is now a growing appreciation that one of the mechanisms by which 
microbes interact with the host is through bacterial signalling to the enteric nervous 
system (Sharkey and Savidge, 2014). With respect to secretomotor function, our data 
indicate that L. salivarius UCC118 preferentially inhibits neurally-driven responses 
following chronic administration. Acute exposure of colonic preparations to L. 
salivarius UCC118 in the presence TTx further suggests a role for the enteric 
nervous system in mediating the effects this particular microbe on colonic ion 
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transport. The enteric nervous system also appears, although to a lesser degree, to 
contribute to the effects of B. infantis 35624 on the short-circuit current response 
elicited after short-term exposure in vitro. It is known, however, that different 
microbes have the capacity to differentially influence enteric nerve activity (Kunze 
et al., 2009a; Bercik et al., 2011; Khoshdel et al., 2013; Mao et al., 2013b). For 
example, Lactobacillus reuteri (Kunze et al., 2009a) and Bacteroides fragilis (Mao 
et al., 2013b) enhance, or activate, enteric nerve activity while Bifidobacterium 
longum  exerts an inhibitory effect (Bercik et al., 2011; Khoshdel et al., 2013). The 
inhibitory effect of L. salivarius UCC118, in particular, on enteric nerve activity may 
be of therapeutic importance in pathogen-mediated diarrheal diseases, in which 
neural pathways have been implicated, such as those caused by  Salmonella spp., 
Clostridium difficile (Jones and Blikslager, 2002) and rotavirus (Jodal et al., 1993). 
 
 The inhibition of cholinergic-induced ion transport by L. salivarius UCC118, 
in acute Ussing chamber studies, provides further evidence for an anti-secretory 
effect of this microbe. I also observed a similar effect of B. infantis 35624 on 
cholinergic responses. However,  others have observed strain-dependent effects for 
different microbes on this response (Heuvelin et al., 2010). Notably, Bifidobacterium  
breve C50 selectively inhibited carbachol-induced ion transport through an inhibition 
of protein kinase C activity (Heuvelin et al., 2010). In contrast,  Bifidobacterium  
breve 15698, Lactobacillus rhamnosus 10893 and  Escherichia rectale L15 had no 
such effect (Heuvelin et al., 2010). In the same study, strain-dependency was also 
noted with respect to the effects of  the different bacterial strains on forskolin-
induced ion transport (Heuvelin et al., 2010). However, I observed no effect of  B. 
infantis 35624 or L. salivarius UCC118 on forskolin-induced responses. Therefore, 
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both B. infantis 35624 and L. salivarius UCC118 appear to selectively inhibit 
cholinergic-induced ion transport relative to cAMP-mediated responses, and do not 
display strain-selectivity in this regard.  
 
 Our pharmacological studies did not discriminate whether the increase in 
short-circuit current observed in response to B. infantis 35624 or L. salivarius 
UCC118 after mucosal addition to the Ussing chamber were secretory or absorptive 
in nature. However, removal of chloride ions significantly increased the tissue 
response to L. salivarius UCC118. In the absence of chloride ions, increased 
secretion of bicarbonate could account for an increase in short-circuit current, similar 
to that which I observed in response to L. salivarius UCC118. However, Cl
-
/HCO3
-
 
exchange, facilitated by apically expressed DRA for example, is dependent on the 
presence of chloride ions, the activity of which would likely be reduced in the 
absence of chloride. Nonetheless, bicarbonate secretion may also occur via CFTR 
(Grubb, 1997). Moreover, in the absence of external chloride, the permeability of 
CFTR to bicarbonate may increase (Shcheynikov et al., 2004). Further 
characterisation of the ionic nature of the response elicited by both B. infantis 35624  
and  L. salivarius UCC118 is now warranted in order to better understand the ion 
transport processes underlying their effects on short-circuit current. Likewise, I can 
only speculate on the divergence observed between studies in which animals were 
fed both strains and those in which tissues were acutely exposed to B. infantis 35624 
or  L. salivarius UCC118. Based on the TTx sensitivity of the response elicited by B. 
infantis 35624 and  L. salivarius UCC118 observed in tissues acutely exposed to 
both strains, I speculate a neural reflex underlies the relatively immediate change in 
short-circuit current. However, following longer periods of exposure, several 
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microbes have been shown to alter the expression of key ion channels or exchangers 
in addition to indirectly influence ion transport through immune modulation 
(Lomasney and Hyland, 2013). 
 
 Collectively, our data suggest that both B. infantis 35624 and L. salivarius 
UCC118 significantly affect gastrointestinal physiology; slowing small intestinal 
transit and significantly influencing colonic secretomotor function. Both display 
anti-secretory effects following addition to Ussing chambers, inhibiting cholinergic-
induced responses. Moreover, L. salivarius UCC118 preferentially inhibits neurally-
evoked ion transport in animals fed the microbe for two weeks, suggesting that this 
strain, in particular, may be of benefit in countering diarrhea associated with neural 
activation. Further studies are now justified with respect to investigating the effects 
of  B. infantis 35624 and L. salivarius UCC118 in disease contexts associated with 
increased small intestinal transit and neurally-mediated diarrhea in particular. 
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Chapter 3: 
Selective Influence of Host Microbiota 
on Colonic Secretomotor Function 
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3.1 Abstract 
 
 More microbes are resident in the distal colon than any other part of the 
body, and this microbiota has the capacity to influence enteric nerve development, 
excitability and gastrointestinal function. Germ free (GF) mice are a valuable tool in 
interrogating the communication between microbiota and host. Despite the intimate 
relationship which exists between the microbiota and the colonic mucosa-
submucosa, there is a paucity of studies examining the influence of the microbiota on 
secretogogue-evoked responses. To this end, I investigated both epithelial and 
neural-evoked ion transport, and the response elicited by two commensal organisms, 
in colonic mucosa-submucosa preparations from GF mice in Ussing chambers. 
Baseline electrical parameters, short-circuit current and transepithelial resistance, 
were comparable between tissues from GF and conventional animals. Noteworthy, 
however, was a hyper-responsiveness of GF colon to forskolin stimulation. In 
contrast, the absence of the microbiota did not influence the tissue response to 
bethanechol. Moreover, responses to the sodium-channel activator, veratridine and 
the TRPV1 receptor agonist, capsaicin were preserved in GF mice relative to 
conventional tissues. Similarly, the short-circuit current response to two well-
characterised commensal organisms occurred independent of an interaction with the 
host microbiota. This is the first comprehensive characterisation of secretomotor 
responses in GF colon.  
Key words: Germ free; mucosa; probiotics; secretomotor; submucosal 
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3.2 Background 
 
The impact of the microbiota on host physiology and behaviour has become 
increasingly appreciated particularly in the context of brain-gut interactions (Cryan 
et al., 2012). Moreover, its influence on the development of the enteric nervous 
system (Collins et al., 2013) and on the excitability of enteric neurons has recently 
been shown (McVey Neufeld et al., 2013). Additionally, the expression of Toll Like 
Receptors by enteric neurons (Barajon et al., 2009), in particular in the submucosal 
plexus, suggests that the microbiota can directly activate intestinal neural responses 
and may, therefore, influence local secretomotor reflexes in the gut. Despite some 
overt secretomotor deficits (e.g. semi-solid feces) being a characteristic feature of 
GF animals (Gordon et al., 1971), to date, there is limited evidence describing a 
direct role for the host microbiota in the regulation of intestinal fluid and electrolyte 
transport in GF tissues (Rösel et al., 1996). As the activity of the microbiota is likely 
to influence host secretory or absorptive function, and given the role the microbiota 
plays in physiology and pathophysiology, particularly in the etiology of 
inflammatory conditions of the gut, I sought to characterise the response of GF 
mucosa-submucosa preparations to neural and epithelial stimulants, and to the 
commensal organisms, Bifidobacterium longum subsp. infantis 35624 and 
Lactobacillus salivarius subsp. salivarius UCC118, in Ussing chambers. 
 
 
 
. 
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3.3 Materials and Methods 
 
3.3.1 Animals 
 
 GF and conventional (CONV) Swiss Webster breeding pairs were supplied 
by Taconic (Germantown, New York, USA) and first-generation offspring were used 
in all experiments. GF Swiss Webster mice were housed 4–5/cage in flexible film 
gnotobiotic isolators under a strict 12-h light/dark cycle. CONV mice were similarly 
housed 4–5/cage in the standard animal facility under the same controlled conditions 
(temperature 20–21 °C, 55–60% humidity) on the same 12 h light/dark cycle. In all 
cases, both GF and CONV mice received the same pelleted diet after it was 
autoclaved (sodium dodecyl sulphate diets, product code 801010). Experiments were 
conducted in accordance with the European Directive 86/609/EEC and the 
Recommendation 2007/526/65/EC, and were approved by the Animal 
Experimentation Ethics Committee of University College Cork. 
 
3.3.2 Materials 
 
 All drugs were obtained from Sigma-Aldrich Ltd. (Ireland). The following 
compounds were used, with the final concentration and diluent in parenthesis, 
bethanechol (100µM; dH2O) (Cameron and Perdue, 2007), capsaicin (3µM; 70% 
ethanol)(Matsumoto et al., 2011), forskolin (10µM; DMSO) (Hyland and Cox, 2005) 
and veratridine (30µM; 70% ethanol) (Hyland and Cox, 2005). B. infantis 35624 (1 x 
10
9
 CFU/ml; Krebs) and L. salivarius UCC 118 (1 x 10
9
 CFU/ml; Krebs) were 
obtained from Alimentary Health Ltd. (Cork, Ireland).  Krebs buffer consisted of the 
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following, 1.2mM NaH2PO4 , 117mM NaCl, 4.8mM KCl, 1.2mM MgCl2, 25mM 
NaHCO3, 11mM CaCl2 and 10mM glucose.  
 
3.3.3 Ussing Chamber Studies  
 
 Mice were euthanized by cervical dislocation and distal colon was removed 
and placed in chilled Krebs solution. Seromuscular stripping was carried out by blunt 
dissection under a dissecting microscope and both the longitudinal and circular 
muscle layers, as well as the myenteric plexus, were removed. The resulting 
mucosal-submucosal segments were mounted in Ussing chambers and bathed with 
Krebs solution (maintained at 37°C, exposed tissue area of 0.12cm
2
). Carbogen 
(95% O2, 5% CO2) provided gas lift to the chambers. Tissues were voltage clamped 
to zero, using an automatic voltage clamp (DVC-1000/EVC-4000, World Precision 
Instruments, Sarasota, USA). Once a stable baseline was achieved, capsaicin and 
veratridine were added to the serosal compartment of the Ussing chamber to 
determine neural activity of the tissues and B. infantis 35624 or L. salivarus UCC118 
were added mucosally as tools to determine the tissue responsiveness to commensal 
organisms. Fifteen minutes later bethanechol and forskolin were added to the serosal 
side of the mounted tissues. All measurements were continuously recorded on a 
computer using LabTrax data acquisition hardware and analysed using DataTrax 
software (World Precision Instruments). Transepithelial resistance (TER) was 
calculated using Ohm’s law.  The peak change in Isc was recorded and expressed as 
µA. cm
-2
. GF and CONV tissues were paraffin wax embedded and processed for 
hematoxylin and eosin staining. ImageJ software was used to calculate mucosal 
thickness. 
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Data were analysed using GraphPad Prism 5 and are presented as the mean +/- 
standard error of the mean. A Student’s unpaired t test was used for comparison 
between CONV and GF tissues and a P<0.05 was considered statistically significant.  
3.4 Results 
 
The Isc response to forskolin, predominantly epithelial-mediated in mouse colon 
(data not shown), was significantly elevated in GF tissues (Fig. 3.1A-C, n=6-8). 
Baseline electrical parameters, Isc and TER, were comparable between CONV and 
GF mouse colon (Fig. 3.1D, n=7-8). Calcium-mediated responses were comparable 
between GF and CONV animals (Fig. 3.1E, n=7-8). Similarly, neural stimulation of 
mucosa-submucosa preparations with veratridine or capsaicin resulted in a similar 
change in Isc in GF and CONV mouse colon (Fig. 3.1F, n=5-8). Moreover, mucosal 
addition of the probiotics, B. infantis 35624 or L. salivarus UCC118, elicited a 
similar Isc response in CONV and GF tissues (Fig. 3.1G, n=7-8). The thickness of 
the colonic mucosa in GF colon was significantly less than that observed in tissues 
from CONV animals (Fig. 3.1I and 3.1H, n=4-5). 
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Figure 3.1. The change in short-circuit current (Isc) elicited by forskolin (, 
forskolin 10μM) was significantly elevated in germ free (GF) tissues compared to 
responses observed in conventional colon (CONV; A, representative trace; B, peak 
response; C, area under the curve (AUC)). Baseline electrical parameters, short 
circuit current (Isc) and transepithelial resistance (TER), were comparable between 
CONV and GF mouse colon (D). Similarly, calcium-mediated responses were 
comparable between GF and CONV animals (E). Veratridine (F; left y axis) and 
capsaicin (F; right y axis) caused a similar change in Isc both in GF and CONV 
mouse colon. Moreover, mucosal addition of either Bifidobacterium infantis 35624 
or Lactobacillus salivarus UCC118 elicited a similar Isc response in CONV and GF 
tissues (F). Mucosal thickness of GF descending colon was significantly decreased 
relative to CONV tissues (H and I; 20X, scale bar 200μm). n=4-8. * P < 0.05. 
 
3.5 Discussion  
 
 Our data suggests that in a coordinated physiological system mucosa-
submucosa responses are largely maintained in GF animals. To the best of our 
knowledge, this is one of the first studies to examine the responsiveness of GF colon 
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to secretogogues in vitro. I observed no change in baseline Isc, suggesting that basal 
electrogenic ion transport in GF tissues is maintained. However, in contrast to a 
suggested aldosterone-induced proabsorptive phenotype observed in GF rats (Rösel 
and von Engelhardt, 1996), GF mouse colon displayed a heightened response to 
forskolin stimulation. This is perhaps not unexpected given that a number of bacteria 
or probiotics have demonstrated inhibitory effects on cAMP-mediated responses 
(Lomasney et al., 2013). However, such a heightened response may serve as a 
protective mechanism to prevent adhesion of pathogenic bacteria. For example, 
secretory diarrhea has long been considered a host defence mechanism based on the 
hypothesis that increased fluid and electrolyte movement into the gut lumen may  
inhibit the adherence of pathogenic organisms (Canny and McCormick, 2008). 
Therefore, a heightened secretory response may potentially act as a non-specific 
protective mechanism in GF colon. Noteworthy however, this heightened response 
to cAMP did not influence the tissue response to two probiotics, B. infantis 35624 or 
L. salivarus UCC118. Given that intrinsic primary afferent neurons from GF 
intestine display decreased excitability, I examined the responsiveness of GF mouse 
colon to veratridine and the sensory nerve activator, capsaicin. Colon from GF and 
CONV animals responded similarly to both stimulants, suggesting that secretomotor 
reflexes are unaltered in GF colon or have adapted to compensate for the lack of the 
microbiota. Moreover, the secretomotor response in our mucosa-submucosa 
preparations is likely to involve not only intrinsic primary afferent neurons, but also 
motor neurons as well as the epithelium which collectively determine the final Isc 
response. Therefore, a level of redundancy may exist in a complex system, such as 
ours, to compensate for alterations at a single cell level which may be influenced by 
the microbiota. In addition to its well established role in the development and 
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maturation of the host immune system, recent evidence suggests that the microbiota 
may also play a role in the development of the enteric nervous system (McVey 
Neufeld et al., 2013). Moreover, morphological studies have identified decreased 
mucosa and muscle thickness as a characteristic feature of GF animals. Here, I 
similarly observed decreased mucosal thickness in the colon of GF mice relative to 
CONV animals. While morphological changes in the intestinal musculature of GF 
animals may account, to some degree at least, for their altered motility, colonic 
secretomotor function appears to be largely maintained despite GF animals 
exhibiting a decrease in colonic mucosal thickness. This study provides further 
evidence that the microbiota is capable of mediating alterations in colonic ion 
transport, and specifically suggests that it can influence cAMP-mediated responses. 
Our data lends support to the hypothesis that an altered microbiota in disorders 
associated with secretomotor abnormalities, for example irritable bowel syndrome, 
may be responsible for symptom generation in such disorders, and further supports 
the utility of the GF mouse model as a tool to characterise the mechanisms by which 
specific microbes may influence secretomotor function. 
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Chapter 4: 
Application of Ussing Chambers to 
Screen for the Functional Activity of 
the Commensal-Derived 
Neuroactive, GABA 
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4.1 Abstract 
 
 Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter 
in the body. Both GABA and its receptors are widely expressed in the 
gastrointestinal tract (GI) where they regulate many physiological functions. An 
additional and increasingly recognised source of intestinal GABA is the host 
microbiota. However, there is a paucity of studies examining the effects of GABA 
on secretomotor function, and none, to date, in the colon. Therefore, I examined and 
characterised the in vitro effects of GABA and bacterial-derived GABA on colonic 
secretomotor function in the mouse. I assessed the influence of GABA and bacterial-
derived GABA on baseline and stimulated short-circuit current (Isc) in Ussing 
chambers. I further characterised the nature of the GABA-mediated effects using the 
GABAA receptor antagonist, bicuculline, the GABAB receptor antagonist, phaclofen 
and the neurotoxin, tetrodotoxin in colonic mucosa-submucosa preparations. GABA 
and bacterial-derived GABA significantly inhibited cholinergic-induced ion 
transport in mouse colon, though neither significantly altered baseline Isc. The 
GABAA receptor antagonist did however significantly reduce baseline Isc in mouse 
colon. GABAA receptor antagonism also reversed the inhibitory effect of GABA on 
cholinergic-induced ion transport, while phaclofen had no effect. Moreover, the 
GABAA receptor-mediated effect most likely occurs at the level of the enteric 
nervous system. GABA and bacterial-derived GABA exert similar effects on colonic 
ion transport in mouse colon, and this effect is mediated by GABAA receptors. 
GABA-producing bacteria, therefore, may prove to be potentially useful tools for 
delivery of GABA to the GI tract. 
Keywords: Cholinergic; Colon; Gamma-aminobutyric acid; Lactobacillus; 
Microbial endocrinology Mouse; Secretomotor; Ussing chamber 
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4.2 Background 
 
Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the 
body and has been localised in both enteric neurones in addition to enterochromaffin 
cells in the gastrointestinal (GI) tract (Krantis, 2000). Hence GABA-mediated 
neurotransmission regulates many physiological functions, including those in the gut 
(Hyland et al., 2010). In addition to host neuronal- and enterochromaffin cell-
derived GABA, the host microbiota is another, and perhaps underappreciated, source 
of intestinal GABA (Li et al., 2010). The ability of microbes to produce 
neurotransmitters, including GABA, has given rise to the concept of microbial 
endocrinology (Lyte, 2011). Moreover, the biosynthetic pathway for the production 
of microbial GABA is identical, in some bacteria, to that in mammalian neuronal 
cells (Park et al., 2005; Mazzoli et al., 2010).  GABA-producing bacteria, therefore, 
have potential as local delivery agents for GABA to the GI tract (Li et al., 2010). In 
this regard, the Ussing chamber offers a unique opportunity to asses the bioactivity 
of proposed neuroactive metabolites ex-vivo.  
There are two major classes of GABA receptors, classified as either 
ionotropic GABAA and GABAC receptors, or metabotropic GABAB receptors 
(Watanabe et al., 2002). Both GABAA and GABAC receptors are neurotransmitter-
gated chloride ion channels and are hetero-oligomeric structures composed of a 
combination of α, β, γ, δ and ε subunits, while GABAC receptors are homo-
oligomeric and composed of ρ1 or ρ2 subunits (Chebib et al., 1999). Moreover, these 
two receptors produce distinctly different pharmacological and electrophysiological 
responses in vitro (Bormann, 2000). GABAB receptors on the other hand are seven 
transmembrane G-protein coupled receptors which activate second messengers and 
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subsequently regulate  Ca
2+
 and K
+
 ion channel activity (Gassmann et al., 2012). 
Moreover, all three GABA receptors have been localised in the GI tract of several 
species (Krantis, 2000; Fletcher et al., 2001). 
 Specifically, both GABA and its receptors are expressed by submucosal 
nerve cell bodies and mucosal nerve fibers (Krantis, 2000), implicating a role for 
GABA in the modulation of secretomotor function.  Indeed, evidence for a tonic 
effect of GABA on intestinal ion transport was demonstrated by Hardcastle and 
colleagues (1991), whereby the GABAA receptor antagonist, bicuculline caused a 
decrease in baseline short-circuit current  (Isc) (Hardcastle et al., 1991). This effect 
was absent following removal of the myenteric plexus and sensitive to inhibition 
with atropine suggesting that GABAA receptors on  myenteric neurones contribute to 
GABAergic regulation of secretomotor function in the rat (Hardcastle et al., 1991). 
In guinea-pig intestine, however, the submucosal plexus was implicated in mediating 
the GABAA receptor effects on intestinal ion transport, and, as in the rat, this effect 
was sensitive to cholinergic receptor blockade (MacNaughton et al., 1996). 
However, in vivo studies, in mouse intestine, suggest that GABAA receptor-mediated 
fluid secretion occurs independent of an interaction with the enteric nervous system 
(Li et al., 2012). This receptor expression pattern, and physiological effect of GABA 
and its receptors, suggests that mucosa-submucosa tissue preparations offer a 
platform for functional screening of putative GABA producing bacteria. I sought, 
therefore, to further investigate the influence of GABA, and its receptors, on 
secretomotor function in  mouse colon (Casanova et al., 2009) as well as the 
physiological effects of bacterial-derived GABA, obtained from an efficient GABA-
producing strain,  Lactobacillus brevis DPC6108 (Barrett et al., 2012) on intestinal 
physiology.  
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4.3 Materials and Methods 
 
4.3.1 Animals 
 
 Male Balb/c mice (22-27g) were obtained from Harlan, UK. All animals 
were kept on a strict 12-12h dark-light cycle with food and water available ad 
libitum. All experiments were conducted following institutional ethics guidelines and 
were in full accordance with the European Community Directive (86/609/EEC). To 
obtain distal colon, mice were euthanised by cervical dislocation, the distal colon 
was removed and immediately placed in chilled Krebs solution. The longitudinal and 
circular muscle layers, as well as the myenteric plexus, were removed by blunt 
dissection under a light microscope. The resulting mucosal-submucosal segments 
were mounted in Ussing chambers.  
4.3.2 Generation of GABA-containing bacterial supernatants 
 
 To generate bacterial-derived GABA-containing supernatants, Lactobacillus 
brevis DPC 6108 (GABA-producing strain) and Lactobacillus reuteri DPC 6100 
(non GABA-producing strain) were routinely propagated in mMRS medium at 37°C 
under anaerobic conditions, followed by inoculation (1% v/v) in mMRS medium 
supplemented with 30mg ml
-1
 monosodium glutamate (MSG) at 37°C for 72h 
anaerobically. After incubation, strains were separated from medium by 
centrifugation (4500 rpm, 30min, 4°C) and the supernatants were re-centrifuged 
(4500 rpm, 30min, 4°C). Supernatants and mMRS medium supplemented with 30mg 
ml
-1
 MSG were aliquoted in 1ml freeze drying vials, lyophilised and subsequently 
analysed for GABA content (Table 4.1). 
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Table 4.1 GABA content of lyophilised preparations obtained from Lactobacillus 
reuteri DPC6100 and Lactobacillus brevis DPC6108 culture media supplemented 
with monosodium glutamate. 
 
  Lactobacillus reuteri 
DPC6100 
Lactobacillus brevis 
DPC6108 
mMRS + 
MSG 
Fresh 
supernatant 
0.014 ± 0.003 mg ml
-1
 27.89 ± 0.13 mg ml
-1
 NA 
After freeze-
drying 
0.016 ± 0.002 mg ml
-1
 23.87 ± 0.18 mg ml
-1
 0.015 ± 0.001 
mg ml
-1
 
GABA per 
powder 
0.000 mg mg
-1
 0.858 mg mg
-1
 0.000 mg mg
-1
 
 
Lactobacillus reuteri DPC6100, non GABA-producer; Lactobacillus brevis 
DPC6108, GABA-producer. MSG, monosodium glutamate; NA, not applicable. 
 
4.3.3 Analysis of GABA content in bacterial-derived lyophilised preparations 
 
 Briefly, to analyse the GABA content of bacterial-derived lyophilised 
preparations, samples were deproteinised by mixing equal volumes of 24% (w/v) 
trichloroacetic acid. They were then allowed to stand for 10min before centrifuging. 
Supernatants were removed and diluted with 0.2M sodium citrate buffer, pH 2.2 to 
yield c. 250nM of each amino acid residue. Samples were then diluted 1 in 2 with the 
internal standard, norleucine, to give a final concentration of 125nM. Amino acids 
were quantified using a Jeol JLC-500/V amino acid analyser fitted with a Jeol Na
+
 
high-performance cation exchange column. 
4.3.4 Ussing chamber studies 
 
 Distal colonic segments were placed between the two halves of the Ussing 
chamber, exposed tissue area of 0.12cm
2
, maintained at 37°C in Krebs solution and 
oxygenated with carbogen gas (95% O2, 5% CO2). Tissues were voltage clamped to 
zero, using an automatic voltage clamp (DVC-1000/EVC-4000, World Precision 
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Instruments, Sarasota, USA). All measurements were continuously recorded on a 
computer using LabTrax data acquisition hardware and analysed using DataTrax 
software (World Precision Instruments).  
4.3.5 Experimental design 
 
 Once a stable Isc was achieved, either GABA (0.5µM - 100µM) (Li et al., 
2012b), Lactobacillus brevis DPC 6108-derived GABA (1µM or 100µM) or 
reconstituted supernatants derived from Lactobacillus reuteri DPC 6100 (non-
GABA control) were added to the serosal compartment of the Ussing chamber and 
the peak change in Isc recorded. Bethanechol (100µM) (Hirota and McKay, 2006b) 
and forskolin (10µM) (Hyland and Cox, 2005) were subsequently added to the 
serosal reservoir 15mins and 30mins later, respectively. For antagonist studies, 
tissues were pre-treated for 15mins with the GABAA receptor antagonist, bicuculline 
(100µM) (Hardcastle et al., 1991; Parkman et al., 1993) or the GABAB receptor 
antagonist phaclofen (100µM)(Parkman et al., 1993). Similarly, tissues were pre-
treated with tetrodotoxin (300nM) (Ikehara et al., 2010) for 15mins prior to addition 
of GABA (100µM), bethanechol and forskolin.  
4.3.6 Statistics 
 
 Data were converted to µA.cm
-2
, and are expressed as the mean +/- the 
standard error of the mean throughout. GraphPad Prism 5 was used for statistical 
analysis, and data were analysed using either a one-way ANOVA followed by 
Dunnett’s post hoc analysis, two-way ANOVA followed by Bonferroni’s post hoc 
analysis or by a Student’s unpaired t-test. A P value less than 0.05 was considered 
significant.  
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4.3.7 Materials 
 
 All drugs were obtained from Sigma Aldrich Ltd. (Ireland). GABA, 
bethanechol, bicuculline and phaclofen were dissolved in dH20. Forskolin was 
dissolved in dimethylsulfoxide and tetrodotoxin in sodium citrate buffer. Krebs 
buffer consisted of the following, 1.2mM NaH2PO4 , 117mM NaCl, 4.8mM KCl, 
1.2mM MgCl2, 25mM NaHCO3, 11mM CaCl2 and 10mM glucose. 
4.4 Results 
4.4.1 Effect of GABA on baseline short circuit current 
 
 Serosal addition of GABA (0.5µM-100µM) to mouse colonic mucosa-
submucosa tissue preparations had no significant effect on baseline Isc (Table 4.2). 
4.4.2 Effect of GABA on bethanechol- and forskolin-stimulated short circuit 
current 
 
 Pre-treatment of tissues with GABA (0.5µM - 100µM) significantly 
influenced both the nature and magnitude of the subsequent tissue response to 
bethanechol (100µM; Figure 4.1 and Figure 4.2). In the presence of GABA (1µM) a 
triphasic response to bethanechol was observed; and this was in contrast to the 
monophasic response in control tissues, and the monophasic, though blunted 
response, seen with 100µM GABA (Figure 4.1). Accordingly, I split the 
bethanechol-induced effect on Isc into three phases; phase I, phase II and phase III, 
measured 30sec, 2mins and 3-5mins (peak response) after addition of bethanechol. 
Phase II and phase III of the bethanechol response were significantly inhibited by 
GABA at all the concentrations tested (0.5µM - 100µM; P < 0.05 – P < 0.001), and 
the phase I response by 0.5µM GABA (P < 0.05; Figure 4.2). For subsequent 
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experiments with GABA receptor antagonists and TTx, phase III of the bethanechol 
response was analysed, and tissues were pre-treated with GABA at a concentration 
of 100µM. 
 GABA (0.5µM - 100µM) had no significant effect on the tissue response to 
forskolin (10µM; Table 4.3).  
 
 
Figure 4.1. Representative response to bethanechol in the presence of GABA. In 
the presence of GABA (1µM) a triphasic response to bethanechol was observed; and 
this was in contrast to the monophasic response in control tissues, and the 
monophasic, though blunted response, seen with 100µM GABA. Phase I, phase II 
and phase III of the bethanechol response represent the  short-circuit current 
response (Isc)  measured 30sec, 2mins and 3-5mins (peak response) after addition of 
bethanechol ().  
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Figure 4.2. The influence of increasing concentrations of GABA on each phase 
of the bethanechol-induced response in mouse colon. Phase II (B) and phase III 
(C) of the bethanechol response was significantly inhibited by GABA; and the phase 
I response only by 0.5µM GABA (A). * vehicle versus GABA, *P < 0.05, 
***P<0.001. n=4-6 
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4.4.3 Effects of the GABAA receptor antagonist, bicuculline and GABAB receptor 
antagonist, phaclofen on baseline short circuit current 
 
 The GABAA receptor antagonist, bicuculline (100µM) significantly 
decreased Isc (P < 0.001) relative to vehicle (Figure 4.3A). In contrast, the GABAB 
receptor antagonist, phaclofen (100µM) did not significantly influence baseline Isc in 
mouse colon (Figure 4.3B). 
4.4.4 Sensitivity of the GABA-mediated effect on bethanechol-induced ion 
transport to GABAA and GABAB receptor antagonism 
 
 To determine whether the inhibitory effect of GABA (100 µM) on 
cholinergic-induced Isc was mediated by either GABAA or GABAB receptors, tissues 
were pre-treated with either bicuculline (100µM) or phaclofen (100µM) prior to 
addition of GABA (100µM) and bethanechol (100µM). Pre-treatment with 
bicuculline significantly relieved the inhibitory effect of GABA on bethanechol-
induced Isc (P < 0.001; Figure 4.4A); in contrast phaclofen had no such effect 
(Figure 4.4B).  
4.4.5 Sensitivity of the GABA-mediated effect on bethanechol-induced ion 
transport to tetrodotoxin 
 
 Tissues were pre-treated with TTx (300nM) to determine whether the 
inhibitory effect of GABA (100µM) on bethanechol-induced Isc involved enteric 
neurones.  Both TTx (P < 0.001) and GABA (P < 0.001) significantly inhibited the 
bethanechol response in mouse colon. Moreover, the combination of GABA and 
TTx together abolished the Isc response to bethanechol (Figure 4.5).  
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Figure 4.3. Effects of GABAA and GABAB receptor antagonism on baseline 
short-circuit current. Bicuculline (100µM; A) significantly reduced baseline short-
circuit current (Isc) in mouse colon. In contrast, phaclofen (100µM; B) did not 
significantly influence baseline Isc. * vehicle versus GABA receptor antagonist, 
***P<0.001. n=6. 
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Figure 4.4. Effects of GABAA and GABAB receptor antagonism on GABA-
induced inhibition of bethanechol responses in mouse colon. Pre-treatment of 
tissues with bicuculline (100µM; A) significantly relieved the inhibitory effect of 
GABA on bethanechol-induced Isc, in contrast phaclofen (100µM; B) had no such 
effect. * GABA versus GABA receptor antagonist + GABA, ***P<0.001. n=4. 
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Figure 4.5. The effects of GABA and tetrodotoxin on bethanechol-induced Isc. 
Both  tetrodotoxin (TTx; 300nM) and GABA (100µM) significantly inhibited the 
bethanechol response in mouse colon, and the combination of GABA and TTx 
together abolished the Isc response to bethanechol. * vehicle versus GABA, 
***P<0.001; 
# 
vehicle versus TTx, 
###
 P < 0.001.  n=5-6. 
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4.4.6 Effects of bacterial-derived, GABA-containing, supernatants on baseline 
and bethanechol-induced ion transport  
 
 Lyophilised supernatants from Lactobacillus brevis DPC6108 were 
reconstituted and added to the serosal compartment of the Ussing chamber to yield a 
final GABA concentration of either 1µM or 100µM, and these were compared to 
supernatants prepared from the non GABA-producer, Lactobacillus reuteri 
DPC6100. Neither 1µM GABA-containing supernatants nor control supernatants had 
a significant effect on baseline Isc, however 100µM GABA-containing supernatants 
significantly increased baseline Isc (Table 4.2).  
 GABA-containing supernatants (1µM and 100µM) derived from  
Lactobacillus brevis DPC6108 significantly inhibited the tissue response to 
bethanechol (P < 0.05; Figure 4.6 A and B). Forskolin responses were unaffected 
following pre-treatment with either GABA-containing or GABA-free supernatants 
(Table 4.3).  
Table 4.2. Effect of exogenous GABA, GABA-containing and GABA-free 
bacterial supernatants on baseline short-circuit current. 
 
 Concentration of GABA (μM) 
0 0.1 1 10 100 
Exogenous GABA  
(Isc μA.cm
-2
) 
0.1±0.2 0.1±0.2 0.4±0.1 0.3±0.1 0.2±0.2 
Lactobacillus reuteri DPC6100  
(Isc μA.cm
-2
) 
 NA NA  0.2±0.03 NA  1.4±0.5 
Lactobacillus brevis DPC6108 
(Isc μA.cm
-2
) 
 NA  NA -1.5±2.0 NA  5.3±0.8 * 
 
Lactobacillus reuteri DPC6100, non GABA-producer; Lactobacillus brevis 
DPC6108, GABA-producer. * P < 0.05, Lactobacillus reuteri DPC6100 versus 
Lactobacillus brevis DPC6108. NA, not applicable. 
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4.4.7 Sensitivity of the bacterial-derived GABA-mediated effect on bethanechol-
induced ion transport to GABAA and GABAB receptor antagonism 
 
To determine whether the inhibitory effect of bacterial-derived GABA (1µM) on 
cholinergic-induced Isc was mediated by either GABAA or GABAB receptors, tissues 
were pre-treated with either bicuculline (100µM) or phaclofen (100µM) prior to 
addition of bacterial-derived supernatants and bethanechol (100µM).  Supernatants 
from the non GABA-producer, Lactobacillus reuteri DPC6100 had no significant 
effect on bethanechol-induced Isc (Figure 4.7 A and B). Those obtained from 
Lactobacillus brevis DPC6108 significantly inhibited tissue responses to 
bethanechol (Figure 4.7 A and B; P < 0.05 – P < 0.01), and this effect was reversed 
in the presence of the GABAA receptor antagonist, bicuculline (Figure 4.7A).  
 
Table 4.3. Effect of exogenous GABA, GABA-containing and GABA-free 
bacterial supernatants on forskolin-stimulated short-circuit current. 
 
NA, not applicable. Lactobacillus reuteri DPC6100, non GABA-producer; 
Lactobacillus brevis DPC6108, GABA-producer. P=0.19 (Lactobacillus reuteri 
DPC6100 (1μM)  vs. Lactobacillus brevis DPC6108 (1μM)), P=0.17 (Lactobacillus 
reuteri DPC6100 (100μM)  vs. Lactobacillus brevis DPC6108 (100μM). 
 
 Concentration of GABA (μM) 
0 0.1 1 10 100 
Exogenous GABA   
(Isc μA.cm
-2
) 
64.4±15.1 48.2.±12.2 80.0±.16.8 80.0±.05 73.4±34.2 
Lactobacillus 
reuteri DPC6100  
(Isc μA.cm
-2
) 
 
NA 
 
NA 
 
336.4±.44.0 
 
NA  
 
239.1±.23.2 
Lactobacillus 
brevis DPC6108 
(Isc μA.cm
-2
) 
  
NA 
 
NA  
 
247±58.5 
 
NA 
 
 
285.2±37.3 
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Figure 4.6. The influence of bacterial-derived GABA on bethanechol-induced 
short-circuit current in mouse colon. GABA-containing supernatants derived from 
Lactobacillus brevis DPC6108 (A, 1 µM and B, 100 µM) significantly decreased 
bethanechol-induced responses compared to supernatants prepared from media alone 
(mMRD + MSG) or the non-GABA-producer, Lactobacillus reuteri DPC6100. * 
GABA-containing bacterial supernatants versus GABA-free supernatants or control 
supernatants, *P<0.05. n=3-5. 
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Figure 4.7. Effects of GABAA and GABAB receptor antagonism on bacterial-
derived GABA-induced inhibition of bethanechol-induced short-circuit current 
in mouse colon. Supernatants from the non GABA-producer, Lactobacillus reuteri 
DPC6100 had no significant effect on bethanechol-induced short-circuit current (A 
and B). Those obtained from Lactobacillus brevis DPC6108 significantly inhibited 
tissue responses to bethanechol (A and B), and this effect was reversed in the 
presence of the GABAA receptor antagonist, bicuculline (A) and unaffected by the 
GABAB receptor antagonist, phaclofen (B). *GABA-containing bacterial 
supernatants versus GABA-free bacterial supernatants, *P<0.05, **P<0.01; 
# 
GABA-
containing bacterial supernatant versus GABA receptor antagonist + GABA-
containing bacterial  supernatant;  
###
 P < 0.001.  n=5-7. 
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4.5 Discussion 
 
Our data suggest that GABA significantly influences colonic secretomotor function 
in the mouse colon. This effect, however, does not appear to be concentration 
dependant. Similarly, GABA derived from an efficient GABA-producing commensal 
organism, Lactobacillus brevis DPC6108 influenced tissue responses to cholinergic 
stimulation in a similar manner to exogenous GABA. The inhibitory effect I 
observed for both exogenous and bacterial-derived GABA on cholinergic responses 
in mouse colon displayed sensitivity to the GABAA receptor antagonist, bicuculline, 
and were unaffected by the GABAB receptor antagonist, phaclofen. Moreover, the 
GABAB receptor agonist, baclofen did not significantly influence baseline Isc in 
mouse colon (unpublished observation). The predominant role of GABAA receptors 
in the regulation of intestinal fluid and electrolyte transport in mouse colon is 
consistent with studies in the small intestine of other species (Hardcastle et al., 1991; 
MacNaughton et al., 1996). In the guinea-pig intestine, the GABAA receptor agonist, 
3-amino-1-pro-panesulfonic acid (3-APS) stimulated an increase in Isc, while 
baclofen had no effect (MacNaughton et al., 1996), and in the rat small intestine 
bicuculline significantly reduced Isc (Hardcastle et al., 1991), further implicating a 
role for GABAA receptors in the regulation of intestinal ion transport.  
 Though GABAA receptors have been implicated in the regulation of intestinal 
ion transport, the nature of the response they mediate appears to vary across species, 
or intestinal region. The observation of GABAA-receptor mediated tone in the rat 
intestine (Hardcastle et al., 1991) supports our findings of GABAergic tone in mouse 
colon, in which bicuculline significantly decreased baseline Isc. These data, suggest 
that GABA, through GABAA receptors, tonically regulates colonic ion transport in 
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the mouse colon, which in the rat intestine was determined to be anti-secretory in 
nature (Hardcastle et al., 1991). Nonetheless, I did observe a modest, albeit 
significant, increase in baseline Isc in response to the supernatant derived from the 
GABA-producing bacterial strain, Lactobacillus brevis DPC6108. I did not, 
however, further characterise this response to determine whether it was GABA 
receptor mediated, though it is known that bacterial factors, independent of GABA, 
can influence intestinal ion transport in vitro (Lomasney et al., 2013).  In guinea-pig 
intestine both GABA and the GABAA receptor agonist, 3-APS significantly 
increased Isc, and in the case of the later this effect was chloride ion dependent, and 
therefore most likely secretory in nature (MacNaughton et al., 1996). Similarly,  in 
vivo studies in mouse small intestine suggest that GABA, again via GABAA 
receptors, stimulates ileal fluid transport, and does so via an epithelial mechanism 
(Li et al., 2012). Moreover, the same authors demonstrated that GABAA receptor 
antagonism in a mouse model of allergic diarrhoea decreased epithelial GABAA 
receptor expression, as well as the percentage of mice with diarrhoea (Li et al., 
2012). Conversely, the response I observed in mouse colon may be considered 
predominantly pro-absorptive, given the significant inhibition by GABA of 
cholinergic-induced ion transport. However, discrepancies between in vivo and in 
vitro studies are perhaps not unexpected, and may be further confounded by the 
nature of GABAA receptors, which have been demonstrated to regulate both 
excitatory and inhibitory responses in guinea pig distal colon (Minocha et al., 1993). 
Therefore, the final response elicited by GABA is likely to depend on the balance of 
GABAA receptor activity on either inhibitory or excitatory interneurons, which may 
differ across species, tissue regions and experimental conditions, as well as on the 
neurochemistry of GABAA receptor expressing neurones.  
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 The predominant mucosal effect of GABA on fluid transport in mouse ileum 
(Li et al., 2012) is, however, in contrast to the effects observed in other species, 
namely rat (Hardcastle et al., 1991) and guinea pig (MacNaughton et al., 1996), in 
which the enteric nervous system has been implicated in mediating the GABAergic 
effects on intestinal ion transport. In the later, TTx abolished the Isc response to the 
GABAA receptor agonist, 3-APS, and in rat small intestine the effects of the GABAA 
receptor antagonist, bicuculline on Isc also displayed sensitivity to the neurotoxin 
(Hardcastle et al., 1991). Moreover, 3-APS significantly inhibited capsaicin-
stimulated Isc responses. I cannot conclusively comment on the site of action, neural 
or epithelial, for GABAergic inhibition of bethanechol-induced ion transport in 
mouse colon. I can speculate however, that GABA may predominantly exert its 
effects at the level of the enteric nervous system, which is responsible, in the most 
part, for facilitating bethanechol-induced ion transport, as I demonstrated a similar 
inhibition of bethanechol-induced responses by either pretreatment with GABA or 
TTx. In mouse colon the bethanechol-induced effect on Isc is predominantly 
muscarinic in nature, though appears to occur independent of M1 receptors (Hirota et 
al., 2006b). Whilst, others have demonstrated, in M3 receptor knockout mouse colon, 
an appreciable decrease in carbachol-induced ion transport in the presence of TTx 
(Haberberger et al., 2006), though there are a paucity of studies characterising 
cholinergic responses in the mouse intestine (Hirota et al., 2006a). Nonetheless, in 
mouse colon both epithelial and neural muscarinic receptors are likely to be involved 
in mediating cholinergic induced ion transport, and as such GABA, indirectly, may 
influence cholinergic responses elicited by bethanechol at both sites. Moreover, 
nicotinic receptor blockade, in guinea pig intestine, did not influence the subsequent 
Isc response to the GABAA receptor agonist, 3-APS (MacNaughton et al., 1996). A 
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neural site of action for GABA in mouse colon is perhaps further supported by the 
depolarising effect of the GABAA receptor agonist, muscimol on intestinal epithelial 
cells (Li et al., 2012), which one would expect to increase Isc, inconsistent  with the 
diminished secretory response I observed in the presence of GABA in mouse colon.  
 
 In the enteric nervous system GABAA receptors may be excitatory 
(Cherubini et al., 1984), and therefore following activation have the potential to 
release both excitatory and inhibitory neurotransmitters. In rat colonic segments for 
example, the GABAA receptor antagonist bicuculline inhibited release of L-
[3H]citrulline, a marker for nitric oxide (NO) biosynthesis  (Grider, 1994),  and may 
be particularly relevant  given the demonstrated inhibitory effects of NO on Isc in 
mouse intestine (Rao et al., 1994), which functionally could dampen the subsequent 
Isc response to secretogogues, such as bethanechol. Moreover, GABAA receptors can 
differentially regulate the release of enterochromaffin-cell derived serotonin (5-HT) 
from guinea pig small intestine, either by directly inhibiting 5-HT release, or, 
conversely,  stimulating its release via a  neural reflex (Schwörer et al., 1989), which 
again could profoundly influence intestinal secretomotor function (Tuo et al., 2004; 
Michel et al., 2005; Yang et al., 2008; Yang et al., 2010). Therefore, further 
pharmacological characterisation of the GABA-induced inhibitory effect on 
cholinergic-induced ion transport in mouse colon is now warranted.  Another 
striking effect of GABA on cholinergic-induced Isc in mouse colon is the differential 
influence it has on the nature of the Isc response at different concentrations. In 
control tissues, the Isc response to bethanechol was monophasic in nature, 
comparable to that previously observed in mouse colon at the same concentration 
(Hirota et al., 2009).  However, at a comparably lower concentration, 1µM, the 
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nature of the Isc response was significantly altered, and tri-phasic in nature. The 
mechanism underlying this differential effect of GABA on the nature of the 
bethanechol-evoked response in mouse colon is unclear, but may be due to 
differential effects of GABA, or GABA-mediated inhibition of cholinergic signaling, 
on either intracellular signaling molecules or ion channels known to contribute to 
cholinergic regulation of epithelial ion transport (Hirota et al., 2006a). 
 
 Our data further support the concept of microbial endocrinology, a relatively 
new inter-disciplinary field bringing together microbiology and neuroscience, with 
the aim of gaining greater insight into host-microbial interactions (Lyte, 2011).  In 
this study, I have demonstrated that GABA derived from Lactobacillus brevis 
DPC6108 influences colonic secretomotor function in a similar manner to exogenous 
GABA and by the same GABA receptor. Furthermore, though both forms of GABA 
were added serosally, GABA receptors are believed to be located primarily on 
enteric neurons (Takahashi et al., 2000b; Casanova et al., 2009a) while 
transepithelial transporters of GABA and GABA analogs (including muscimol) have 
been identified in vitro in Caco-2 cells (Thwaites et al., 2000; Chen et al., 2002; 
Larsen et al., 2008). Moreover, though further studies are warranted, in the context 
of functional GI disorders which often display a leaky epithelial barrier, it may be 
anticipated that high concentrations of luminal GABA may reach enteric nerves via a 
paracellular pathway. Indeed, cholinergic neurons are believed to play an important 
role in controlling epithelial permeability(Sharkey and Savidge, 2014), and enhanced 
neural cholinergic activity is associated with increased permeability (Cipriani et al., 
2011). Therefore targeting neural GABA receptors may have potential therapeutic 
benefit at the level of the intestinal mucosa. 
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 However, though I have been successful in ascribing physiological function 
to bacterial-derived GABA utilising ex-vivo tissue preparations, whether such 
bacteria generate sufficient quantities of GABA mucosally in-vivo to affect 
secretomotor function remains to be determined. Nevertheless, Lactobacillus brevis 
DPC6108, in the presence of other culturable microbes, produced 66.25μg/ml 
(~643μM) GABA after 4h, reaching a maximum of 70.72μg/ml (~686μM) after 9h  
in a pH-controlled faecal-based fermentation in the presence of MSG (Barrett et al., 
2012). This would suggest that the microbiota, and GABA-producing microbes, 
generate luminal concentrations of GABA in excess of those demonstrated to exert 
physiological effects on colonic function in this study. Therefore, identifying 
commensal organisms, or probiotics, such as Lactobacillus brevis DPC6108, capable 
of producing physiologically high concentrations of GABA (Barrett et al., 2012),  
may provide a novel and safe delivery mechanism of neuroactive compounds locally 
to the GI tract. In the context of our findings of GABAA receptor-mediated inhibition 
of cholinergic-stimulated ion transport, Lactobacillus brevis DPC6108, or GABAA 
receptor agonists, may be therapeutically relevant in the context of diarrhoea, with 
the caveat that sufficient quantities of GABA reach the secretomotor apparatus to 
affect colonic fluid and electrolyte transport.  
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Chapter 5: 
General Discussion 
  
 140 
5.1  A Summary of Results 
 
In this thesis I present data that further supports the concept of host microbe 
interactions and the influence of probiotics, the host microbiota and commensal 
organisms on intestinal function, in particular colonic ion transport. In addition, I 
have identified strain-specific effects of Bifidobacterium infantis 35624 and 
Lactobacillus salivarius UCC118 on intestinal ion transport in ex-vivo colonic tissue 
exposed to both microbes, acutely and following probiotic feeding for two weeks in 
the Ussing Chamber.  
 First, in Chapter 2, I examined the influence of the two different probiotic 
strains, B.infantis 35624 and L.salivarius UCC118, on Isc responses in murine colon. 
B.infantis 35624 has demonstrated therapeutic potential clinically, in IBS 
(O’Mahony et al., 2005; Whorwell et al., 2006), while both have shown potential 
benefits in pre-clinical models of ulcerative colitis (O’Mahony et al., 2001; 
McCarthy et al., 2003; Ewaschuk et al., 2008; Feighery et al., 2008). Ex-vivo tissue 
studies allowed us to further characterise the influence of B.infantis 35624 and L. 
salivarius UCC118 on the GI function by examining their effects on colonic ion 
transport in particular. Our data suggest that L. salivarius UCC 118 mediates its 
effects on Isc predominantly via a neurally driven pathway, with B.infantis 35624 
exerting less of an influence on enteric neuron activity. Both probiotics also 
significantly attenuated cholinergic induced changes in Isc, and may therefore be 
considered to have anti-secretory properties. Neither probiotic influenced cAMP-
mediated ion transport. Additional pharmacological studies suggested that neither 
apical ENaC nor basolateral NKCC1channels were involved in mediating the effects 
of B.infantis 35624 and L. salivarius UCC118 on baseline Isc following acute 
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addition to Ussing chambers. However, ion exclusion experiments did suggest a role 
for a Cl
-
-independent pathway as a potential mechanism by which L. salivarius UCC 
118 induces changes in baseline ion transport. In-vivo administration of probiotics 
for two weeks similarly suggested that L. salivarius UCC118 preferentially 
influences enteric neural activity compared to B. infantis 35624. Both probiotics, 
however, similarly affected small intestinal transit.  
 In Chapter 3, I next examined the influence of the host microbiota on Isc by 
taking an alternative approach. Rather than examining the effect of commensal 
organisms on colonic ion transport, I examined the effect of a germ-free environment 
on colonic secretomotor function. I found that the absence of the host microbiota 
significantly increased cAMP induced colonic ion secretion, while neurally- and 
cholinergic-driven ion transport remained unchanged. Moreover, in the absence of a 
host microbiota, baseline Isc and TER were comparable to tissues examined from 
colonised mice. Tissues from germ free animals responded similarly to two 
commensal organisms, B. infantis 35624 and L. salivarius UCC118. 
 Finally, in Chapter 4, I utilised the Ussing chamber method to determine 
whether GABA derived from L.brevis DPC6108 influenced intestinal ion transport 
and compared these responses to those obtained with the effects of commercially 
obtained GABA on colonic ion transport. I demonstrated that GABA inhibits 
cholinergic-induced ion transport and that this effect is GABAA receptor mediated. 
Furthermore, I were able to show that GABA produced by a probiotic, L.brevis 
DPC6108 in the presence of other secreted bioactives, similarly influenced 
cholinergic-induced ion transport by a GABAA receptor dependent pathway.  
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 Collectively, this thesis provides insight into host-microbe interactions and in 
particular their impact on colonic secretomotor function. Moreover, it demonstrates 
that distinct bacteria may differentially influence colonic ion transport. In this regard, 
L. brevis DPC6108 most likely does so as a result of its ability to generate GABA. 
However, with respect to the influence of specific commensal organisms, namely B. 
infantis 35624 and L. salivarius UCC118, as well as the host microbiota, on colonic 
ion transport, the specific bacterial components or metabolites which contribute to 
the effects observed in our studies remain, as yet, uncharacterised.  
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Figure 5.1. Summary of Key Findings - Germ Free mice displayed elevated 
cAMP induced ion transport. No effect on secretomotor neuron responses were 
observed. The elevated cAMP induced secretion may indicate an increase in 
bicarbonate which would prime the mucosa for colonisation and promote production 
of mucous. Chronic exposure to B. infantis 35624, previously characterised as an 
immunomodulatory probiotic effective in the treatment of IBS, caused a decrease in 
basal ion transport and small intestinal transit (SIT) in-vivo in healthy mice while no 
influence on neurally mediated ion transport was observed. Acute exposure to the 
same probiotic in ex-vivo distal colon submucosal preparation attenuated cholinergic 
secretory responses via a non-neurally mediated mechanism. Furthermore, the 
effects of B. infantis 35624 on basal ion transport were mediated by a heat resistant 
secreted bioactive. Chronic exposure of healthy mice to  L. salivarius UCC118, 
previously known to produce bacteriocin, targeting infectious microbes, 
demonstrated a similar attenuation of basal ion transport and SIT with the added 
effect of lowering neurally evoked ion transport. In line with this observation, basal 
responses following acute exposure ex-vivo were neurally mediated, while  L. 
salivarius UCC118 also caused a decrease in cholinergic ion transport, an effect 
which also appeared to be sensitive to neural blockade. With the caveat that not all 
functional effects can be predicted in-vivo, ex-vivo Ussing Chamber studies 
correlated with in-vivo studies and have the potential to predict possible uses in a 
clinical setting. L. salivarius UCC118, known to produce potent anti-microbials, 
may also be effective in treating pathogenic diarrhoea associated with the ENS e.g. 
rotavirus (Lundgren et al., 2000), while B. infantis 35624 as previously 
demonstrated, would be more effective in diseases targeting the epithelium and 
immune function. Finally supernatant from  L. brevis DPC6108, previously isolated 
from human intestine and show to produce high levels of GABA was shown to 
attenuate cholinergic induced ion transport in an manner analogous to exogenous 
GABA and in a similar manner to B. infantis 35624 and  L. salivarius UCC118. 
This identified GABA as probiotic bioactive with the ability to modulate ion 
transport function and may suggest GABA a possible bioactive involved in the 
effects on cholinergic ion transport mediated by B. infantis 35624 and  L. salivarius 
UCC118. Importantly, it also demonstrated the potential of screening previously 
identified bioactives, to understand the mechanisms of probiotics and to identify the 
bioactives involved. 
 
5.2 Host-Microbe Interface and Secretomotor Function 
 
 Examining host-microbe interactions represents the study of complex and 
highly dynamic ecosystems, in which both the host and its inhabitants interact to 
ultimately determine the state of the environment at any particular time. The host 
environment will play a crucial role in the establishment of particular phylogenies, as 
well as determining subsequent activities executed in order for each organism to 
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adapt, survive and grow. In turn, the activity of these organisms can impact on the 
host environment - inextricably linking both. In particular, host factors should be 
taken into account when ascribing physiological function to the microbiota, in 
particular host species and segmental tissue differences along the intestine.   
 In the mouse, the neuronal composition of the submucosal plexus exclusively 
contains Dogiel Type I neurons which display S-type electrophysiology, while no 
Dogiel Type II neurons, or IPANs, have been identified thus far in any segment of 
the mouse intestine (Wong et al., 2008; Mongardi Fantaguzzi et al., 2009; Foong et 
al., 2014). This would suggest that the mouse may not be a particularly good model 
for examining submucosal sensory neurotransmission in the gut. However, it is 
possible that uni-axonal sensory neural function exists in the mouse, as previously 
observed in the guinea pig (Spencer and Smith, 2004; Mazzuoli and Schemann, 
2009). Nevertheless, the innate uniformity of mouse submucosal neurons suggests a 
relatively incomplete secretomotor circuit in comparison to other species (Vanner 
and Macnaughton, 2004b). Moreover, McVey Neufeld et al., (2013) recently 
examined the influence of the microbiota on mouse enteric nerve activity, and found 
no effect of a germ free environment on the electrophysiological parameters of 
myenteric S-type neurons. Though this study focussed on myenteric rather than 
submucosal neurons, it is possible that the development of submucosal S-type 
neurons may not be influenced by enteric microbes, and may explain why I found no 
differences in neurally stimulated ion transport in Chapter 3. The same group did 
however, report abnormal myenteric plexus development corresponding with a 
decrease in the size of myenteric ganglia and an increase in the proportion of in 
nitrergic neurons (Collins et al., 2014). This study was carried out in early post-natal 
GF mice and neurochemistry should now be examined in adult GF mice. 
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 Differences in the ENS have also been reported along the length of the 
intestine, in both the myenteric and submucosal plexus and therefore the response 
elicited by microbes in the small intestine may not mirror those in the colon and vice 
versa (See Introduction). The proportion of cholinergic neurons in mouse is 
significantly greater in the submucosal plexus of the small intestine compared to the 
large intestine (Mongardi Fantaguzzi et al., 2009; Foong et al., 2014). The same is 
true for the myenteric plexus (Sang and Young, 1998). Moreover, the 
neurochemistry of enteric neurones differs along the mouse intestine. In the ileal 
submucosal plexus, only 50% of cholinergic neurons are CGRP-IR (Mongardi 
Fantaguzzi et al., 2009), while all colonic cholinergic neurons are positive for this 
neuropeptide (Foong et al., 2014). In addition, cholinergic innervation of the colonic 
submucosal plexus increases from proximal to distal colon (Foong et al., 2014). 
Given the inhibitory effect I observed for L. salivarius UCC118 in vivo on enteric 
nerve activity in the mouse colon, and the TTx sensitivity of the Isc response elicited 
by two commensal organisms following acute exposure in Ussing chambers, the 
functional consequences of the inhibitory effect of these microbes on enteric nerve 
activity is likely to differ depending on the tissue segment examined. Indeed, as 
discussed in Chapter 2 studies have already demonstrated that the effects of 
probiotics on motility can vary depending on the intestinal region studied (Massi et 
al., 2006b; Wu et al., 2013).  
 On the other hand,  the most significant effect of the GF state on active 
intestinal ion transport in rat, was observed in the distal segment of the distal colon 
in which baseline Isc  was over twice that observed in SPF animals, and represented 
46% of the net absorptive sodium flux compared to 26% in SPF rats (Rösel and von 
Engelhardt, 1996). However, these dramatic changes in electrolyte transport were 
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not observed in the proximal segment of the distal colon. Therefore, commensal 
microbes may also contribute to segmental differences in the gut function. Indeed, 
the structural, immuno-histochemical and functional changes to myenteric plexus 
reported in GF mice were observed in jejunum and ileum, but not the duodenum 
(Collins et al., 2014) Furthermore, as discussed in Chapter 2 several studies, 
including our own, have already demonstrated a divergence in the ability of specific 
commensal microbes to influence enteric nerve activity (Kunze et al., 2009a; 
Khoshdel et al., 2013; Mao et al., 2013b). The gradient in host commensal microbes 
along the intestinal tract varies from a low numbers of bacteria in stomach and 
duodenum [up to 10
3
 colony-forming units (cfu) per millilitre (cfu x mL
-1
)], 
increasing numbers in jejunum and ileum (10
4–108 cfu x mL-1) with the greatest 
number in the colon (10
9–1012 cfu x mL-1)(Blaut and Clavel, 2007). Given that 
neurally active factors, including acetylcholine, catecholamines, serotonin and 
GABA, among other neurotransmitters, are produced by specific strains of several 
species of bacteria common to the gastrointestinal tract, such as Lactobacillus and 
Bifidobacteria (Table 5.1) (Roshchina, 2010), differences in microbial populations 
could significantly impact on gut function and secretomotor activity. For example, 
free catecholamines in the gut lumen of mouse differed along the length of the 
intestine, with the highest levels of norepinephrine and dopamine being produced in 
the colon. Functionally, the higher levels of catecholamines are predicted to 
contribute to increased fluid and electrolyte absorption, as demonstrated by injection 
of colonic loops with high concentrations of dopamine (Asano et al., 2012). The 
effect may be mediated by epithelial dopamine receptor activation. It would be 
tempting to speculate that colonisation patterns of the gut by GABA-producing 
bacteria may similarly impact secretomotor function (Table 1.2).  
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Table 5.1 Host commensal microbes known to produce neurally active 
metabolites - Adapted from (Lyte, 2011) and reviewed in (Roshchina, 2010). 
Genus 
Neurally Active 
Metabolite 
Lactobacillus, Bifidobacterium GABA 
Escherichia, Bacillus, Saccharomyces  Norepinephrine 
Candida, Streptococcus, Escherichia, Enterococcus Serotonin 
Bacillus, Serratia Dopamine 
Lactobacillus Acetylcholine 
 
Noteworthy also is the expression of TLRs by enteric neurones which would suggest 
that the ENS has the capacity to respond to a host of bacterial components. TLRs 
have been are  expressed by the ENS along the length of the GI tract (Barajon et al., 
2009; Wang et al., 2010d; Brun et al., 2013). TLRs are known to play a crucial role 
in recognising and responding to luminal microbes and have been found on enteric 
neurons where they are vital to ENS development, regulation and function (Anitha et 
al., 2012; Brun et al., 2013). In the mouse, TLR-2,3,4 and 7 are expressed 
differentially within the ENS and mucosa of the small and large intestine (Barajon et 
al., 2009; Wang et al., 2010d; Anitha et al., 2012; Brun et al., 2013). Pertinent to our 
studies, TLR-4 is more highly expressed in the distal colonic submucosal plexus and 
mucosa of the mouse (Barajon et al., 2009; Wang et al., 2010d), while TLR-2 is 
more highly expressed proximally in the small intestinal ENS (Brun et al., 2013) and 
proximal colonic mucosa (Wang et al., 2010d). Therefore, the responses to 
probiotics which express ligands for TLR-2, such as EPS which may be produced by 
probiotics used in this thesis (Raftis et al., 2011; Fanning et al., 2012), could 
influence ENS function differentially in the small intestine compared with large 
intestine. Given that TLRs play such a key role in intestinal host-microbe 
communication, these segmental differences in the pattern of receptor expression, are 
also likely to influence the way in which particular populations of enteric neurones 
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respond to microbial components. In support of this, a recent study in mouse 
demonstrated that exposure of the distal colon to fecal slurry from the cecum and 
proximal colon induced a TLR-2 expression pattern similar to that normally 
observed in proximal intestinal regions (Wang et al., 2010d). Therefore, it is possible 
that differences in TLR expression patterns along the mouse intestine may reflect 
regional differences in the host microbiota.  
 From birth to old age, as we mature and grow our microbiome evolves with 
us  and may even contribute to senescence itself (Biagi et al., 2010; Rampelli et al., 
2013; Heintz and Mair, 2014). Age related neurodegeneration of the enteric nervous 
system has been well documented  and is believed to contribute significantly to 
senescence driven GI dysfunction, such as constipation, due to alterations in motility 
as well as nutrient, fluid and electrolyte transport (Camilleri et al., 2008). In rodent  
models of healthy aging an increase in alpha synuclein and a loss loss in cholinergic 
neurons has been observed in both the myenteric and submucosal plexus (Phillips et 
al., 2003, 2007, 2013). Other studies have found a decrease in nitric oxide 
innervation and production (Takahashi et al., 2000b). Given  that colonic 
constipation in elderly patients may be associated with a change in the expression of 
this neurotransmitter (Britton and McLaughlin, 2013), such a change in 
neurochemistry may underlie the altered GI function associated with aging. 
However, given that key neurotransmitters, such as noradrenaline, can influence the 
host microbiota (Lyte and Ernst, 1992), the possibility exists that an altered 
neurochemical profile of the ENS during aging may influence the microbiota.  
 Conversely, changes in microbially produced neuroactive metabolites (Table 
5.1) could also impact on ENS function. Several studies have demonstrated changes 
in the ratios of certain phyla such as Bacteroidetes and Firmicutes (Mariat et al., 
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2009; Rampelli et al., 2013) which, due to the their ability to produced important 
neuroactive metabolites, could significantly impact on ENS and secretomotor 
function. For example, a recent study reported an age-related reduction in the 
quantity of genes associated with SCFA production in fecal microbiota samples in 
humans (Rampelli et al., 2013). Such changes would be expected to influence 
epithelial fluid and electrolyte transport (Binder and Mehta, 1989; Vidyasagar et al., 
2005; Zeissig et al., 2007) and motility (Soret et al., 2010; Suply et al., 2012).  
 Equally, during early life and ENS development, an altered microbiota may 
dictate long-term changes in the structure of function or the ENS into adulthood 
(Collins et al., 2014).  
 
5.3 Influence of Secretory Activity on Host Microbiota 
 
 A major finding of this thesis was that forskolin-induced changes in Isc were 
significantly enhanced in the germ free colon, suggesting that the microbiota can 
influence cAMP-stimulated ion transport, and that its absence results in a hyper-
secretory response to forskolin. Moreover, this elevated forskolin response, along 
with bethanechol responses in GF mice, remained unchanged compared to 
conventional animals following acute exposure to either B.infantis 35624 or L. 
salivarius UCC118. Indeed forskolin responses to all probiotic treatments, including 
L. brevis DPC6108 supernatants remained unaltered throughout our studies. In 
contrast, a recent in-vitro study has demonstrated that both live pathogenic 
(E2348/69 and 86/24) and live non-pathogenic (C1, C28/2 and F18, Nissle 1917) E. 
coli strains attenuated forskolin induced changes in Isc (Ohland et al., 2012). While 
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these influences may be related to the gram-negative cell wall of these bacteria, a 
similar outcome has been observed for Lactobacillus rhamnosus 10893 (Heuvelin et 
al., 2010).  
 I propose that the heightened response to forskolin stimulation exhibited by 
germ free colon may be a protective mechanism, possibly to prevent pathogen 
invasion or adherence. A number of studies have previously demonstrated the ability 
of enteric pathogens to cause an attenuation of cAMP mediated responses  (Philpott 
et al., 1996; Hecht and Koutsouris, 1999; Li et al., 1999), and in one such study the 
effects were associated with increased bacterial adherence (Li et al., 1999). Of note, 
germ free colon mounted a similar Isc response to two commensal organisms relative 
to conventional tissues. However , I did not assess the responsiveness of germ free 
tissue to pathogenic bacteria. Moreover, in NHE3 and NHE8 deficient mice, which 
display compromised secretory function, an increase in bacterial translocation was 
observed (Laubitz et al., 2008). Conversely, a recent study determined that cAMP-
driven chloride secretion prevented the translocation of enteric pathogens across the 
intestinal epithelium  (Keely et al., 2012). In particular, lubiprostone-stimulated Isc 
was associated with a decrease in the translocation of both E. coli ATCC33694 and 
S. typhimurium ATCC700408, anaerobic and aerobic pathogens respectively (Keely 
et al., 2012). Elevated levels of cAMP in the absence of the host-microbiota could 
also reflect differences in the luminal levels of nutrients, neurotransmitters or 
atmospheric CO2 levels, normally produced by host commensals, which could all 
potentially modify intracellular cAMP (Gancedo, 2013). 
 Another mechanism by which germ free intestine adapts to colonisation, here 
again, potentially as a protective mechanism, is the production of mucous. 
Stimulation of germ free intestine with common bacterial products, such as 
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lipopolysaccharide or peptidoglycan, stimulates establishment of a functional 
mucous layer (Petersson et al., 2011). A characteristic feature of GF animals is a 
much thinner mucous layer, and fewer goblet cells compared to conventional 
mice/rats (Sharma et al., 1995). Therefore, the microbiota plays a role in establishing 
a functional mucous layer, which in turn decreases the translocation of bacteria 
across the epithelial barrier (Liong, 2008). Moreover, a balance exists between 
secretory activity and mucous formation, with CFTR deficient mice displaying an 
over accumulation of mucous (Garcia et al., 2009). Therefore, in germ free colon, in 
the absence of a functioning mucous layer, increased secretory function may act as a 
non selective protective mechanism.  
 Noteworthy, a recent study has demonstrated a role for epithelial ion 
transporters in microbial niche development (Engevik et al., 2013). Mice deficient 
for the apical anion exchanger, NHE3 (Figure 1.1), resulted in an increase in 
Bacteroidetes and decreased Firmicutes phyla both in the luminal and mucosa-
associated bacterial populations (Engevik et al., 2013). Importantly, this study also 
demonstrated that the growth and proliferation of a specific commensal microbe 
Bacteroidetes thetaiotaomicron ATCC 29741 in the terminal ileum was directly 
dependent on the level of luminal Na
+
. Keely et al., (2012) also determined that  
lubiprostone significantly influences the host microbiome, and observed alterations 
primarily within the Firmicutes and Bacteroides phyla, as well as an over 
representation of Lactobacillus in mouse faeces, indicating a direct effect of 
increased fluid secretion on microbial phylogeny. Together these results support the 
concept that ion transport may play an important and direct role in establishing a host 
microbial niche. 
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5.4  The Ussing Chamber as a Tool to Examine Host-
Microbe Interactions.  
 
Our increased understanding of the host microbiota as a complex organ, capable of 
shaping our development and maintaining our health, has led to a significant increase 
of microbiota-related research in a variety of disciplines, including physiology and 
neuroscience, which classically have not been associated with microbiology. While 
this is certainly exciting, a significant drawback is the lack of appropriate tools to 
tackle the enormous task of studying the impact of microbes on host physiology and 
function. Thus far, many of the most significant advances in our knowledge of host-
microbe interactions , to some degree, have focused on the host immune system 
(Sommer and Bäckhed, 2013). With regards to ENS function, recent ex-vivo studies 
have provided some exciting insights into the functional and developmental impact 
of these interactions, demonstrating robust, strain dependant effects on sensory 
neural signalling (Kunze et al., 2009b; Mao et al., 2013a) and intestinal motility 
(Wang et al., 2010b) Furthermore, studies have now begun to investigate the 
influence of the microbiota and probiotics on intestinal secretory function, perhaps 
due to the availability of techniques which facilitate the examination of host-microbe 
interactions in this context, for example Ussing chambers (Rösel and von 
Engelhardt, 1996; Lomasney and Hyland, 2013).  
 The Ussing chamber is a particularly useful tool to examine the influence of 
the microbiota on host physiology, especially with regard to intestinal ion transport 
and barrier function. Ussing chambers are considered the gold standard for the study 
of epithelial ion transport (Hamilton, 2011). Since Ussing’s original experiment 
examining the active transport properties of frog skin (Ussing and Zehran, 1951), 
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Ussing chambers have been continually used to better understand the molecular 
mechanisms underlying epithelial ion transport (Clarke, 2009a). Moreover, they have 
proven to be a useful tool in characterising the molecular mechanisms underlying 
pathogen-induced diarrheal diseases (Field, 2003). Perhaps the greatest advantage of 
Ussing Chambers is that they provide a relatively precise method of measuring 
electrical and transport parameters in polarised tissue (Clarke, 2009a), and can be 
adapted to examine ex-vivo tissue samples, including human biopsies (Larsen et al., 
2001). In addition, they facilitate examination of tissues, such as the upper GI tract 
and small intestine, which are normally difficult to study in-vivo (Wu et al., 2013). 
 Thus far, the majority of studies examining the ability of probiotics to 
influence intestinal ion transport have utilised intestinal epithelial cell lines, such as 
T-84 and Caco-2 cells(Lomasney and Hyland, 2013). While representing a good 
model for studying epithelial ion transport (Dharmsathaphorn and Madara, 1990), 
and a practical and cost effective one (Cencic and Langerholc, 2010), how 
physiologically relevant such in-vitro approaches are remains open for discussion. 
This is primarily due to structural differences between epithelial mono-layers grown 
for in-vitro studies, notably the absence of other critical cell types in mono-culture 
systems such as enteric neurones and mucosal immune cells. Ex vivo tissue analysis, 
such as that employed in our studies, may overcome some of the limitations 
associated with in vitro cell line-based experiments, particularly with respect to 
tissue architecture and presence of tissue-associated immune and neural elements.  
 Short-circuit current, or Isc, is a measurement of the sum of active ionic 
currents across an epithelium, and fluctuation in this current is considered an 
indicator that the net fluid transport in a tissue has changed (Clarke, 2009a). As a 
tool to screen probiotics for their effects on intestinal physiology, this technique 
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offers potential for determining the effects of putative probiotics to modify ion 
transport, thus giving an indication toward their application in particular disorders. 
However, Isc alone is a relatively simple measurement and does not reflect the 
complexity of the physiological system. Indeed, most results require a certain 
amount of interpretation, even with regard to the most basic nature of the response 
measured. For example, Isc alone does not provide definitive information on the 
direction of ion flux (Larsen, 2011). To truly understand the ionic nature of a 
response, further experimentation, such as ion substitution experiments and 
pharmacological inhibition of transporters are often required. Moreover, stripped 
tissue, lacking the myenteric plexus and associated muscle layers, while influencing 
tissue viability, may also result in an under estimation of Isc responses to certain 
stimulants, particularly those involving a myenteric reflex, such as GABA-
stimulated ion transport (Hardcastle and Hardcastle, 1996). The physical 
consequences of tissue preparation and dissection may also activate stretch receptors 
and subsequent release of compounds including eicosanoids, potentially confounding 
subsequent Isc responses.  
 In addition, although voltage clamping is the accepted method in many 
laboratories for studying active ion transport, given that probiotics can alter 
electroneutral ion exchange (Lomasney and Hyland, 2013), it is also important to 
measure passive transport processes. In this regard, measuring the potential 
difference (PD) may be of more benefit as in general, PD reflects the voltage 
gradient generated by the tissue, therefore, any alterations in ion channel or 
exchanger activity will be picked up. Moreover, measuring the flux of radioactive 
isotopes, such as 
22
Na
+
 , or ion substitution experiments can to help determine the 
nature of changes in PD (Rösel and von Engelhardt, 1996; Clarke, 2009). Used in 
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conjunction with Isc, these approaches may give more insight with regard to the 
influence of host-microbe interactions on intestinal fluid and electrolyte transport 
(Rösel and von Engelhardt, 1996). However, whether such techniques can be 
successfully applied in the presence of bacteria and their supernatants remains to be 
determined. 
 In addition to recording Isc, the Ussing chamber facilitates measurement of 
TER. TER has been used in numerous studies, including those presented in this 
thesis, to assess the impact of microbes on intestinal barrier integrity. However, TER 
represents an overall measure of the whole exposed area of the experimental 
chamber and consists of a para-cellular and a trans-cellular resistance in parallel. 
Therefore, while TER is useful when used in conjunction with Isc, as a direct 
indicator for the physical "tightness" of the para-cellular seal, it is not always a 
dependable indicator of actual para-cellular permeability and barrier function. 
Indeed, molecular differences in the TJ complexes responsible for para-cellular 
permeability to ions, solutes and water, do not always result in a change in TER and 
barrier integrity, though they may affect transport function (Schulzke et al., 2005). 
Equally, as discussed in Chapter 2, changes in TER do not always manifest as a 
change in either para-cellular permeability or TJ protein gene expression. .This can 
be due to the physiochemical properties and thus selective permeability of TJ 
proteins, which in some cases, may be altered without modifying the integrity of 
other protein complexes involved in cell-cell adhesion, such as desmosomes and 
apical junctional complexes (Suzuki, 2013). This is likely because TJ formation has 
to be dynamic to accommodate homeostatic intestinal epithelial cell turnover.  
 Furthermore, in ex-vivo intestinal tissue, TER and Isc may also be influenced 
by the resistance of underlying subepithelial tissues, such as blood vessels, muscle 
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and other non-epithelial tissue (Gitter et al., 1998). Indeed, in leaky epithelial tissues, 
such as those found in the intestine, the subepithelial resistance can exceed the TER 
(Fromm et al., 1985; Hemlin et al., 1988). Therefore, TER measurements in ex-vivo 
tissue, containing subepithelial structures, may not accurately represent changes in 
epithelial barrier permeability and transport alone.  
Moreover, intestinal enterocytes can adapt both morphologically and functionally to 
compensate for fluctuations in fluid and ion transport capacity, for example, 
following intestinal resection (Whang et al., 1996; Rubin et al., 1998; Gillingham et 
al., 2000; Healey et al., 2010). Therefore, physical changes such as the decreased 
mucosal thickness of GF mice described in Chapter 3, may represent an adaption to 
compensate for the increased secretory capacity in the absence of a functioning 
microbiota. Though morphological changes to the mucosa do not necessarily 
indicate a change in active function of ion transporters or indeed barrier permeability 
(Gillingham et al., 2000), nevertheless, these parameters were not accounted for and 
may have impacted on the results observed in this study. 
 A useful method to measure barrier permeability which is commonly used is 
para-cellular flux measurements. This involves the addition of labelled hydrophilic 
solutes, such as mannitol, horseradish peroxidase or dextran-FITC, to one reservoir 
and subsequent measurement of their flux across the tissue. These molecules do not 
typically undergo trans-cellular transport and in addition, molecules of different sizes 
can be used to further probe para-cellular permeability (Clarke, 2009)   
 Limitations in measuring TER may also be overcome by employing a 
conductance scanning method, which uses a horizontal Ussing Chamber and 
scanning electrodes to measure voltage drops both at the apical membrane of the 
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epithelial cells and at the TJ. (Gitter et al., 1997), or impedance spectroscopy (IS) 
(Günzel et al., 2012). Overall, when assessing the influence of the microbiota or 
putative probiotics on secretomotor or barrier function, multiple experimental 
approaches are warranted  to accurately draw conclusions with respect to the 
influence of the microbiota on host secretomotor and barrier function. 
5.5 Application of the Ussing Chamber a Tool to Ascribe 
Physiological Function to Bacterial Factors 
 
 Recent developments in our understanding of the influence of the  microbiota 
on host physiology and function has led to the advent of numerous new concepts, 
including Microbial Endocrinology. Microbial Endocrinology represents the 
intersection of host neurophysiology with the microbiome in which neuroendocrine-
bacterial interactions are a governing mechanism (Lyte, 2013) 
 
 In Chapter 4 I applied the Ussing chamber technique to determine whether 
the bioactive metabolite, and neurotransmitter, GABA, derived from Lactobacillus 
brevis DPC6108, could influence colonic physiology in the same way as 
commercially sourced GABA. A similar approach has been taken by others to draw 
conclusions about which bacterial components or metabolites influence enteric nerve 
activity (Kunze et al., 2009b; Mao et al., 2013b). For example, Tram-34 and 
clotrimazole, antagonists of IKCa channels, mimicked the effects of  Lactobacillus 
reuteri on sensory nerve activity (Kunze et al., 2009b)  Mao et al., 2013 took a 
similar approach, and demonstrated that polysaccharide A mirrored the effects of 
Bacteroides fragilis on sensory nerve activity. Both approaches have provided key 
functional insights of how commensal microbes can communicate with the ENS. 
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 Despite such studies, screening for, and identifying, probiotics with the 
potential to produce significant levels of  neuroactive metabolites in-vivo is 
challenging. However, Ussing chambers at least offer the opportunity to determine 
whether putative neuroactive-producing probiotcs exert similar effects on intestinal 
physiology compared to endogenous neurotransmitters.  
 The growing availability of genome sequences as well as the corresponding 
molecular tools allows us to pursue more knowledge-driven approaches. The 
growing availability of genome sequences and annotations provides information for 
the encoded gene functions, including their metabolic and biosynthetic pathways, 
stress responses, cell-wall associated proteins, and potential host interaction factors. 
Such methods may be applied in an effort to identify potential probiotics with the 
ability to produce known metabolites. Meta-genomics, for example, is the study of 
collective genomes within an eco-system. Large scale meta-genomic approaches 
such as shot-gun sequencing or pyrosequencing in combination with bioinformatics 
can be applied to assemble genetic based infomation on functional communities 
within a microbiome (Fraher et al., 2012). Such approaches could be used to 
examine the expression of genes associated with the production of bacterial 
metabolites with known, or hypothesised, effects on intestinal physiology. Another 
approach, metabolomics,  may be used to identify particular metabolites, or 
metabolite foot prints, associated with particular microbes or more complex 
populations by examining the metabolite mass:charge ratios, which can then be 
compared to pre-existing data bases (Reigstad and Kashyap 2013). This approach 
has already proven useful in identifying commensal-derived metabolites which 
influence intestinal transit in mice (Kashyap et al., 2013a). This study determined 
that diet influenced changes in the microbiome, and microbial metabolite production, 
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thereby altering altered GI transit time. This effect was accompanied  by lower levels 
of the serotonin metabolite, 5-HIAA (Kashyap et al., 2013a).  
 Finally, in the interest of fully elucidating host-microbe relationships in the 
intestine, it is important to also understand host mucosal responses at the genomic 
level. One study has already successfully examined host transcriptomal responses in 
human intestinal tissue to three specific Lactobacillus strains (van Baarlen et al., 
2011). This study not only observed differential induction of gene-regulatory 
pathways by each probiotic, but intriguingly it also found that host-transcriptomal 
response profiles to each probiotic strain were notably comparable to the response 
profiles observed for specific drugs and bioactive molecules. Indeed, several gene-
regulatory pathways identified were thought to be involved in water retention and 
ion homeostasis, including angiogenin and oxytocin (van Baarlen et al., 2011) 
Therefore, studies using this approach, in conjunction with tools to examine 
functional changes in physiology, such as the Ussing Chamber, will likely provide 
the best means to ascribing and understanding the physiological impact of probiotics 
and their bioactives. 
 
5.6 Utility of Germ-Free Animals as a Tool to Investigate 
Host-Microbe Interactions 
 
 Germ free animals offer a unique opportunity to investigate host-microbe 
interactions. With regard to studying individual bacterial strains,  mono-colonisation 
studies have provided some unique insights as to how individual microbes can 
influence intestinal health and development (Hooper et al., 2001). Some of the first 
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evidence demonstrating a role for specific bacterial strains in modulating MMC of 
the intestine took such a mono-colonisation approach (Husebye et al., 2001) Mono-
colonisation with L. acidophilus A10 or colonisation in combination with B.bifidum 
B11, Clostridium tabificum VP 04 promoted MMC activity, while E. coli X7 was 
without effect and Micrococcus luteus suppressed MMC activity. These experiments 
provided some of the first evidence that specific bacterial strains may modulate 
intestinal physiology. In addition, the activity of bacteria depends very much on the 
host, and may be influenced by in-situ microbial populations (Sonnenburg et al., 
2006; Goodman et al., 2009). Such microbe-microbe interactions are difficult to 
predict using ex-vivo or indeed in-vitro approaches. Studies using GF mice to look at 
specific combinations of commensal microbes can help further our understanding of 
the complex interactions between commensals and the host in vivo, in an integrative 
system.  
 However, GF animals are not without their limitations, in particular the 
influence of species specific development in the host microbiota. To address this 
limitation, a novel approach has been developed, that of humanised mouse models of 
GI microbiota. These have already been proven very useful for predicting the impact 
of diet on the intestinal microbiome (Faith et al., 2011). An investigation of species 
abundance and microbial gene expression in a model community of ten sequenced 
human gut-derived bacteria introduced into GF mice, examined responses to 
randomised perturbations of four specific dietary components. This allowed the 
subsequent development of a statistical algorithm capable of predicting over 60% of 
the variation in microbial species abundance in response to precise dietary changes 
(Faith et al., 2011). In addition, a more recent study employing humanised mice was 
able to demonstrate an inextricable link between intestinal transit, diet as well as the 
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host-microbiota and its metabolites  and they could point to 5-HT as an important 
mediator of these interactions (Kashyap et al., 2013). Collectively, these studies 
provide strong evidence that such an approach could be employed with great effect 
to predict and understand the effects of probiotic bioactives such as GABA, on the 
intestinal microbiome and GI function. 
 Indeed, with regard to the use of humanised mice in the context of studying 
disease, this approach has already helped characterise the role of the microbiota in 
obesity (Turnbaugh et al., 2009). However, humanised mice may be particularly 
useful for unravelling the complex relationships between the host and its microbiota 
in disorders such as IBS, which display diverse symptom heterogeneity, including 
polarised alterations in fluid and electrolyte transport, associated with distinct 
microbial populations (Parkes et al., 2012). Mice containing specific microbial 
"phenotypes" of disease could be used not only to understand disease pathology, but 
indeed how to approach treatment, for example, which probiotic to use and why. 
 One further limitation of GF animals however is that they exhibit altered 
physiology and immune function in adulthood (Smith et al., 2007). Though 
colonisation reverses many of the effects, the timing of colonisation on GI function 
is also critical, as only colonisation early in life can completely reverse many of the 
differences in immune function observed in GF animals (Smith et al., 2007). A 
recent study, however, has provided an interesting and innovative approach to the 
use of GF mice to study host-microbe interactions, utilising reversible colonisation 
(Hapfelmeier et al., 2010). The reversible colonisation was carried out using an m-
DAP auxotrophic Δasd mutant E. coli K-12 strain JM83 derivative χ6096, with a 
requirement for essential nutrients that could not be satisfied by any mammalian host 
metabolites. Therefore, animals recolonised with these mutants returned to their GF 
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status 72 hours after the last exposure (Hapfelmeier et al., 2010). Importantly, GF 
animals which had been transiently mono-colonised, and examined 14 days after the 
last dose of E. coli K-12 JM83, demonstrated similar immunological changes to 
permanently recolonised mice. More studies are now required to determine whether 
such an approach can fully reverse all the immune alterations observed in GF mice, 
allowing for subsequent and more physiologically relevant GF studies.  
 Nevertheless, despite changes in GI physiology, this is likely an adaption to 
the absence of host-microbes and certain functional aspects do remain unchanged in 
GF mice. For example, although GF mice display an enlarged caecum and increased 
fluid content, ex-vivo studies demonstrated that the absorptive capacity of the tissue 
remains almost unchanged (Gordon and Pesti, 1971; Grover and Kashyap, 2014). 
Our studies promote this concept and emphasise that colonic secretomotor function 
is predominantly maintained in GF mouse making it a useful model for future studies 
examining the influence of host-microbe interactions on intestinal fluid and 
electrolyte transport. 
 
5.7 Therapeutic Application of Probiotics in Disorders 
Associated with Altered Secretory Function.  
 
 The efficacy of probiotics for the treatment of GI disorders has long been 
under debate, and a growing number of studies  are now beginning to demonstrate 
their therapeutic potential (Lee and Bak, 2011). However, identifying specific 
probiotics for the treatment of a particular disorder remains uncertain at best, and 
reliable predictions may be hindered by the lack of mechanistic characterisation of 
putative probiotics. Pre-clinical findings indicate that the selection of strain, or strain 
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combinations, as well as disease pathology, is of the utmost importance when 
considering probiotics as a therapeutic approach to treat specific GI disorders. 
 Both B. infantis 35624 and L. salivarius UCC 118, in both  preclinical and 
clinical studies, display differential effects on particular symptoms and disease 
severity (McCarthy et al., 2003; O’Mahony et al., 2005; Whorwell et al., 2006). The 
differential effects of these two organisms on host physiology is further supported by 
our current work in the context of secretomotor function. Therefore, future 
therapeutic application of probiotics should consider the influence of strain when 
selecting treatment options. In past years, many clinical trials testing the efficacy of 
probiotics in GI disorders have failed to specify the exact strain used, thus making it 
more difficult to replicate any positive therapeutic effects described(Ritchie et al., 
2012). For example, two separate clinical trials using strains of Lactobacillus 
acidophilus display differential clinical efficacy for the treatment of Travellers 
diarrhea (TD) (Boulloche et al., 1994; Katelaris et al., 1995). Katelaris et al., (1995) 
did not specify the specific strain of Lactobacillus acidophilus tested, therefore, 
while the discrepancy between studies is likely strain related, a number of other 
confounding factors account for the discrepancy between these studies in the context 
of TD. Consideration of disease aetiology is critical to the design of most in 
considering therapeutic strategies and probiotic therapy is no exception to this rule. 
Indeed, a recent meta-analysis demonstrated no overall efficacy of probiotic 
treatment for TD (Ritchie and Romanuk, 2012). Therefore, despite the similar 
functional consequences of infections with certain enteric pathogens (i.e. acute 
diarrhoea), it is important that future studies provide specific information on the 
original causative agents of disease, which may determine susceptibility to treatment 
with particular probiotic strains or combinations.  
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 In the context of anti-biotic associated diarrhea (AAD), which occurs shortly 
after the administration of antibiotics, and is believed to be due to a loss in host-
microbial populations and diversity, fermented milk containing a multi-strain 
probiotic combination, demonstrated an 80% prevention rate (Wenus et al., 2008). 
Therefore, certain disorders associated with a significant overall loss in host-
microbiota, may be more amenable to multi-strain probiotic therapy aimed at 
restoring the host microbiota rather than targeting specific pathogen-induced changes 
in host function. This is further supported by the recent success of fecal microbiota 
transplantation for the treatment of diarrhea caused by Clostridium difficile (CDAD) 
(Shankar et al., 2014). Certain single strains such as Lactobacillus rhamnosus GG 
ATCC 53103 (Floch et al., 2011) and L. plantarum 299v (Wullt et al., 2003) have 
shown efficacy in the treatment of and prevention of CDAD, however the choice 
between single and multi-strain use remains controversial (Chapman et al., 2011).  
The success of such treatment is believed to be due to a restoration in host-microbe 
population and diversity rather than specific anti-microbial activity, the restoration of 
which is also likely to influence secretomotor pathways.   
 On the other hand, the ability of certain single strains to provide global relief 
to conditions such as IBS, which display remarkable symptom heterogeneity, 
particularly with regard to fluid and electrolyte transport, would suggest that certain 
strains may be better equipped to act as pivotal regulators of intestinal function 
(Whorwell et al., 2006; Ducrotté et al., 2012). For example, the mechanism by which 
B. infantis 35624 exerts such beneficial effects in IBS likely occurs through 
modulation of both intestinal and systemic immune function (Konieczna et al., 2012) 
Groeger et al., 2013), indirect effects of which may also beneficially influence host 
physiology. Such multi-facetted strains may represent an opportunity to gain insight 
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into a plethora of beneficial host-microbe interactions relatively easily by focusing 
extensively on one strain. However, such an approach is unlikely to provide a true 
understanding of the role these microbes play in health and disease. 
5.8 Conclusions and future perspectives 
 
 It is clear that there is much to learn with respect to pin pointing the precise 
mechanisms which underlie host-microbe communication, particularly with respect 
to the effects of microbes on host GI physiology. However, significant strides 
forward have been made in the last decade and have opened up countless avenues of 
novel approaches to research which will undoubtedly shed further light on the true 
extent and influence of these interactions. Future research into novel probiotics will 
likely be focussed on finding appropriate species, or mix of species, which can re-
establish a certain microbial niche, depending on the  individual. The emergence of 
fecal microbiota transplantation for the successful treatment of reoccurring 
Clostridium difficile induced diarrhoea, as well as inflammatory bowel diseases is 
also promising for host-microbe targeted therapies. However, short and long-term 
health consequences of this type of treatment remain relatively unknown, and given 
the importance of the host microbiota for maintaining long-term health, it is still 
necessary to elucidate the precise functional roles that specific microbes play in 
developing and maintaining host microbial communities, and subsequently their 
influence on the maintenance and protection of host health and physiological 
function. It is only by understanding these interactions completely that the full 
potential of probiotic and microbial based therapeutics for the treatment of disorder 
in the gut and indeed beyond can be realised. To aid in the screening and 
identification of functionally relevant probiotics and effecter molecules, future 
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studies should employ multi-omics approaches in combination with robust 
physiological experimentation ex-vivo. GF studies should be used to aid in the 
understanding of applying these identified microbes in-vivo. Mice containing 
humanised microbiota will help to further improve the translational value of these 
pre-clinical studies. 
 In conclusion, this thesis has furthered our understanding of the functional 
impact of host-microbe interactions on colonic secretomotor function. It has not only 
provided insight into the strain specific mechanisms through which individual 
probiotics can influence fluid and electrolyte transport, but has provided an 
important step in understanding the role of the host-microbiota on intestinal fluid and 
electrolyte transport.  
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Appendix A 
List of Abbreviations 
 
5-HT Serotonin 
ACh Acetylcholine : 
AC Adenylyl Cyclase 
AHP: Afterhyperpolarising potential 
ATP: Adenosine triphosphate 
BCh Bethanechol: 
CaCC Calcium Activated Chloride Channel 
cAMP: Cyclic Adenosine Monophosphate 
CalB: Calbindin 
CalR: Calretnin 
CFTR: Cystic Fibrosis Transmembrane Conductance Regulator 
CGRP: Calcitionin Gene Related Peptide 
CM: Conditioned Medium 
CT: Cholera Toxin 
DAG: Diacylglycerol 
DIDS: 4,4'-diisothiocyano-2,2'-stilbene disulphonic acid 
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DRA Down-regulated in Adenoma 
EHEC: enterohaemorragic Escherichia coli 
EIEC: Enteroinvasive Escherichia coli 
ENaC Epithelial Sodium Channel: 
ENS: Enteric Nervous System 
EPEC: Entero-pathogenic Escherichia coli 
ERK: Extracellular Signal-Regulated Kinases 
FSK Forskolin: 
GABA γ-amino butyric acid: 
GF: Germ Free 
IFN: Interferon 
IL: Interleukin 
IP3: Inositol 1,4,5 triphosphate 
IP4:Inositol 3,4,5,6-tetrakisphosphate 
IPAN Intrinsic Primary Afferent Neuron 
Isc Short Circuit Current: 
mAChR: Muscarinic Acetylcholine Receptor  
nAChR: Nicotinic Acetylcholine Receptor 
MAPK  Mitogen-activated protein kinase 
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NKCC1: Sodium Potassium Chloride Symporter 
NPY: Neuropeptide Y: 
NHE: Sodium Hydrogen Exchanger 
NOS: Nitric Oxide Synthase 
KCa3.1 Small Conductance K
+
 channel 
KV7.1 Voltage Gated K
+
 channels 
MMC: Migrating Motor Complexes 
PAT-1: Putative Anion Transporter-1  
PGE2: Prostaglandin E2 
PI3K: Phosphatidyl-inositol 3 kinase 
PIP2: Phosphatidylinositol 4-5 bisphosphate 
PKA: Protein Kinase A 
PKC: Phospholipase C 
SCFA : Short Chain Fatty Acid 
SGLT1:Sodium glucose transporter 1  
SOM:Somatostatin 
SP: Substance P 
SPF: Specific Pathogen Free 
SSTR: Somatostatin Receptor 
  197 
T3SS: Type 3 Secretion System 
TER Transepithelial Electrical Resistance 
TH: Tyrosine Hydroxylase 
TJ: Tight Junction 
TLR: Toll-Like Receptor 
TNF: Tumor Necrosis Factor 
TRPV-1: Transient Receptor Potential Cation Channel Subfamily V member 1 
TTX: Tetrodotoxin 
VIP: Vasoactive Intestinal Peptide 
VGSC: Voltage Gated Sodium Channels 
Y: NPY receptor 
ZO: Zonula occludens 
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Appendix B: 
The Isc response to a commensal 
Bifidobacterium was sustained in 
the presence of loperamide 
 
Introduction 
 
 Loperamide (4-[4-chlorophenyl]-4-hydroxy-N-dimethyl-alpha, alpha-
diphenyl-1-piperidine-butanamide hydrochloride) is a phenylpiperidine derivative, a 
potent μ-opioid receptor (μ-OR) agonist and the most common over-the-counter 
medication approved for the control of diarrheal symptoms in numerous GI 
disorders, including travellers' diarrhoea and irritable bowel syndrome (Baker, 2007; 
Hanauer, 2008). Electrophysiological recordings in enteric neurons have 
demonstrated that opiates and opioid peptides mediate their effects through 
suppression of neuronal excitability (Wood and Galligan, 2004). Early studies in-
vivo demonstrated  the ability of the μ-OR specific agonist, DAMGO, to 
significantly increase intestinal absorption of an isotonic solution following 
intracerebroventricular injection (Jiang et al., 1990). In contrast, a study carried out 
by the same group, in isolated jejunal segments mounted in Ussing Chamber, 
demonstrated a local effect, observing a decrease in Isc following serosal addition of 
DAMGO (Sheldon et al., 1990b). Furthermore, this effect appeared to be neurally 
mediated as tissues stripped of the enteric neural plexi did not not display such an 
effect (Sheldon et al., 1990b). This has been supported recently by immuno-
histochemical studies  which demonstrated μ-OR expression on enteric nerve 
endings in the myenteric plexus as well as the submucosal plexus (Pol et al., 2001).  
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 Therefore I sought to determine whether a commensal Bifidibactetrium could 
influence Isc in the presence of loperamide. 
Materials and Methods 
Materials 
 
Bethanechol and forskolin were obtained from Sigma  Aldrich (Tallaght, Dublin) 
while loperamide was obtained from Tocris (Bristol, United Kingdom).  
Methods 
 
Mucosal-submucosal preparations of descending colon from male Swiss Webster 
mice (25-35g) were mounted in Ussing chambers, voltage clamped at 0mV and were 
super fused with Krebs buffer solution bubbled with carbogen (95% O2, 5% CO2) 
and maintained at 37°C. Changes in short circuit current (Isc) were continuously 
recorded using DataTrax software. Bacteria were added to the mucosal compartment 
at 1x10
9
 CFU/ml in Krebs). Loperamide (0.1-0.5μg/ml in DMSO), bethanechol 
(BCh; 100µM in dH2O) and forskolin (FSK; 10µM), were added serosally.  
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Results  
 
Figure B1. (A) Serosal addition of loperamide caused a significant increase in Isc 
compared to vehicle. The increase was independent of dose. (B) In the presence of 
loperamide, a Bifidobacterium elicited an increase in Isc. (C) The combination of 
loperamide and a Bifidobacterium significantly decreased BCh and (D) forskolin-
induced Isc. n=5-6, *P<0.05,**P<0.01. 
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Appendix C 
Supplementary Material for 
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Materials 
 
 All drugs were obtained from Sigma-Aldrich Ltd. (Ireland) unless otherwise 
stated. The following compounds were used, with the final concentration and diluent 
in parenthesis, amiloride (100µM dissolved in dH2O), bethanechol (100µM; 
dissolved in dH2O), forskolin (10µM dissolved in DMSO), furosemide (100µM 
dissolved in DMSO), Chromanol 293b (100µM dissolved in DMSO) tetrodotoxin 
(300nM dissolved in sodium citrate buffer), BPIPP (10µM dissolved in 
DMSO),veratridine (30µM; dissolved in 70% ethanol) Bordetella pertussis toxin 
Wortmannin (10µM dissolved in DMSO), PD98059 (10µM dissolved in DMSO)   
Krebs buffer was prepared as follows, 1.2mM NaH2PO4 , 117mM NaCl, 4.8mM KCl, 
1.2mM MgCl2, 25mM NaHCO3, 11mM CaCl2 and 10mM glucose. Chloride-free 
buffer consisted of 116mM NaNO3, 5.4mM KNO3, 1.2mM NaH2PO4, 2.5mM 
Ca(NO3)2, 1.2mM Mg(NO3)2, 22mM NaHCO3 and 11.2mM glucose. Calcium-free 
buffer consisted of 1.2mM NaH2PO4 , 117mM NaCl, 4.8mM KCl, 1.2mM MgCl2, 
25mM NaHCO3, and 10mM glucose. B. infantis 35624 and L. salivarius UCC 118 
were from Alimentary Health Ltd. (Cork, Ireland). 
Results 
 
 To further determine the mechanisms involved in the modulation of ion 
transport by B. infantis 35624 and L. salivarius UCC 118 observed  in Chapter 2, 
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additional pharmacological manipulation and ion substitution was carried out. 
Neither, Chromanol 293b (KV7.1 blocker) or low Ca
2+
 Krebs buffer significantly 
affected the baseline response to either probiotic. Similarly, Bordetella pertussis (Gαi 
- protein coupled receptor signalling inhibition) Wortmannin (PI3K inhibition), 
PD98059 (MAPK inhibition) had no effect, suggesting intra-cellular signalling 
mechanisms may not be involved. Importantly, the cGMP inhibitor, BPIPP did not 
block the response to either probiotic, indicating that this pathway did not mediate 
the change in baseline Isc (Table C1).  
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Table C1 Pharmacological Manipulations and Ion Substitution Experiments 
 
Pharacological 
Manipulation
B.infantis 
35624
L. salivarius 
UCC 118
Bethanechol 
(following 
B.infantis 
35624)
Bethanechol 
(following 
L.salivarius
UCC118)
Forskolin 
(following 
B.infantis 
35624)
Forskolin 
(following 
L.salivarius
UCC118)
8-Bromo 
cGMP 
Amiloride 20.74±5.18 
(n=6)
25.52±3.32(n
=5)
22.50±39.4 
(n=6)
24.4±8.6 
(n=5)
188.6±26.
4 (n=5)
163.3±49.7 
(n=5)
Vehicle  
(dH2O)
26.07±1.31  
(n=10)
27.47±4.47 
(n=5)
39.44±8.82 
(n=10)
16.71±5.184
(n=5)
185.7±33.
6 (n=5)
149.2±50.9 
(n=5)
Furosemide 25.24±3.71  
(n=6)
28.81±0.71 
(n=6)
8.6±2.6*   
(n=6)
21.5±6.2 
(n=5)
108.4±19.
55 (n=5) 
P=0.11
192.3±46.9 
(n=5)
Vehicle 
(DMSO)
21.77±7.94  
(n=7)
23.12±3.04 
(n=6)
61.98±21.0
9 (n=6)
29.4±0.6 
(n=5)
228.7±58.
63(n=5)
261.3±28.4 
(n=5)
Chromanol 
293b 
20.11±3.32 
(n=15)
27.66±5.51 
(n=9)   
P=0.19
47.30±17.6 
(n=15) 
P=0.18
23.7±5.4 
(n=9)
138.4±14.
1 
(n=15)**
142.0±26.0 
(n=15) 
P=0.40
Vehicle 
(DMSO)
27.66±5.51 
(n=10)
40.39±7.62(n
=9)
19.86±9.2 
(n=10)
19.6±3.2 
(n=9)
236.7±27.
91 (n=10)
181.9±37.31 
(n=10)
Wortmannin 11.67±3.2 
(n=4)
36.88±20.4 
(n=4)
240.6±90.
64 (n=5)
Vehicle 
(DMSO)
16.45±4.2 
(n=4)
29.82±16.4 
(n=5)
245.6±12.
96 (n=4)
PD98059 17.91±4.8 
(n=5)
23.41±11.9
0 (n=4)
338.0±19.
51 
(n=5)**
Vehicle 
(DMSO)
16.47±4.2 
(n=4)
32.52±8.7 
(n=5)
245.6±12.
96 (n=4)
BPIPP 33.62±6.17 
(n=6)
34.06±10.5
6 (n=6) 
P=0.14
171.4±68.
98 (n=6)
16.49±8.
9 (n=6)
Vehicle 
(DMSO)
26.08±3.0 
(n=6)
70.0±18.11 
(n=6)
134.7±68.
98 (n=6)
23.41±8.
4 (n=6)
Bordetella 
pertussis  toxin
10.91±3.2 
(n=6)
16.45±5.91 
(n=6)
19.14±5.88 
(n=5)
16.84±7.1 
(n=6)
216.5±20.
41(n=6)
198.5±35.16 
(n=5)
Vehicle   
(dH2O)
9.41±2.0 
(n=6)
20.08±6.642 
(n=5)
46.63±11.0 
(n=6)
25.92±15.57
(n=6)
202.1±31.
5 (n=6)
175.7±36.64 
(n=5)
Chloride-free 
Krebs
17.30±3.24  
(n=6)
52.70±12.00 
*(n=6)
30.52±3.5 
(n=5)
25.72±3.8 
(n=5)
163±19.24 
(n=5)
172.2±26.4 
(n=5)
Krebs 18.91±4.21  
(n=6)
22.53±7.45 
(n=6)
45.12±8.3 
(n=5)
41.52±6.3 
(n=5)
300.34±15
.2 (n=5)*
280±21.14 
(n=5)*
Calcium-free 
Krebs
21.12±3.13 
(n=5)
38.28±8.62 
(n=4)
30.09±6.3 
(n=5)
20.91±4.9 
(n=5)*
157.7±39.
6 (n=5)
185.7±23.09 
(n=5)
Normal Krebs 21.77±7.94 
(n=6)
29.57±4.727 
(n=5)
61.9±21.1 
(n=5)
37.12±6.2  
(n=5)
228.7±58.
6 (n=5)
240.5±48.9 
(n=5)
Baseline Responses (µA.cm
-2
) to:
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Figure D1. Effect of B.infantis 35624 or L. salivarius UCC118 on the transepithelial 
resistance (TER) exhibited by GF colon following acute addition to Ussing 
chambers.  Neither organism significantly influenced TER after 30 mins. n=7-8. 
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Results 
 
 The GABAA agonist, muscimol, and positive allosteric modulation of 
GABAAα1, CDP, induces a decrease in baseline Isc implying a role for this receptor, 
and receptor subtype,  in regulating  colonic secretomotor function. 
 
Figure E1. Baseline Isc response to Muscimol, CDP and Baclofen: Both muscimol 
(A) and CDP (B) caused a decrease in Isc with CDP inducing a significant response 
at 100μm (Data for 0.1μM and 1μM not shown (N=4).(C) The GABAB agonist 
Baclofen had no significant effect on baseline Isc (N=6) **P<0.005.  
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Figure E2. Cholinergic Responses following Muscimol and CDP: (A) GABAA 
agonist Muscimol (100μM) induced a pattern of decrease in cholinergic induced 
responses similar to that of exogenous GABA (N=6) *P<0.05, **P<0.005. (B) CDP 
(0.1-100μM), a positive modulator of GABAAα1 receptors did not mimic this effect 
(N=3). Data for 0.1μM and 1μM not shown (N=4). 
 
